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general IntroduCtIon
1. Influence of infant growth on adult health
1.1	 Hypotheses
There are several epidemiological studies showing associations between low birth 
weight, and the risk for obesity, type 2 diabetes and cardiovascular diseases in later 
life.(1-3) Several hypotheses have been postulated over time to explain the underlying 
mechanism. 
Fetal origin hypothesis
Barker et al. were the first to formulate a hypothesis in the early 1990s, based on the 
inverse association between birth weight and adult disease. They suggested that events 
during pregnancy leading to fetal malnutrition could result in permanent endocrine and 
metabolic changes, so-called re-programming of the fetus (Figure 1). At first the fetus 
would benefit from these adaptations, as it would remain alive during fetal life, but this 
re-programming increases the risk for adult diseases in later life.(4)
Low birth weight  
Placental, Maternal, Fetal, 
Environmental Factors
Low intrauterine nutrient supply
Re-Programming
Development of adult disease
figure 1. Representation of the fetal origins hypothesis. Adapted from Barker et al.(3)
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Fetal insulin hypothesis
This hypothesis was generated in 1999 and states that the inverse association between 
birth weight and adult insulin resistance is in principal genetically mediated (Figure 2).(5) 
Fetal genes leading to insulin resistance could result in low fetal growth and to type 2 
diabetes in later life.
Growth acceleration hypothesis
Singhal and Lucas postulated in 2004 that not low birth weight per se, but growth 
acceleration during childhood is responsible for the increased risk for adult diseases 
(Figure 3).(6, 7)
 
+ 
_ 
Maternal glucose concentration
(third trimester)
Glucose sensing by 
fetal pancreas
Insulin secretion by
fetal pancreas
Fetal genetics
Insulin mediated 
fetal growth
Birth weight
Fetal insulin 
resistance
Insulin resistance 
in later life
figure 2. Simplified representation of the fetal insulin hypothesis. Adapted from Hattersley et al.(5)
+ 
Fetal growth restriction
Postnatal growth acceleration
Relative to their
growth potential
Nutrient-enriched diets
Development of adult disease
figure 3. Representation of the growth acceleration hypothesis. Adapted from Singhal et al.(7)
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Fat accumulation hypothesis
In the PROGRAM-study, started in 2002, our research group showed that not growth 
acceleration as such but fat accumulation during childhood was associated with deter-
minants of adult diseases, such as a higher body fat percentage, increased serum levels 
of total cholesterol, triglycerides, low density lipoprotein cholesterol (LDL) and higher 
systolic and diastolic blood pressure in early adulthood.(8) This study also showed that 
the fi rst 3 months of life are a critical window in which increased weight for length 
should be avoided to reduce the risk for obesity, type 2 diabetes and cardiovascular 
diseases in later life (Figure 4).(8-10) 
1.2	Non-alcoholic	fatty	liver	disease
Non-alcoholic fatty liver disease (NAFLD) is a condition that resembles that of alcohol 
induced liver injury, but occurs in patients who do not abuse alcohol.(11) NAFLD has the 
potential to progress to steatohepatitis, fi brosis, cirrhosis, and hepatocellular carcinoma.
(11) Furthermore, NAFLD is considered as the hepatic manifestation of the metabolic 
syndrome, and has been associated with several risk factors for cardiovascular disease 
(CVD) and type 2 diabetes, such as adverse lipid profi le and body composition, and insu-
lin resistance.(11, 12) Given the strong association of NAFLD with obesity, the prevalence 
of NAFLD is rapidly increasing.(13) Some studies demonstrated an association between 
small size at birth and NAFLD.(14) Given that NAFLD is considered the hepatic metabolic 
syndrome,(15) it might well be that the previously found association between small size 
at birth and NAFLD can also be ascribed to accelerated weight gain in early life.
+ 
Fetal growth restriction
Postnatal growth acceleration
Relative to their
growth potential
Nutrient-enriched diets
Development of adult disease
Fat accumulation 
during childhood
figure 4. Fat accumulation model. Adapted from Leunissen et al.(8)
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Preterms
Nowadays, 8-10% of all newborns in developed countries is born preterm and due to 
advances in neonatal intensive care, most of them survive and reach adulthood.(16) 
Preterm infants are frequently exposed to fetal growth restriction, glucocorticoid treat-
ment and stressful events, which may contribute to the development of organ dysfunc-
tion and adverse vascular outcome later in life. In recent years, long-term outcomes for 
young adults born preterm were found to be less favorable than for those born term. 
Adults born preterm are at increased risk for developing cardiovascular diseases (CVD)
(17-19), and have increased cardiovascular mortality.(20, 21) Because many preterm 
infants are prone for accelerated weight gain after an initial period of weight loss (22), 
it might be that adults born preterm with accelerated weight gain after term age are at 
increased risk for NAFLD compared with those without accelerated weight gain during 
infancy. Like in term infants, alterations in growth during this highly dynamic develop-
mental time window might have programming effects on risks for non-alcoholic fatty 
liver disease.
1.2.1 Fatty liver index (FLI)
The FLI is a measure to predict hepatic steatosis in the general population (23), and 
is determined using an algorithm based on BMI, waist circumference, triglycerides, 
and gamma-glutamyltransferase (γ-GT), with an accuracy of 0.84 (95%CI 0.81-0.87) in 
detecting fatty liver.(24, 25) The FLI has been widely used in NAFLD research, and has 
recently been validated for identifying NAFLD in a large population-based study.(24-28) 
2. early life determinants of obesity, type 2 diabetes and cardiovascular disease
Over the last 20 years, the prevalence of overweight in Dutch children aged 4 to 12 
years, increased from 7% to 11%.(29) Childhood obesity is associated with short-term 
morbidity, such as asthma and psychological problems, and with an increased risk for 
obesity, chronic morbidity and mortality in adulthood.(30-32) 
2.1	Accelerated	catch-up	in	weight	for	length
Accelerated catch-up in weight for length in the first months of life is associated with 
higher risk for obesity, type 2 diabetes and cardiovascular diseases in adulthood. Besides 
this, it is associated with a higher fat mass percentage and a worse cardiovascular and 
metabolic profile in young adults.(8, 9, 33, 34) Also associations between weight gain in 
early life and childhood obesity have been described.(35-37) It is, however, unclear how 
accelerated catch-up in weight in the first months of life determines body composition 
in early life.
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2.2	Infant	body	composition
There is increasing evidence that fat mass in early life influences fat mass in later life. 
Adiposity at the age of 6 months of life is a major risk factor for adult diseases, because 
it tracks into adulthood.(38-40) Unfortunately there were very limited data on the devel-
opment of the body composition in the first 6 months of life. It is crucial to accurately 
measure body composition in these months and to generate reference data for infant 
boys and girls. Differentiation in gender is important because gender differences in body 
composition might be present due to different sex hormones levels in boys and girls in 
early life. It was known that newborn girls have higher fat mass and lower fat free mass 
compared to newborn boys, but there were very limited data on gender differences later 
in infancy.(41-43) 
Relationships between weight gain and later health was mainly studied retrospectively 
or during follow-up of intervention trials.(9, 10) Due to the lack of available methods for 
infants below 6 months of age, most studies focused on weight, length, and skinfolds 
as a proxy for adiposity in infancy, instead of accurately measured body composition.
(44, 45) 
2.2.1 Methods for measuring infant body composition
Neonatal body composition is traditionally evaluated by measuring birth weight and 
birth length and then calculating the ponderal index, but these measures do not reflect 
true body composition. 
Peapod
Nowadays, whole-body composition 
can be assessed by air-displacement 
plethysmography (Peapod, Infant 
Body Composition System, COSMED)
(Figure 5). This ADP system assesses 
fat mass and fat free mass by direct 
measurements of body volume and 
body mass, based on the whole-body 
densitometric principle. Details of the 
principle and operating procedure of 
the Peapod have been described.(46, 
47). These studies have shown that this 
method is valid for measurement of 
body composition in neonates.(43-44) 
http://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=20748&vid=5&download=1[29-01-2016 8:31:35]
figure 5. A picture of the Peapod
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Ultrasound
Not only the total amount of fat, but also the location of fat is important. Increased 
visceral fat is a major risk factor for future cardiovascular diseases (CVD).(48) In obese 
children, greater abdominal adipose tissue is associated with an unfavorable metabolic 
profile.(49) Ultrasound (US) is a non-invasive method to estimate abdominal adipose 
tissue distribution in infancy. US-visceral fat thickness and abdominal subcutaneous fat 
thickness are reliable and reproducible estimates of respectively internal-abdominal 
(visceral) adipose tissue and abdominal subcutaneous adipose tissue.(50)
2.3	Infant	feeding	
Nutrition will very likely affect adiposity rate and body composition in early life. Breast-
feeding is known as the optimal infant feeding, because it is associated with a lower 
incidence of childhood obesity and type 1 and type 2 diabetes in later life.(51) Studies 
about the influence of breastfeeding on body composition at 6 months showed, how-
ever, conflicting results.(52-56).
2.4	Maternal	characteristics
Maternal pre-pregnancy weight and gestational weight gain are important determinants 
of birth weight. Pre-pregnancy weight and maternal weight gain during pregnancy 
influence fetal growth, birth weight and fat mass percentage at birth (57-59), but it is 
unclear if they also influence adiposity development in the infants in the first months 
of life. This is of particular importance as the prevalence of overweight in adult women 
has increased from 29.8% to 43%.(29) Thus, many pregnant women are nowadays over-
weight or obese. 
2.5	Appetite	regulating	hormones 
Growth during early infancy may influence the appetite regulatory system by program-
ming appetite regulating hormones, such as orexigenic (ghrelin) and anorectic (peptide 
YY) hormones, as shown in animal studies.(60) Stimulating hormones, such as ghrelin, 
are important in the initiation, cessation and frequency of eating. Other hormones, 
such as leptin and peptide YY (PYY), decrease food intake and increase metabolic rate. 
The glucose-dependent insulinotropic peptide (GIP) stimulates pancreatic beta-cells in 
response to the ingestion of meals or glucose.(61, 62) All these signals act at several cen-
tral nervous system (CNS) sites but the pathways converge to the hypothalamus, which 
contains a large number of peptides and other neurotransmitters that influence food 
intake. Adipose tissue influences appetite regulation by producing appetite regulating 
hormones, which play a role in the regulation of food intake and body composition by 
signaling satiety and energy reserves through hypothalamic receptors. However, little 
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is known about the relation of type of feeding and body composition with appetite 
regulating hormones in early life.(63) 
2.6	Microbiome
It has been suggested that several other factors contribute to the development of obe-
sity, such as (epi)genetic factors, hormones, stress, underlying illnesses, medications, 
infections and also the gut microbiome.(64)
The human gut is colonized with 100 trillion microbe cells, which are part of the intes-
tinal microbiome. The composition of the microbiome varies between individuals. It is 
well-known that gut microbiota play an important role in human health by providing a 
barrier for colonization of pathogens, by stimulating the development of the immune 
system, but also by exerting important metabolic functions.(65) Because the human gut 
microbiota are involved in many aspects of human health, it is essential to understand 
how the composition of the microbiome is established. In early life, there are major 
changes in the composition of the intestinal microbiome.(66-71) It has been proposed 
that obesity in adults may be related to the composition of the gut microbiota.(72, 73) 
Obese adults have different microbiota compared to non-obese individuals and it has 
been shown that adults who lost weight develop different stool microbiota, but there 
are limited data available about the gut microbiota in infants, particularly during periods 
of losing or gaining weight.(74) Differences in growth and body composition could play 
a role in the establishment of the microbiome or vice versa. Longitudinal data about the 
development of the microbiome in parallel with data on type of feeding and body com-
position (ea. fat mass percentage (FM%) and fat-free mass (FFM) are essential to unravel 
the interactions between early life factors and the composition of gut microbiota.
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3. hypotheses 
We hypothesized that accelerated gain in weight for length in the first months of life 
leads to the development of an unfavorable body composition with higher FM% and 
more visceral fat in infancy and a higher risk for non-alcoholic fatty liver disease (NAFLD) 
in young adulthood, in those born term as well as those born preterm. 
We also hypothesized that maternal data, type of feeding, levels of appetite regulating 
hormones will influence the development of infant body composition. Besides this, we 
hypothesized that an unfavorable gut microbiome will be associated with an unfavor-
able infant body composition.
4. the program and prems study cohorts and sophia pluto study birth cohort
To investigate the relationship between childhood growth and determinants of adult 
disease in early adulthood, the PROgramming factors for Growth and Metabolism 
(PROGRAM) study and PREMaturity and Small for gestational age (PREMS) study were 
initiated. The inclusion and exclusion criteria are described in Appendix A. The PRO-
GRAM study consists of 323 healthy young adults born term and the PREMS study of 169 
healthy young adults, born preterm (gestational age < 36 weeks).
Based on the outcomes of the PROGRAM study, the Sophia Pluto Study birth cohort 
was initiated to prospectively identify determinants of adult diseases in early life. The 
inclusion and exclusion criteria are described in Appendix B. The inclusion into the 
Sophia Pluto Study is ongoing.
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5. aims of the studies
This thesis describes the results of 2 studies performed in young adults, aged 18-24 
years, who participated in either the PROGRAM or PREMS study. These studies were 
started to investigate if size at birth, preterm birth, and different growth patterns during 
childhood influence determinants of adult diseases, in this thesis non-alcoholic fatty 
liver disease. Study designs are described in Appendix A.
Based on the outcomes of the PROGRAM study, the Sophia Pluto Study birth cohort 
was started in 2012. This study was started to examine the postnatal determinants of 
body composition development during infancy. Study design is described in Appendix 
B. In this thesis we describe the results of 5 studies in healthy infants, born term, who 
participate in the Sophia Pluto Study. 
5.1	Growth	in	early	life	and	risk	for	non-alcoholic	fatty	liver	disease
First year growth data were analyzed to investigate if gain in weight relative to length 
during a specific time period in the first year had an influence on determinants of non-
alcoholic fatty liver disease in young adults born term. Subsequently, we investigated if 
adults born preterm with accelerated weight gain after term age are at an increased risk 
for NAFLD compared with those without accelerated weight gain during infancy.
5.2	Body	composition	during	first	months	of	life
To investigate the development of body composition during early infancy, including 
total fat mass (FM) and total fat mass percentage (FM%), measured by Peapod and 
abdominal subcutaneous fat and visceral fat, measured by ultrasound and to generate 
reference values for healthy newborns and infants.
5.3	Determinants	influencing	body	composition	at	birth	and	in	the	first	months	of	life
To investigate the influence of maternal, fetal, feeding and growth determinants on 
body composition at birth and during the first 6 months of life. 
5.4	Body	composition	and	appetite	regulating	hormones
To investigate (fasting) serum ghrelin, leptin, insulin, GIP, PP and PYY at 3 months and 
6 months and associations with type of feeding and body composition (including FM% 
and visceral and subcutaneous fat) at 1, 3 and 6 months of age.
5.5	Body	composition	and	microbiome
To study the composition of the gut microbiome, including secretory immunoglobulin 
A (sIgA), short-chain fatty acids and bacteria, at the first and third month of life and 
subsequently identify correlations of microbiota with type of feeding, early weight gain 
and infant’s body composition in the first months of life.
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6. outline of the thesis
Chapter 1 gives an introduction in the topics described in this thesis.
Chapter 2 reports the association of gain in weight relative to length during different 
periods with determinants of non-alcoholic fatty liver disease in young adults born term.
Chapter 3 reports the association of gain in weight relative to length during different 
periods with determinants of non-alcoholic fatty liver disease in young adults born 
preterm.
Chapter 4 presents associations of fetal growth, maternal data and neonatal anthropo-
metrics with infant’s body composition at birth.
Chapter 5 presents longitudinal reference data of body composition, including total fat 
mass and subcutaneous and visceral fat.
Chapter 6 reports determinants of (changes in) body composition during infancy, 
including infant characteristics, type of feeding and maternal determinants.
Chapter 7 presents levels of appetite regulating hormones in association with type of 
feeding and body composition at 3 and 6 months of age.
Chapter 8 describes the composition of the gut microbiome at the first and third month 
of life and present correlations of sIgA, short-chain fatty acids and microbiota with type 
of feeding, early weight gain and infant’s body composition in the first months of life. 
Chapter 9 discusses the results of the studies in relation to the current literature and 
gives conclusions, clinical implications and directions for future research.
Chapter 10 summarizes the findings of the studies in English and Dutch.
1General introduction 19
appendix a
The	PROGRAM	and	PREMS	study	cohorts
To investigate the relationship between childhood growth and determinants of adult 
disease in early adulthood, the PROgramming factors for Growth and Metabolism (PRO-
GRAM) and PREMaturity and Small for gestational age (PREMS) were initiated. 
Subjects
The PROGRAM study consists of 323 healthy young adults born term, the PREMS study of 
169 healthy young adults born preterm (gestational age <36 weeks). Participants were 
recruited from hospitals in The Netherlands, where they had been registered because of 
being small at birth (SGA with a birth length below - 2 SDS) and/or showing short stature 
(with an adult height below - 2 SDS after being born SGA or appropriate for gestational 
age). In addition, healthy subjects (neither small at birth nor having short stature) from 
schools with different educational levels were randomly asked to participate. 
Inclusion criteria 
· Chronological age at inclusion: 18.00-23.99 years
· Neonatal period without signs of severe asphyxia (defined as an Apgar score below 
three after five minutes), no serious diseases such as long-term artificial ventilation 
and oxygen supply, bronch-pulmonary dysplasia or other chronic lung disease
· Well documented growth data
· Caucasian
· Born singleton
· Signed informed consent
· PROGRAM study: gestational age of 36 weeks or more
· PREMS study: gestational age of less than 36 weeks
Exclusion criteria
· Chromosomal disorders, known syndromes and serious dysmorphic symptoms sug-
gestive for a yet unknown syndrome, except Silver-Russell Syndrome
· Any disease, endocrine or metabolic disorder that could interfere with growth dur-
ing childhood (such as diabetes, growth hormone deficiency, malignancies, severe 
chronic disease)
· Treatment that could have interfered with growth (such as radiotherapy or growth 
hormone treatment)
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Study design
The PROGRAM and PREMS study were cross-sectional studies. The wide range in birth 
size and childhood growth patterns increased the contrast in the study population, 
which increased the statistical power to detect relationships between various factors. 
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appendix B
The	Sophia	Pluto	study	cohort
The Sophia Pluto Study birth cohort was initiated based on the outcomes of the PRO-
GRAM study, to prospectively identify determinants of adult disease in early life.
Subjects
At the time of the studies, 300 healthy infants were included in the Sophia Pluto Study 
and were included in this thesis. The inclusion into this study is still ongoing.
Inclusion criteria 
· Gestational age of 37 weeks or more 
· Age < 28 days
· Uncomplicated neonatal period without signs of severe asphyxia (defined as an 
Apgar score below three after five minutes), sepsis or long-term complication of 
respiratory ventilation 
Exclusion criteria
· Known congenital or postnatal diseases that could interfere with body composition 
development
· Confirmed intra-uterine infection
· Maternal use of corticosteroids or significant maternal medical condition that could 
interfere with infant’s body composition development (e.g. diabetes)
Study design
The Sophia Pluto Study is a prospective observational follow-up study of a birth cohort. 
The infants were included before 28 days and visited the outpatient clinic at 1, 3, 6 and 
9 months and 1 year, 18 months and 2 years. During the visits, anthropometrics, body 
composition and various other parameters were measured. Before the age of 9 months, 
total FM% was measured by air-displacement plethysmography (Peapod) and after this 
age by DXA-scan. Visceral and subcutaneous fat were measured by ultrasound. 
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aBstraCt
Introduction
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic metabolic syndrome. 
Some studies demonstrated an association between small size at birth and NAFLD. 
Rapid catch-up in weight often follows small birth size and has been associated with 
metabolic syndrome, but its association with NAFLD remained unknown.
patients and methods
In 268 adults aged 18-24 yrs, BMI, waist circumference, triglyceride, gamma-glutam-
yltransferase (γ-GT), alkaline phosphatase (ALP), alanine aminotranserase (ALT), and 
aspartate aminotransferase (AS) levels were determined. Fatty liver index (FLI, 0-100) 
was calculated. Associations of birth weight SDS and first year gain in weight- and 
length SDS were determined with FLI and other liver markers. Comparisons were per-
formed between subjects with and without rapid catch-up in weight in the first year of 
life. Furthermore, a FLI-score (low, intermediate, high risk for NAFLD) was assigned to 
each participant to determine clinical relevance, and ordinal regression analyses were 
performed. 
results
Gain in weight in the first three months of life was associated with FLI as a continuous 
variable, whereas low birth weight was not. There were no significant associations with 
γ-GT, ALT, or AST. 
Of the subjects with rapid catch-up in weight for length, 27.8% had an intermediate or 
high FLI at the age of 21 years, compared with 5.3% of subjects with slow catch up. Rapid 
catch-up was also associated with a higher FLI-score after adjustments (odds ratio:11.7, 
p-value:0.016).
Conclusion
Accelerated gain in weight for length in the first three months of life is associated with a 
higher risk for NAFLD in early adulthood, whereas small size at birth is not.
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IntroduCtIon
Non-alcoholic fatty liver disease (NAFLD) is a condition that resembles that of alcohol 
induced liver injury, but it occurs in patients who do not abuse alcohol.(1) NAFLD has the 
potential to progress to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma.
(1) Furthermore, NAFLD is considered being the hepatic manifestation of the metabolic 
syndrome, and has been associated with several risk factors for cardiovascular disease 
(CVD) and type 2 diabetes, such as adverse lipid profile and body composition, and in-
sulin resistance.(1,2) Given the strong association of NAFLD with obesity, the prevalence 
of NAFLD is rapidly increasing.(3)
Although some findings point to an association of low birth weight with liver diseases 
(4), only few studies investigated associations between early life factors and NAFLD in 
adulthood. Fraser et al. reported an association between low birth weight and increased 
markers of liver damage in a large group of women aged 60-79 year.(5,6) Furthermore, 
Nobili et al. reported an association between pediatric NAFLD and being born small 
for gestational age (SGA).(7) However, the role of growth during the first year of life in 
these associations remained unknown. The majority of children born SGA show catch-
up growth within 2yrs after birth, resulting in a normal stature.(8) Accelerated gain in 
weight for length in early life has been associated with prevalence of the metabolic 
syndrome at age 21 years, independently from birth weight (9). Given that NAFLD is 
considered the hepatic metabolic syndrome,(10) it might well be that the previously 
found association between small size at birth and NAFLD can also be ascribed to acceler-
ated early weight gain. Based on our previous work,(11,12) we hypothesized that rapid 
gain in weight for length in the first three months of life, rather than low birth weight, is 
associated with increased risk for developing NAFLD. We therefore investigated associa-
tions of birth weight, first-year gain in weight for length, and rapid catch-up in weight 
with the fatty liver index (FLI) at 21 years.(13) The FLI is a measure to predict hepatic 
steatosis in the general population (14), and is developed using an algorithm based on 
BMI, waist circumference, triglycerides, and gamma-glutamyltransferase (γ-GT), with an 
accuracy of 0.84 (95%CI 0.81-0.87) in detecting fatty liver.(13,15) The FLI has been widely 
used in NAFLD research,(16-20) and has been recently validated for identifying NAFLD 
in a large population-based study.(15) Additionally, we investigated associations with 
individual biochemical markers of the FLI, and with other markers indicating liver dam-
age (alanine aminotranserase (ALT), aspartate aminotransferase (AST), γ-GT, and alkaline 
phosphatase (ALP, mainly associated with cholestasis)).(2,6,21,22) 
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study desIgn
subjects
The PROGRAM study cohort consists of 323 healthy participants with an age between 
18 and 24 years. Participants were recruited from hospitals in the Netherlands, where 
they had been registered because of being small at birth (SGA with a birth length below 
-2 SDS, n=108) (23) and/or showing short stature (with an adult height below -2 SDS 
after being born SGA or appropriate for gestational age n=77).(24) In addition, healthy 
subjects (neither small at birth nor having short stature) from schools with different 
educational levels were randomly asked to participate (n=83). 
This design was purposely chosen to increase the contrast within the study popula-
tion regarding birth size and adult stature. All participants fulfilled the same inclusion 
criteria: 1) age 18-24 years, 2) born singleton, 3) born at term (≥ 36 weeks of gestational 
age), 4) Caucasian, 5) uncomplicated neonatal period without signs of severe asphyxia 
(defined as an Apgar score below 3 after 5 minutes), without sepsis or long-term com-
plications of respiratory ventilation, such as broncho-pulmonary dysplasia, 6) maximum 
duration of respiratory ventilation and/or oxygen supply in the neonatal period of 2 
weeks. Subjects were excluded if they had been suffering from any serious complication 
or condition (including necrotizing enterocolitis, intra-ventricular hemorrhage with a 
degree of 3 or more, spastic hemiplegia or quadriplegia), from any disease or had re-
ceived any treatment known to interfere with growth (e.g. growth hormone deficiency, 
severe chronic illness, emotional deprivation, growth hormone treatment, treatment 
with glucocorticosteroids, radiotherapy) or if they had endocrine or metabolic disorders, 
chromosomal defects, syndromes or serious dysmorphic symptoms suggestive for a yet 
unknown syndrome. 
Birth data were taken from records of hospitals, community health services and 
general practitioners. Information regarding socio-economic status (SES), alcohol 
use,and oral contraceptive use was obtained using questionnaires. Educational level of 
the participant was used as socio-economic indicator to determine SES.(25) None of 
the participants had alcoholic abuse. In the Netherlands, periodical measurements of 
weight and length are performed for each child. Thus, weight and length at 3, 6, 9, and 
12 months after birth had been measured prospectively at primary health care centers 
or hospitals. These data were collected from the records of the health care centers and 
hospitals during the study period March 2006-September 2007. 
The Medical Ethics Committee of Erasmus Medical Centre, Rotterdam the Netherlands, 
approved the study. Written informed consent was obtained from all participants. Of 
323 subjects, data on biochemical markers of NAFLD, liver damage and liver function 
were available for 268 subjects (of whom n=80 were born SGA). Data on first-3 month’s 
growth were available for 182 of 268 subjects. 
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measurements
All participants visited the Erasmus Medical Centre in Rotterdam and were reimbursed 
for travel expenses. Prior to the visit, participants fasted for at least 12 hours and ab-
stained from smoking and drinking alcohol for at least 16 hours. All anthropometric 
measurements were performed twice; the mean value was used for analyses. Height was 
measured to the nearest 0.1cm by a Harpenden stadiometer and weight to the nearest 
0.1kg by a scale (Servo Balance KA-20-150S).
All fasting blood samples were drawn between 0800-13.00 h, centrifuged after clot-
ting, and were kept frozen until assayed (-80°C). All serum parameters were determined 
in the same laboratory. Triglycerides were measured using the GPO-PAP reagent kit 
(Roche Diagnostics). γ-GT, ALP, ALT, and AST levels were determined using standard 
laboratory routines. 
statistical analysis
SD-scores for birth length, birth weight, and first year weight and length were calculated 
to correct for gestational age and sex.(23) SD-scores for adult height and weight were 
calculated to correct for sex and age.(24) The Fatty Liver Index (FLI) was used to deter-
mine the risk for fatty liver disease.(13) FLI is calculated as: FLI = (e0.953 * ln (triglycerides) + 0.139 * BMI 
+ 0.718 * ln (γ-GT) + 0.053 * waist circumference – 15.745) / (1/ e0.953 * ln (triglycerides) + 0.139 * BMI + 0.718 * ln (γ-GT) + 0.053 * waist circum-
ference – 15.745) x 100, and varies between 0 and 100. To identify associations of birth weight 
SDS, birth length SDS, and gain in weight for length in the first three months of life with 
markers of NAFLD, and liver damage, we performed linear regression analyses with the 
dependent variables FLI, triglycerides, BMI, waist circumference, γ-GT, AF, ALT, and AST. 
Non-parametric correlations were performed to study associations of gain in length SDS 
and gain in weight SDS in first three months of life with FLI. All regression analyses were 
adjusted for age, gender, gestational age, and SES, and in additional analyses for adult 
weight SDS. All weight gain analyses were additionally adjusted for gain in length SDS 
in the same period. The interaction term of birth weight SDS and infant weight gain was 
not significant (p=0.534), and was therefore not added to the model. When residuals 
deviated from homogeneity, outcome variables were log transformed. Next, a FLI-score 
was assigned to the participants as follows: a FLI below 30 resembling a low risk (FLI-
score 1, sensitivity=87%(13)), from 30 up to 60 an intermediate risk (FLI-score 2), and 
above 60 a high risk (FLI-score 3, specificity=86%(13)) for fatty liver. Ordinal regression 
analyses were performed to determine associations of FLI-score with birth weight SDS, 
birth length SDS, and weight gain during the four three-month periods in the first year 
of life. 
To study the generalizability of the results in the total group separate analyses were 
performed using only subjects born appropriate for gestational age. 
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Additionally, the total study group was divided into two groups, irrespective of birth 
length or birth weight, one with catch-up in weight during the first year of life and one 
without it. Catch-up in weight was defined as an SDS of more than 0.67 of weight gain in 
the first year of life.(26) Of the group with weight catch-up, two subgroups were formed 
based on rapid (SD>0.5) or slow (SD<0.5) weight gain during the first three months.
(11,12) Of the group with rapid weight gain (n=54), 35 subjects were born SGA, and of 
the group with slow weight gain (n=19), 12 subjects were born SGA. The unadjusted dif-
ferences between subjects with rapid and slow catch-up with regard to FLI-score were 
determined with Pearson Chi-Square, and adjusted differences with ordinal regression. 
Adjusted differences with regard to FLI as a continuous variable were determined us-
ing estimated marginal means. All subgroup-analyses were adjusted for age, gender, 
gestational age, SES, and gain in length in the first year of life.
Statistical package SPSS version 20.0 (SPSS, Inc., Chicago, IL) was used for analyses. 
Results were regarded statistically significant if p was <0.05 (two-sided). 
results
Clinical characteristics, the Fatty Liver Index (FLI) and its components, and other liver 
markers are shown in Table 1. Mean(SD) FLI was 13.0(17.1). A high FLI score was present 
in 3% of the total study group. 
table 1. Clinical characteristics, components of the FLI, and other markers for liver damage
Total study group
Subgroups with catch-up in first year
p-valueRapid catch-up Slow catch-up
N Mean(SD) N Mean(SD) N Mean(SD)
Age 268 20.9(1.66) 54 20.7(1.68) 19 21.0(1.94) 0.557
Gender (M/F) 268 107/161 54 17/37 19 11/8 0.042
Gestational age 268 39.2(1.59) 54 38.6(1.46) 19 39.2(2.00) 0.145
Birth weight SDS 268 -1.12(1.36) 54 -2.19(0.69) 19 -2.09(0.90) 0.620
3 months weight SDS 182 -0.91(1.10) 54 -0.70(0.87) 19 -2.13(0.95) <0.001
6 months weight SDS 181 -0.83(1.02) 54 -0.40(0.80) 19 -1.51(0.81) <0.001
9 months weight SDS 178 -0.80(1.07) 54 -0.36(0.73) 19 -1.00(0.82) 0.002
12 months weight SDS 173 -0.72(1.01) 54 -0.28(0.74) 19 -0.77(0.78) 0.017
Birth length SDS 268 -1.39(1.41) 54 -2.13(1.15) 19 -2.07(1.55) 0.859
3 months length SDS 182 -1.02(1.21) 54 -1.04(1.01) 19 -1.71(1.14) 0.018
6 months length SDS 180 -0.94(1.19) 54 -0.61(0.99) 19 -1.60(1.08) <0.001
9 months length SDS 178 -0.91(1.26) 54 -0.45(0.93) 19 -1.27(1.03) 0.002
12 months length SDS 176 -0.92(1.20) 54 -0.42(0.94) 19 -1.16(1.02) 0.005
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fatty liver index
Total	study	population
In Table 2, results from linear regression analyses are shown, with FLI (0-100) and indi-
vidual components of the FLI (TG, BMI, waist circumference, and serum levels of γ-GT) 
as dependent variables. Gain in weight SDS for length SDS in the first three months of 
life was significantly associated with FLI at age 21 years (FLI increased with 27.4% per 
SDS increase in weight gain, p=0.003, Model 2). Gain in weight SDS for length SDS in 
the first three months of life showed also significant associations with higher serum TG 
level, BMI, and waist circumference. Furthermore, lower birth weight SDS was initially 
associated with a higher TG level and waist circumference at age 21 years (Model 1), but 
this association disappeared after additional adjustment for adult weight SDS (data not 
shown). There were no significant associations of gain in weight SDS (p=0.227) without 
correction for length or gain in length SDS (p=0.144) in the first three months of life 
with FLI. To study the generalizability of our results for all infants we performed separate 
analyses using only the subjects born appropriate for gestational age. This also showed 
table 1. Clinical characteristics, components of the FLI, and other markers for liver damage (continued)
Total study group Subgroups with catch-up in first year
Rapid catch-up Slow catch-up p-value
N Mean(SD) N Mean(SD) N Mean(SD)
Adult height SDS 268 -1.00(1.36) 54 -0.63(0.91) 19 -1.01(0.91) 0.118
Adult weight SDS 268 -0.63(1.43) 54 0.04(1.12) 19 -0.72(1.03) 0.011
TG (mg/dl) 265 91.0(44.2) 54 103.9(46.3) 19 85.1(29.2) 0.102
BMI (kg/m) 268 22.4(3.51) 54 23.5(3.59) 19 21.8(2.45) 0.060
Waist (cm) 268 76.9(9.98) 54 91.4(11.2) 19 75.7(8.65) 0.047
γ-GT (U/l) 266 17.3(13.5) 54 22.4(24.6) 19 16.9(8.40) 0.342
FLI 264 13.0(17.1) 54 21.6(23.4) 19 10.2(12.1) 0.046
FLI-
score%
Low 233 88.3 39 72.2 18 94.7
Intermediate 23 8.7 11 20.4 1 5.3
High 8 3.0 4 7.4 0 0
ALT (U/l) 266 20.3(15.3) 54 23.1(24.2) 19 19.4(11.2) 0.527
AST (U/l) 266 25.8(30.2) 54 25.7(13.2) 19 25.1(10.0) 0.928
ALP (U/l) 267 69.0(22.1) 54 70.5(19.6) 19 70.9(24.1) 0.931
SDS: Standard deviation score, waist: waist circumference, BMI: body mass index, TG: triglycerides, γ-GT: 
glutamyltransferase, FLI: fatt liver index (0-100), ALT: alanine aminotransferase, AST: aspartate aminotrans-
ferase. ALP: alkaline phosphatase. An FLI-score below 30 resembling a low risk (FLI-score 1), from 30 up to 
60 an intermediate risk (FLI-score 2), and above 60 a high risk (FLI-score 3) for fatty liver.
Rapid catch-up= weight gain >0.67 SDS in first year of life and weight gain >0.5 SDS in first three months, 
compared with slow catch-up (weight gain >0.67 SDS in first year of life and weight gain <0.5 SDS in first 
three months) 
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a significant association of gain in weight SDS for length SDS in the first three months 
with FLI (p=0.032). 
There were no significant associations of birth weight SDS or infant weight gain with 
ALT, AST, and ALP, also not after additional correction for adult weight SDS. 
Catch-up subgroups 
To assess if tempo of weight gain was associated with determinants of NAFLD in young 
adults, those with catch-up in weight were divided in two subgroups with either rapid or 
slow catch-up in weight. Of all young adults with a clinically relevant catch-up in weight 
of at least 0.67 SDS in the first year of life (n=73), 54 had a weight gain of more than 0.5 
SDS in the first 3 months (rapid catch-up), while 19 had a weight gain of less than 0.5 SDS 
in the first 3 months (slow catch-up). The clinical characteristics of these two subgroups 
and unadjusted differences are shown in Table 1. Besides the differences in early growth, 
the rapid weight catch-up group had higher unadjusted FLI (p=0.046), adult weight SDS 
(p=0.011), and waist circumference (p=0.047) at age 21yr. Furthermore, subjects with 
rapid catch-up had a higher mean FLI than subjects with slow catch-up, adjusted for 
gender, SES, gestational age, and gain in length during the first year of life (p=0.019, 
Figure 1). This difference remained also significant (p=0.016) after additional adjustment 
for birth weight SDS. Because the rapid catch-up group comprised of relatively more 
female than male subjects, and 78% of the female subjects in the present study popula-
tion used oral contraceptives, we additionally adjusted for oral contraceptive use, which 
did not change the results (data not shown).
figure 1. Adjusted Fatty Liver Index of subjects with rapid compared to slow catch-up
Estimated marginal means (95% confidence interval)
Rapid catch-up = weight gain >0.67 SDS in first year of life and weight gain >0.5 SDS in the first three 
months. Slow catch-up = weight gain >0.67 SDS in first year of life and weight gain <0.5 SDS in first three 
months. Adjusted for gender, SES, gestational age and gain in length in first year of life. P=0.017 after ad-
ditional adjustment for birth weight SDS.
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fatty liver index score 
A FLI-score was assigned to each participant in order to obtain a NAFLD-risk score (1: 
low, 2: intermediate, or 3: high). This NAFLD-risk score is used to determine the clinical 
relevance of findings with a FLI <30 resembling a low risk for fatty liver, a FLI from 30 up 
to 60 resembling an intermediate risk, and a FLI >60 a high risk for fatty liver.(13) 
Influence	of	early	catch-up	in	weight
Of all participants, 3% (n=8) had a high FLI-score, and 8.7% (n=23) had an intermedi-
ate FLI-score (Table 1). Table 3 shows the results of the ordinal regression analyses with 
FLI-score as dependent variable. Gain in weight SDS in the first three months of life was 
associated with a higher FLI-score at the age of 21 years (OR: 1.83, CI: 1.15-2.92), adjusted 
for age, gender, gestational age, SES, and gain in length in the same period. Thus, per 
one SDS increase in early weight gain, the risk of having a higher FLI-score at 21 years 
increases with 83%. There were no significant associations between weight gain dur-
ing the other three-month periods in the first year of life and the FLI-score. Lower birth 
weight SDS was also not associated with a higher FLI-score at 21 years. 
table 3. Associations of birth size and first year weight gain with FLI-score at 21 years
FLI-score
Odds ratio 95% CI p-value
Birth weight SDS1 0.64 0.39-1.07 0.077
Gain in weight SDS
0-3 months2 1.83 1.15-2.92 0.011
3-6 months2 1.08 0.45-2.61 0.859
6-9 months2 1.52 0.45-5.11 0.498
9-12 months2 0.87 0.23-3.25 0.830
Rapid versus slow catch-up3 11.7 1.12-113.2 0.016
FLI-score determined as follows: an FLI<30 equals a low risk (score 1), an FLI of 30-60 an intermediate risk 
(score 2), and an FLI >60 a high risk (score 3) for fatty liver
Rapid catch-up= weight gain >0.67 SDS in first year of life and weight gain >0.5 SDS in first three months, 
compared with slow catch-up (weight gain >0.67 SDS in first year of life and weight gain <0.5 SDS in first 
three months)
Significant odds ratios are indicated in bold
CI: confidence interval
1Adjusted for age, gender, gestational age, SES, and birth length SDS
2Adjusted for age, gender, gestational age, SES, and gain in length SDS in the same period
3Adjusted for age, gender, gestational age, SES, and gain in length SDS in the first year of life
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Rapid	versus	slow	catch-up	in	weight
Of the subjects with rapid catch-up in weight for length, 27.8% had an intermediate 
or high FLI-score compared with 5.3% of the subjects with slow catch-up in weight for 
length. Ordinal regression analyses showed that rapid catch-up was significantly associ-
ated with a higher FLI-score (OR: 11.7, CI: 1.12-113.2), adjusted for age, gender, gesta-
tional age, SES, and gain in length during the first year of life (Table 3). The association 
remained significant after additional adjustment for birth weight SDS (data not shown). 
dIsCussIon
In the present study we investigated whether low birth weight and/or accelerated infant 
weight gain are associated with increased risk for developing non-alcoholic fatty liver 
disease (NAFLD) in early adulthood. We showed that gain in weight SDS in the first three 
months of life was associated with a higher fatty liver index (FLI) at 21 years, a validated 
measure to predict hepatic steatosis in the general population, whereas low birth weight 
SDS was not. This was also found in subjects born appropriate for gestational age. 
We also found that subjects with rapid catch-up in weight for length have a sig-
nificantly higher FLI in early adulthood than subjects with slow catch-up in weight, also 
after adjustment for birth weight SDS. Furthermore, when a FLI-score (low, intermediate, 
or high risk for NAFLD) was assigned to each participant, and ordinal regression analyses 
was performed, it was shown that higher gain in weight for length in the first three 
months of life associates with more risk of having a higher FLI-score in early adulthood 
(odds ratio:11.7, p-value:0.016), whereas low birth weight does not.
Not only subjects born small for gestational age were at risk for having a higher 
fatty liver index after accelerated weight gain in weight SDS for length SDS in the first 3 
months, but also subjects born appropriate for gestational age. We, therefore, conclude 
that the our findings are not specific for children born SGA but can be generalized to the 
whole population of infants.
The FLI refers to a clustering of risk factors, being a condition underlying hepatic ste-
atosis.(13) As our study population consists of healthy young adults, it was not possible 
to study hard endpoints such as NAFLD, steatohepatitis, and fibrosis. We therefore used 
FLI as a proxy. A limitation of this approach is the arbitrary character of the FLI definition 
and the subsequent possibility to miss critical information. We, therefore, decided to also 
study the components of the FLI separately, and in addition to investigate determinants 
of liver damage (ALT, AST, ALP). Although the participants of the present study were 
relatively young, a high FLI was already found in 8 participants. A high FLI-score (above 
60) has a positive predictive value of 72.2% for fatty liver.(14) Furthermore, it was striking 
that 27.8% of the subjects with rapid catch-up in weight for length had an intermediate 
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or high FLI at the age of 21 years, compared with 5.3% of the subjects with slow catch-up 
in weight for length. 
Components of the Fatty Liver Index overlap the components of metabolic syndrome, 
but the FLI give additional information. It is possible to have adiposity without an higher 
risk for NAFLD and also it is possible to have a Non-Alcoholic fatty liver disease as a lean 
person.(27,28)
To our knowledge, this is the first study investigating the relationship of both small size 
at birth and accelerated weight gain during infancy with NAFLD risk in early adulthood. 
One recent paper reported that small body size at birth and at age two was associated 
with a higher likelihood of NAFLD in adulthood.(29) Furthermore, the authors showed 
that the most pronounced results were among the subjects who were smallest at age two 
and subsequently obese in adulthood. Unfortunately, these results cannot be compared 
with the results of the present study because gain in weight during the first year of life 
was not studied. We previously showed that accelerated weight gain during infancy is 
associated with risk factors for cardiovascular disease, insulin resistance, obesity, and the 
metabolic syndrome in adulthood,(9,11,12,30,31) outcomes which are closely related 
to NAFLD.(1,2,32) The present results show that subjects with higher gain in weight for 
length in the first three months of life are also at higher risk of developing NAFLD in 
early adulthood. We did, however, not find an association of accelerated infant weight 
gain with all the components of the FLI. More specifically, no significant association was 
found with γ-GT, and other markers of liver damage, such as ALT and AST. Furthermore, 
some of the components used to determine NAFLD risk in the present study overlap 
with the components of the metabolic syndrome.(13,33) Our findings warrant further 
research into more specific diagnostic markers of NAFLD to confirm our hypothesis that 
subjects with rapid catch-up in weight for length during infancy have higher risk to 
develop NAFLD in adulthood. Examples of more specific diagnostic markers of NAFLD 
are liver ultrasound measurements and the gold standard liver histology. The latter is, 
however, not feasible because it is unethical to perform liver biopsy in healthy subjects.
Other studies showed that low birth weight was associated with higher NAFLD preva-
lence.(5-7) These studies, however, did not investigate or adjust for the effect of early 
weight gain, which appears to be highly associated with low birth weight. In the present 
study we did not find a significant association between a low birth weight SDS and FLI. 
Furthermore, we showed that the difference between subjects with and without rapid 
catch-up in weight during infancy is not due to small size at birth, as the difference 
remained significant after adjustment for birth weight SDS. 
Formula-fed infants have a higher risk of being overweight in childhood and later 
in life.(34,35) Infant feeding might thus influence later risk for NAFLD. Studies in rats 
showed that the liver might act as a systemic buffer, largely increasing its lipid content 
in the early stage of high-fat feeding.(36) It has also been suggested that breast feed-
2Risk for NAFLD in young adults born term 39
ing protects against the development non-alcoholic steatohepatitis (NASH) in children 
with NAFLD.(37) Our study did not have nutritional data to investigate the relationship 
between early nutrition, growth in infancy, and NAFLD risk factors in later life, but our 
findings suggest that the use of nutrient-enriched formulas, which induce rapid weight 
gain in early life, might increase the risk for NAFLD later in life. 
In conclusion, our study indicates that accelerated gain in weight compared to length 
in the first three months of life is associated with a higher risk to develop NAFLD in 
adulthood. Long-term prospective studies are warranted to study the effect of early gain 
in weight for length on more specific markers of NAFLD, and the role of infant feeding. 
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supplemental table 1.
Subgroups with catch-up in first year
SGA AGA p-value
Clinical characteristics N Mean(SD) N Mean(SD)
Age 108 21.0(1.6) 160 20.8(1.7) 0.349
Gender (M/F) 108 44/64 160 63/97 0.823
Gestational age 108 39.0(1.5) 160 39.4(1.6) 0.023
Birth weight SDS 108 -2.14(0.7) 160 -0.43(1.3) <0.001
3 months weight SDS 77 -1.47(1.0) 105 -0.49(1.0) <0.001
Birth length SDS 108 -2.79(0.7) 160 -0.45(0.9) <0.001
3 months length SDS 76 -1.74(1.0) 106 -0.51(1.1) <0.001
Adult height SDS 108 -1.24(1.2) 160 -0.84(1.5) 0.017
Adult weight SDS 108 -0.55(1.4) 160 -0.68(1.4) 0.460
TG (mg/dl) 108 96.4(47.5) 157 87.3(41.6) 0.100
BMI (kg/m2) 108 23.1(3.9) 160 21.9(3.1) 0.006
Waist (cm) 108 78.6(10.9) 160 75.8(9.2) 0.023
γ-GT (U/l) 108 19.0(18.1) 158 16.1(8.9) 0.078
FLI 108 16.4(20.6) 156 10.7(13.8) 0.007
FLI-score%
Low 91 84.3 142 91.0
0.471Intermediate 12 11.1 11 7.05
High 5 4.63 3 1.92
ALT (U/l) 108 22.0(19.1) 158 19.2(11.9) 0.139
AST (U/l) 107 25.3(14.7) 159 26.2(37.3) 0.823
ALP (U/l) 108 71.7(22.5) 159 67.1(21.6) 0.097
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aBstraCt
Background
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of 
metabolic syndrome. Accelerated catch-up in weight during infancy in subjects born 
term has been associated with increased risk for NAFLD in adulthood, but this associa-
tion has not been studied in subjects born preterm.
methods
In 162 young adults, gestational age<36 weeks, we assessed associations between fatty 
liver index (FLI, 0-100) and birth weight SDS and first year gain in weight. We performed 
comparisons between subjects with and without accelerated catch-up in weight in the 
first year after term age. A FLI-score was assigned to each participant to determine clini-
cal relevance, and regression analyses were performed.
results
Accelerated gain in weight in the first three months after term age was associated with 
FLI as a continuous variable, whereas gestational age and low birth weight were not. 
Of the subjects with accelerated catch-up in weight for length after term age, 7.3 % 
had a high FLI at the age of 21 years, whereas none of the subjects without accelerated 
catch-up in weight had a high FLI.
Conclusion 
Our study shows that accelerated weight gain after term age is associated with increased 
risk for developing NAFLD in young adults born preterm. 
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IntroduCtIon
Nowadays, 8-10% of all newborns in developed countries are born preterm and due 
to advances in neonatal intensive care, most of them reach adulthood.(1) Preterm in-
fants are frequently exposed to fetal growth restriction, glucocorticoid treatment and 
stressful events, which may contribute to the development of organ dysfunction and 
adverse vascular outcome later in life. In recent years, long-term outcomes for young 
adults born preterm were found to be less favorable than for those born term. Adults 
born preterm are at increased risk for developing cardiovascular diseases (CVD)(2-4), 
and have increased cardiovascular mortality.(5, 6)
Non-alcoholic fatty liver disease (NAFLD) is considered to be the hepatic manifesta-
tion of metabolic syndrome, and has been associated with several risk factors for CVD.
(7) As NAFLD is strongly associated with obesity, its prevalence is rapidly increasing.(8)
Recently, our group showed that young adults, who were born term and underwent 
accelerated weight gain during infancy had an increased fatty liver index, a measure of 
NAFLD in early adulthood.(9) While the gold standard for determining NAFLD is liver 
biopsy, the Fatty Liver Index (FLI) is widely used and has recently been validated for 
identifying NAFLD in a large population-based study.(10-14) The FLI is a measure to 
predict hepatic steatosis in the general population, using an algorithm based on BMI, 
waist circumference, triglycerides, and gamma-glutamyltransferase (γ-GT), with in case 
of a high FLI-score (above 60) a positive predictive value of 72.2% in detecting fatty liver. 
Because many preterm infants are prone for accelerated weight gain after an initial 
period of weight loss (15), we hypothesized that adults born preterm with accelerated 
weight gain after term age are at increased risk for NAFLD compared with those without 
accelerated weight gain during infancy. We also hypothesized that adults born preterm 
have a higher FLI than adults born term.(9, 16, 17) We, therefore, investigated associa-
tions of birth weight, gain in weight for length and accelerated catch-up in weight in the 
first year after term age with the FLI in general and with individual biochemical markers 
of FLI as well as with other markers indicating liver damage in a cohort of young adults 
born preterm.(7, 18-21)
materIals and methods
study design
Subjects
The study population consisted of 162 healthy young adults (PREMS study) who were 
registered because of being born preterm (gestational age<36 weeks). Data of partici-
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pants were compared with data of 268 young adults born term (PROGRAM study) (9) 
Both cohorts had similar in- and exclusion criteria, research center, and measurements, 
except of a different gestational age. All included subjects were aged 18-24 years, 
Caucasian, born singleton and had an uncomplicated neonatal period without severe 
asphyxia (defined as an Apgar score below three after five minutes), sepsis, or long-term 
complications of respiratory ventilation and/or oxygen supply. Birth data were obtained 
from medical records, primary health care records, and general practitioner records. 
Data on educational level, socioeconomic status (SES), use of medication and alcohol 
use were obtained using questionnaires.(22) None of the participants had alcohol 
abuse, defined as a maladaptive pattern of alcohol use leading to clinically significant 
impairment or distress. Weight and length at 3, 6, 9, and 12 months after birth had been 
measured prospectively at primary health care centers or hospitals. The Medical Eth-
ics Committee of Erasmus Medical Centre, Rotterdam, The Netherlands, approved the 
study. Written informed consent was obtained from all participants. 
Measurements
All participants visited the Erasmus Medical Centre in Rotterdam and were reimbursed 
for travel expenses. Prior to the visit, participants fasted for at least 12 hours. All anthro-
pometric measurements were performed twice; the mean value was used for analyses. 
Height was measured to the nearest 0.1cm by a Harpenden stadiometer and weight 
to the nearest 0.1kg by a scale (Servo Balance KA-20-150S).Waist circumference was 
measured to the nearest 0.1 cm using plastic flexible measuring tape. It was measured 
at the midway between the lower margin of the lowest rib and the upper margin of the 
iliac crest, at the end of a normal expiration.
All fasting blood samples were drawn between 08.00-13.00 h, centrifuged after clotting, 
and were kept frozen until assayed (-80°C). All serum parameters were determined in 
the same laboratory. Triglycerides were measured using the GPO-PAP reagent kit (Roche 
Diagnostics). γ-GT, ALP, ALT, and AST levels were determined using standard laboratory 
routines. 
statistical analysis
SD-scores for birth length, birth weight, and first year weight and length were calculated 
to correct for gestational age and sex.(23) SD-scores for adult height and weight were 
calculated to correct for sex and age.(24) The FLI was used to determine the risk for fatty 
liver disease.(18) FLI is calculated as: FLI = (e0.953 * ln (triglycerides) + 0.139 * BMI + 0.718 * ln (γ-GT) + 0.053 * waist 
circumference – 15.745) / (1/ e0.953 * ln (triglycerides) + 0.139 * BMI + 0.718 * ln (γ-GT) + 0.053 * waist circumference – 15.745) x 100, 
and varies between 0 and 100. A FLI-score was assigned to the participants as follows: 
a FLI below 30 resembling a low risk (FLI-score 1, specificity=87%), from 30 up to 60 an 
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intermediate risk (FLI-score 2), and above 60 a high risk (FLI-score 3, specificity=86% for 
fatty liver).(18)
Multiple linear regression analyses were performed to investigate the association 
between weight gain per each three months during one year after term age, and several 
markers of NAFLD and liver damage in young adults born preterm. The four periods 
were analyzed separately from each other. In addition, we investigated effect of weight 
gain from birth to term age at the FLI at 21 years. We performed a multiple regression 
analysis with FLI at 21 years as dependent variable and as independent variables gesta-
tional age, gender, socio-economic status, adult age and as dummy a loss of weight ≥ 1 
SDS between birth and term age and no loss in weight.
Ordinal regression analyses were performed to determine associations of FLI- scores 
with birth weight SDS, birth length SDS, and weight gain during the five periods in the 
first year of life.
All regression analyses were adjusted for age, gender, gestational age, and SES. To 
investigate the association between weight and outcome variables independently of 
length, as a measure for adiposity, adjustments were made for length growth during the 
same period.
Catch-up in weight in the first year after term age was defined as a weight gain SD-
score of more than 0.67, because this represents the width of each percentile band on 
standard growth curves (second to ninth percentile, ninth to 25th percentile, etc.).(25)
Of the group with catch-up in weight, one subgroup was formed based on accelerated 
(SD≥0.5) weight gain during the first three months after term age. Additionally, young 
adults born preterm with accelerated catch-up and without accelerated catch-up in 
weight were compared to those born term. Differences in clinical characteristics were 
determined by an independent t-test. 
Statistical package SPSS version 20.0 (SPSS, Inc., Chicago, IL) was used for analyses. 
Results were regarded statistically significant if p was <0.05 (two-sided).
results
Clinical characteristics, the FLI and its components, and other liver markers are shown in 
Tables 1 and 2. Mean(SD) FLI was 12.7 (16.4). A high FLI score was present in 5% of the 
total preterm study group.
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fatty liver index
Total	study	population	of	adults	born	preterm
In Table 3 results from linear regression analyses are shown, with FLI (0-100) and indi-
vidual components of the FLI (TG, BMI, waist circumference, and serum levels of γ-GT) 
as dependent variables. Gain in weight SDS adjusted for length SDS in the first three 
months after term age was significantly associated with FLI at age 21 years (FLI increased 
with 29.1% per 1 SDS increase in weight gain, p=0.034, model 2). In addition, the gain in 
weight SDS for length SDS in the first three months after term age showed a significant 
association with waist circumference (p=0.004). Birth weight SDS and gestational age 
were not significantly associated with the FLI or with the individual components of the 
FLI (Model 1).
In addition, subjects with a loss in weight ≥ 1 SDS between birth and term age had 
a higher FLI at the age of 21 years than those without any loss in weight SDS (p=0.01).
Adults	born	preterm	with	catch-up	in	weight	after	term	age
To determine if tempo of weight gain after term age was associated with determinants 
of NAFLD in young adults born preterm, those with catch-up in weight in the first year 
after term age were divided in two subgroups with either accelerated or without ac-
celerated catch-up in weight. Of all young adults with a clinically relevant catch-up in 
weight of at least 0.67 SDS in the first year after term age (n=91), 55 had a weight gain 
of more than 0.5 SDS in the first 3 months after term age (accelerated catch-up), while 
36 had no accelerated catch-up, defined as a weight gain of less than 0.5 SDS in the first 
3 months after term age. The clinical characteristics of these two subgroups are shown 
in Table 1. 
Gestational age, sex, age, birth length SDS and birth weight SDS were not different 
between the accelerated and non-accelerated catch-up group. The accelerated catch-up 
group had a higher FLI (p=0.012), adult weight SDS (p=0.001), BMI (p=0.004), and waist 
circumference (p=0.010) at age 21 year than the non-accelerated catch-up group, even 
after adjustment for gender, SES, gestational age, and gain in length during the first year 
of life (p=0.003, Figure 1). 
To investigate whether the effect of accelerated catch-up in weight in subjects born 
preterm was similar to that in subjects born term, we compared the tempo of catch-
up in young adults born preterm versus term (Table 2). Our data showed no difference 
between subjects born term versus preterm.
Fatty	liver	index	score 
A FLI-score was assigned to each participant in order to obtain an NAFLD-risk score (1:low, 
2:intermediate, or 3:high). Of all adults born preterm, 5% (n=8) had a high FLI-score, and 
54 Chapter 3
5% (n=8) an intermediate FLI-score (Table 2). In the accelerated catch-up group, 7.3% 
had a high FLI-score and 3.6% an intermediate FLI-score, while in the non-accelerated 
catch-up group, 0% had a high FLI-score and 2.9% an intermediate score. Lower birth 
weight and gestational age were not associated with a higher FLI-score at 21 years.
dIsCussIon
Our study in 162 young adults born preterm shows that accelerated infant weight gain 
after term age is associated with an increased risk for developing NAFLD in early adult-
hood. We also demonstrate that subjects born preterm with accelerated weight gain 
after term age have a signifi cantly higher FLI in early adulthood than subjects without 
accelerated catch-up in weight, independent of size at birth and gestational age. Those 
fi ndings are similar to those found in young adult born term.
We found an association between accelerated weight gain during infancy in preterm 
born subjects and a higher NAFLD risk in early adulthood. Previous studies reported as-
sociations between small body size at birth and risk factors for NAFLD in adulthood (26, 
27), but associations with preterm birth were not investigated. Some studies showed an 
association between preterm birth and waist circumference, a component of the Fatty 
Liver Index (FLI), but none of these studies investigated associations with the FLI.(28, 29)
Because our study population consisted of young adults, hard endpoints such as 
NAFLD and steatohepatitis could not be studied. The FLI was used as a proxy for a 
figure 1. Adjusted Fatty Liver Index of subjects with accelerated compared to non-accelerated catch-up 
after term age
Estimated marginal means (95% confi dence interval) Accelerated catch-up= weight gain >0.67 SDS in fi rst 
year after term age and weight gain >0.5 SDS in fi rst three months after term age. Non-accelerated catch-
up= weight gain >0.67 SDS in fi rst year after term age and weight gain <0.5 SDS in fi rst three months after 
term age. Adjusted for gender, SES, gestational age and gain in length in fi rst year of life after term age
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clustering of risk factors, a condition which precedes hepatic steatosis. A high FLI-score 
(above 60) has a predictive value of 72.2% for a fatty liver(18) and although our study 
population was relatively young and healthy, with a relatively low BMI, a high FLI-score 
was found in 5% of subjects born preterm.
In addition, it was striking that 10.9% of subjects born preterm with accelerated catch-
up in weight for length after term age had an high or intermediate FLI at the age of 21 
years, compared with only 2.9% of the subjects without accelerated catch-up in weight 
for length. We previously showed a similar association between accelerated infant 
weight gain and increased risk for NAFLD in young adults born term.(9) Our present 
study shows that this association is also apparent in young adults born preterm. Besides 
this, our study shows that preterm subjects with a loss in weight ≥ 1 SDS between birth 
and term age had a higher FLI at 21 years than those without any decrease in weight. 
These both findings indicate that a balance in neonatal gain in weight compared to 
length is also important for preterm infants to reduce the risk for developing NAFLD. 
This may be achieved by modifying nutritional intervention according to weight for 
length trajectories, particularly in the first months after term age. These data should not 
be interpreted that we recommend slow weight gain in preterm babies, but discour-
age accelerated catch-up in weight for length after term age. It also points out that not 
only weight but also length should be routinely measured during infancy. Earlier stud-
ies showed that accelerated weight gain, mediated by nutrition-enriched diets, have 
adverse effects on cardiovascular risk factors in later life.(6, 30) Our findings warrant 
informing parents about the long-term effects of accelerated weight gain, as the first 
months after discharge of preterm infants, usually around term age seem to be a critical 
window for the programming of later body composition.
We acknowledge that when investigating differences between subjects born preterm 
and term, differences in early nutritional intake should be taken into account. The 
prevalence and duration of breastfeeding is less in infants born preterm.(31) Formula-
fed infants have a higher risk of being overweight in childhood and in later life.(32, 33) 
Infant feeding might thus influence later risk for NAFLD. Studies in rats showed that 
the liver might act as a systemic buffer, largely increasing its lipid content in the early 
stage of high-fat feeding.(34) It has been suggested that breastfeeding protects against 
the development non-alcoholic steatohepatitis (NASH) in children.(35) We did not have 
sufficient nutritional data to investigate differences in nutritional intake in early life 
between adults born preterm or term, and its relation with growth in infancy and the 
risk for NAFLD, but our results warrant further investigations.
In conclusion, our study shows that accelerated gain in weight compared to length in 
the first three months after term age in subjects born preterm is associated with a higher 
risk to develop NAFLD in adulthood. Long-term prospective studies are warranted to 
study the effects of various infant feeding practices on the risk for NAFLD.
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aBstraCt
Background
Body composition in early life influences the development of obesity during childhood 
and beyond. It is, therefore, important to adequately determine neonatal body composi-
tion. Fetal growth and maternal factors might influence neonatal fat mass percentage 
(FM%), independent of birth weight.
methods
In 194 healthy neonates, we investigated neonatal body composition, measured by air-
displacement plethysmography, and its associations with estimated fetal weight (EFW), 
neonatal anthropometric data and maternal preconceptional BMI and maternal weight 
gain during pregnancy. 
results
There was a large variation in neonatal FM%, even in case of a similar birth weight, 
corrected for gender and gestational age. Neonatal FM% was associated with EFW at 
30 and 36 weeks of gestation and with catch-up in weight between 30 and 36 weeks 
of gestation, but not with EFW at 20 weeks (p<0.01, p<0.01, p=0.64, resp.). Neonatal 
FM% was also associated with preconceptional BMI of the mother (p<0.01). There was 
no correlation with maternal weight gain. 
Conclusion
Our study shows that term neonates have a large variation in fat mass percentage. 
Neonatal FM% is associated with EFW at 30 and 36 weeks, catch-up in weight between 
30 and 36 weeks of gestation and preconceptional BMI of the mother. 
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IntroduCtIon
Over the last 20 years, the prevalence of overweight in Dutch children aged 4 to 12 
years, increased from 7% to 11%.(1) Childhood obesity is associated with short-term 
morbidity, such as asthma and psychological problems, and with an increased risk for 
obesity, chronic morbidity and mortality in adulthood.(2-4) Accelerated catch-up in 
weight in the first months of life is associated with a higher fat mass percentage and 
a worse cardiovascular and metabolic profile in young adults.(5-7) There is increasing 
evidence that fat mass in early life tends to track into adulthood.(8-10) 
The prevalence of overweight in adult women has increased from 29.8% to 43%.(1) 
As a result, many pregnant women are nowadays overweight or obese. Preconceptional 
maternal weight and maternal weight gain during pregnancy influence fetal growth and 
birth weight.(11, 12) Only few population-based studies investigated infant fat mass in 
relation with maternal weight and observed associations between preconceptional 
body mass index (BMI) and weight gain during pregnancy and infant body composition.
(13-18)
Most studies have focused on weight, length, and other anthropometric measures as 
a proxy for neonatal adiposity, but given the well-known relationship between adiposity 
and health outcomes, it is reasonable to question whether body composition, rather 
than just body weight, might better explain or predict health risk. Due to superior data 
collection, enhanced feasibility and increasing availability; Peapod is increasingly used 
to measure neonatal body composition as a marker of health, however, fetal and mater-
nal factors that may affect newborn findings are still not fully recognized.(19-21)
We hypothesized that neonates have different fat mass percentages due to differences 
in fetal growth, gestational age at delivery, gender, preconceptional maternal BMI and 
weight gain of the mother during pregnancy. 
We, therefore, investigated associations between these fetal and maternal determi-
nants and FM% of the neonate, measured by Peapod. For clinical practice, we assessed 
whether measurement of skinfolds could be a proxy for FM% measured by Peapod.
 
materIal and methods
subjects
The study population comprised 194 healthy neonates, born between February 2012 
and July 2013 at the department of Obstetrics of the Erasmus University Medical Center, 
Rotterdam, The Netherlands. The recruitment took place directly after birth.
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Inclusion criteria were a gestational age between 36 and 42 weeks, and an uncom-
plicated neonatal period without severe asphyxia (Apgar score <3 at 5 minutes), sepsis, 
respiratory ventilation and/or oxygen supply. Written informed consent was obtained 
from both parents unless mother was single. 
The Medical Ethics Committee of Erasmus Medical Center approved the study.
fetal growth
Fetal ultrasound examinations were carried out at standard time points, at a median 
gestational age (IQR) of 20.4 weeks (20.1-20.7), 30.3 weeks (29.9-30.6) and 36.1 weeks 
(35.6-36.4). Fetal ultrasound examinations were carried out by well-trained staff at the 
department of Obstetrics and Gynaecology using standardized ultrasound procedures. 
Ultrasound examinations were performed using the Aloka model SSD-1700 (Tokyo, Ja-
pan) or the ATL-Philips Model HDI 5000 (Seattle, WA, USA). Estimated fetal weight (EFW) 
was calculated using the formula by Hadlock.(22) Longitudinally measured EFW can be 
used as proxy for fetal growth.(23, 24) The fetal growth charts generated in the Dutch 
Generation R study were used to calculate standard deviation scores.(25) 
maternal and pregnancy characteristics
Maternal data, i.e. preconceptional weight and weight just before delivery, height, par-
ity, smoking, ethnicity and complications during pregnancy (gestational hypertension, 
pre-eclampsia, gestational diabetes), were obtained from the medical records. Height 
and weight were measured and smoking/alcohol intake were asked at the begin-
ning and during their pregnancy. Ethnicity was classified as previously described.(26) 
Women, who reported any or no smoking during pregnancy were respectively classified 
as ‘smokers’ and ‘non-smokers’. 
Data on gestational age was extracted from medical records.
Maternal underweight was defined as a BMI <18.5 kg/m2, overweight as a BMI ≥25 kg/
m2, and obesity as a BMI ≥30 kg/m2. Weight gain during pregnancy was classified as low, 
appropriate and high, according to the Institute of Medicine guideline, a guideline with 
commendations for total weight gain during pregnancy, by preconceptional BMI.(27) 
anthropometrics of the neonate
Measurements took place within 24 hours after birth. Neonatal weight was measured to 
the nearest 0.1 g on the integrated electronic scale of the Peapod and neonatal length 
and head circumference to the nearest 0.1 cm using measuring tape (SECA, circumeter). 
Skinfolds (subscapular, biceps, triceps and suprailiacal) were measured to the nearest 
mm using a skinfold caliper (slimguide C-120, Creative Health). Central skinfolds were 
calculated as the sum of subscapular and suprailiacal skinfolds and peripheral skinfolds 
as the sum of biceps and triceps skinfolds.(8)
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Body composition
Whole-body composition was assessed using air-displacement plethysmography (Pea-
pod, Infant Body Composition System, COSMED). This air-displacement plethysmography 
system assesses fat mass and fat free mass by direct measurements of body volume and 
body mass, based on the whole-body densitometric principle. Details of the principle 
and operating procedure of the Peapod have been described.(19, 21) These studies have 
shown that this method is valid for measurement of body composition in neonates. All 
measurements were obtained by experienced personnel, using standardized protocol. 
The Peapod was calibrated every day, according to the instructions of COSMED. 
statistical analysis
SD-scores for birth length and birth weight were calculated to correct for gestational 
age and gender (28). All SD-scores were calculated using Growth Analyser software 
(http://www.growthanalyser.org). 
All variables were normally distributed. Differences between boys and girls were 
examined with Student’s t-tests, chi square tests or ANOVA analysis. The associations 
of maternal anthropometrics with FM% of the neonate were assessed using linear re-
gression models. Similar models were used to examine associations of FM% with EFW 
at a median gestational age (IQR) of 20.4 weeks (20.1-20.7), 30.3 weeks (29.9-30.6) and 
36.1 weeks (35.6-36.4), gestational age, gender, birth weight, neonatal BMI, Ponderal 
Index and skinfolds measurements. Multiple linear regression analysis was performed to 
determine associations with the dependent variable FM%. In model A we entered ges-
tational age at delivery, gender, birth weight and birth length standard deviation score 
(SDS). In model B, we investigate the association of EFW on body composition. EFW at 
30 weeks was, therefore, added, and we removed birth weight SDS and birth length SDS 
because of multicollinearity. Additionally we added EFW at 36 weeks in model C, instead 
of EFW at 30 weeks. In model D, we investigated the role of preconceptional BMI of the 
mother and weight gain during pregnancy on neonatal body composition.
In addition, we examined the effect of catch-up in EFW on FM% at birth. We used the 
change in SD-scores of EFW from 20 to 30 and 30 to 36 weeks of gestation. Catch-up 
in EFW was defined as a gain in weight-SD-score >0.67, indicating clinically significant 
catch-up growth.(29)
SPSS statistical package version 20.0 (SPSS Inc. Chicago, Illinois) was used. All statisti-
cal tests were performed two-sided and results were regarded statistically significant if 
the p-value was <0.05. 
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results
Clinical characteristics
Clinical characteristics of the study population are shown in Table 1. Mean (SD) gesta-
tional age was 39.3 (1.4) weeks and birth weight SDS was 0.07 (1.2). Mean (SD) age of the 
mothers was 31.0 (5.4) years and weight gain during pregnancy was 14.6 (6.1) kg. Fifty 
percent of the mothers had a Dutch Caucasian ethnicity. 
table 1. Clinical characteristics
Total population N=194 Mean (SD)
Neonatal characteristics
Gestational age at birth * 39.3 (38.4-40.6)
Male (%) 54
Birth weight (kg) 3.384(0.5)
Birth weight SDS 0.07 (1.2)
Birth length (cm) 49.8(2.5)
Birth length SDS -0.24 (1.2)
Maternal characteristics
Age at child’s birth (yr) 31.0 (5.4)
Height (cm) 168 (0.08)
Preconceptional weight(kg) 71.5 (16.4)
Preconceptional BMI (kg/m2) 25.5 (5.6)
Highest weight in pregnancy (kg) 86.6 (17.2)
Weight gain during pregnancy (kg) 14.6 (6.1)
Primiparity (%) 50.5
Ethnicity (%)
Dutch Caucasian 50
Surinamese and Dutch Antillean 14.5
Moroccan and Turkish 13.5
Others 22
Smoking during pregnancy (%) 7
Complications of pregnancy (%) 25
Gestational hypertension 3.7
Pre-eclampsia 2.8
Gestational diabetes 4.9
Others 13.8
*median (interquartile range)
4Determinants of neonatal body composition 67
Body composition
Table 2 shows the mean (SD) parameters of body composition measured in the neo-
nates. Fat mass percentage (FM%) of the neonates was 10.3 (4.0) % (Table 2). Mean (SD) 
fat free mass percentage was 89.8 (3.9) %. Mean(SD) sum of all skinfolds was 19.1 (3.3) 
mm, central skinfolds 9.1(1.9) mm and peripheral skinfolds 9.9 (1.7) mm. 
Variation in fat mass percentage (FM%) was high, even in neonates with a similar 
weight SDS or Ponderal Index (Figure 1 and 2). For instance, in neonates with a birth 
weight of 3.5 kg, the difference in fat mass amounted to 0.5 kg, while the variation in 
FM% was 15%. 
relation-ship between fetal growth and fm%
EFW at gestational ages of 30 and 36 weeks was significantly associated with FM% at 
birth (p<0.01, p<0.01, resp.) (Table 3). After adjustment for gender and gestational age, 
EFW at 30 and 36 weeks was still significantly associated with FM% (Model B and C, 
Table 4). EFW at 20 weeks was not associated.
table 2. Body composition of neonates
Total Boys Girls  p-value
Weight (kg) 3.259 (0.49) 3.332 (0.52) 3.171 (0.44) 0.022
Weight SDS 0.07 (1.2) 0.06 (1.2) 0.07(1.1) 0.947
Length (cm) 49.8 (2.5) 50.1 (2.6) 49.6 (2.4) 0.25
Length SDS -0.02 (1.2) -0.16 (1.2) 0.14 (1.1) 0.08
Head circumference (cm) 34.7 (1.5) 34.9 (1.5) 34.5 (1.5) 0.06
Head circumference SDS 0.08 (1.3) -0.01 (1.4) 0.21 (1.2) 0.24
BMI (kg/m2) 13.0 (1.4) 13.2 (1.5) 12.8 (1.2) 0.01
BMI SDS -0.30 (1.1) -0.16 (1.2) -0.47 (1.0) 0.06
Ponderal Index 26.2 (3.1) 26.6 (3.3) 25.8 (2.8) 0.08
Fat mass (kg) 0.345 (0.17) 0.3430 (0.17) 0.3469 (0.16) 0.87
Fat mass percentage (%) 10.3 (4.0) 10.0 (3.9) 10.6 (4.0) 0.31
Fat-free mass (kg) 2.916 (0.4) 2.990 (0.4) 2.826 (0.3) 0.003
Fat-free mass percentage (%) 89.8 (3.9) 90.0 (3.9) 89.4 (3.9) 0.27
Triceps skinfolds (mm) 5.1 (1.0) 5.1 (1.0) 5.2 (1.0) 0.89
Biceps skinfolds (mm) 4.7 (1.0) 4.7 (1.0) 4.9 (1.0) 0.17
Subscapular skinfolds (mm) 5.0 (1.3) 4.9 (1.3) 5.1 (1.3) 0.66
Suprailiacal skinfolds (mm) 4.1 (1.1) 4.1 (1.2) 4.3 (1.0) 0.20
Sum of all skinfolds (mm) 19.1 (3.3) 18.9 (3.3) 19.5 (3.4) 0.26
Sum of central skinfolds (mm) 9.1 (1.9) 9.0 (2.0) 9.4 (1.8) 0.22
Sum of peripheral skinfolds (mm) 9.9 (1.7) 9.8 (1.6) 10.1 (1.8) 0.30
Data expressed as mean (SD)
Significant P values (p<0.05) are indicated in boldface
68 Chapter 4
figure 1. Relationship between birth 
weight SDS and fat mass percentage after 
birth
Birth weight SDS is corrected for gestational 
age and gender.
Correlation coefficient= 0.57, p<0.001
figure 2. Relationship between Ponderal 
Index and fat mass percentage after birth
Correlation coefficient= 0.28, p<0.001
figure 3. Difference in FM% between catch-
up and non catch-up in estimated fetal 
weight between 30 and 36 weeks of gesta-
tion
Catch-up = estimated fetal weight gain 
>0.67 SDS in period between 30 and 36 
weeks of gestation
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No association was found in the gain in EFW between 20 and 30 weeks and neonatal 
FM%, but the gain between 30 and 36 weeks was associated with FM% (r=0.46 p<0.01). 
Neonates with catch-up in fetal weight (gain in weight-SD-scores > 0.67) between 
30 and 36 weeks of gestation had a higher FM% compared to those without catch-up 
(p<0.001) (Figure 3).
relationship between maternal variables and fm%
Preconceptional BMI of the mother was associated with neonatal FM%, even after cor-
rection for gestational age, gender, birth weight SDS, birth length SDS and weight gain 
of the mother during pregnancy (Tables 3 and 4).
Neonates had a significantly higher FM% as well as fat mass in kg when mothers were 
overweight before pregnancy, compared with those of preconceptional underweight 
mothers (p=0.05, p=0.03 resp.). Weight gain of the mother during pregnancy was, 
however, not associated with neonatal FM%. FM% tended to be higher in mothers with 
a high weight gain during pregnancy, according to the guideline, versus those with 
low weight gain, but the difference was not statistically significant (p=0.09). The higher 
the preconceptional BMI of the mothers, the lower the weight gain during pregnancy 
(r=-0.17, p=0.03). In the same line, mothers with preconceptional obesity, defined as a 
BMI>30, tended to show less weight gain than mothers with a preconceptional normal 
BMI between 18 and 25 (p=0.10).
There were no significant differences in neonatal FM% between ethnic groups and 
between mothers with and without complications. 
relationship between neonatal characteristics and fm%
Regression analyses showed that neonatal FM% and fat mass were associated with birth 
weight, also after adjustment for gestational age and gender (R2= 0.32 and R2= 0.51 
resp.). 
Neonatal FM% and fat mass(kg) were also associated with the BMI (β=1.52 p<0.01, 
β=0.08 p<0.01, resp.) and the Ponderal Index of the infant (β=0.45 p<0.01, β=0.02 
p<0.01, resp.). BMI was significantly different between boys and girls (p=0.01). However, 
there was no significant difference in FM% between neonate boys and girls, as the me-
dian (IQR) FM% was 9.8 (7.0-12.6) in boys and 10.3 (7.4-13.0) in girls (p=0.31). Mean (SD) 
fat free mass was significantly higher in boys than in girls, being respectively 3.0 (0.4) 
and 2.8 (0.3)kg (p<0.01). The fat free mass % was, however, not significantly different. 
FM% was associated with gestational age, after adjustment for birth weight SDS, birth 
length SDS and gender (model A, Table 4). 
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relationship between skinfolds thickness and fm%
Skinfold measurements were associated with FM% (Table 3). The correlation with biceps 
skinfolds was 0.35 (p<0.001), triceps 0.54 (p<0.001), subscapular 0.48 (p<0.001) and 
suprailiacal 0.40 (p<0.001). The correlation between FM% and central skinfolds was 0.52 
(p<0.001) and between FM% and peripheral skinfolds 0.51 (p<0.001). The correlation 
between FM% and total sum of skinfolds was 0.56 (p<0.001).
table 3. Univariate linear regression analysis for FM% in neonates and pre- and postnatal determinants
Fatmass percentage(FM%) β 95% CI p-value
Fetal growth
EFW at 20 weeks of gestation (kg) 2.38 -7.72, 12.48 0.64
EFW at 30 weeks of gestation (kg) 5.51 3.93, 7.08 <0.01
EFW at 36 weeks of gestation (kg) 4.70 3.91, 5.49 <0.01
Maternal characteristics
Age of mother (yrs) 0.03 -0.32, 0.91 0.34
Height (m) 3.42 -0.63, 7,48 0.10
BMI before pregnancy (kg/m2) 0.11 0.05, 0.16 <0.01
Weight gain during pregnancy (kg) 0.01 -0.42, 0.07 0.66
Neonatal characteristics
Gestational age (wks) 0.13 -0.97, 0.36 0.26
Gender 0.25 -0.40, 0.88 0.45
Birth weight (kg) * 0.005 0.005, 0.006 <0.01
BMI of newborn * 1.52 1.32, 1.73 <0.01
Ponderal Index of newborn * 0.45 0.35, 0.56 <0.01
Sum of skinfolds (mm) 0.65 0.57, 0.73 <0.01
Sum of central skinfolds (mm) 1.05 0.91, 1.20 <0.01
Sum of peripheral skinfolds (mm) 1.05 0.91, 1.20 <0.01
EFW= estimated fetal weight, BMI=body mass index, weight gain during pregnancy= difference be-
tween weight at 36 weeks of gestation – pre-pregnancy weight, FM% = fat mass (grams)/ weight at 
birth(grams) x 100, sum of central skinfolds=suprailiacal skinfolds + subscapular skinfolds, sum of periph-
eral skinfolds=biceps skinfolds + triceps skinfolds
β= unstandardized regression coefficients and reflecting the difference in fat mass percentage for mater-
nal, fetal and postnatal anthropometrics. Gender: male=0, female=1
*: adjusted for gestational age 
Significant p-values (p<0.05) are indicated in boldface.
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dIsCussIon
Our study evaluated the differences in neonatal body composition in 194 healthy neo-
nates and the possible explanations of these differences. It shows that term neonates 
have a large variation in fat mass percentage, ranging from 1.4 to 19.9%, also after cor-
rection for gender and gestational age, indicating that is difficult to predict fat mass 
based on weight or ponderal index at birth. EFW at 30 and 36 weeks and catch-up in 
weight between 30 and 36 weeks of gestation as well as preconceptional BMI of the 
mother were positively associated with more FM% of the neonate. In addition, skinfolds 
were moderately correlated with FM% measured by Peapod.
In this study, a large variation in FM% in neonates was observed, even in neonates 
with a similar weight. The average FM% was 10.3%, which is in line with reported FM% 
in term neonates.(15, 30) However, the large variation in FM% in neonates with a similar 
birth weight has not yet been reported. 
We showed associations of FM% with EFW at 30 and 36 weeks of gestation. Catch-up 
in weight between 30 and 36 weeks of gestation was positively associated with neonatal 
FM%, but catch-up between 20 and 30 weeks was not. This implicates that only gain in 
fetal weight in this last period is associated with FM% at birth. 
Besides associations of FM% in neonates with fetal growth, we also showed associa-
tions with the preconceptional BMI of the mother. However, no differences in FM% could 
be found in neonates of mothers with a high weight gain during pregnancy compared 
to those with a low weight gain. It has been reported that neonates of women who 
gained excessive weight in the first part of pregnancy have higher FM% compared to 
table 4. Multiple regression for determinants of neonatal FM% 
Model A Model B Model C Model D
β P value β P value β P value β P value
Gestational age (wk) 0.013 0.031 -0.021 0.946 -0.141 0.586 0.400 0.008
Gender 0.001 0.976 -0.130 0.871 0.588 0.375 0.895 0.868
Birth weight SDS 0.099 <0.001 0.098 <0.001
Birth length SDS 0.009 0.124 0.152 0.127
Estimated fetal weight at 30 wks 0.005 0.003
Estimated fetal weight at 36 wks 1.238 <0.001
Preconceptional BMI of the mother 0.004 0.016
Weight gain mother during pregnancy 0.001 0.961
Overall p-value <0.001 0.027 <0.001 <0.001
Adjusted R2 0.518 0.073 0.177 0.557
Significant p-values (P<0.05) are indicated in boldface. β=unstandardized regression coefficients. Gender: 
male=0, female=1
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neonates of women who gained weight later in pregnancy.(31-33) As it is common in 
the Netherlands to gain more weight in the last trimester of pregnancy (34), this might 
explain why we found no differences in FM% in neonates of mothers with a high weight 
gain compared to those without. Our findings show that mothers with a higher pre-
conceptional BMI tend to have less weight gain during pregnancy than those with a 
normal preconceptional BMI. This might indicate that the international guideline with 
recommendations for total weight gain during pregnancy based on preconceptional 
BMI is followed successfully.(27) This could also be an explanation why no differences in 
FM% can be found in neonates of mothers with a high weight gain compared to those 
without. In mothers with a high preconceptional BMI caretakers will try to control the 
weight gain during pregnancy.
Despite a significant difference in BMI between boys and girls, we found no significant 
difference in FM%. It is known that female children and adult women have more fat 
mass and less lean body mass than males, but there are less data about differences in fat 
mass between neonatal boys and girls. Possibly the difference in FM% is still very small 
at birth, but becomes larger later in childhood.(30, 35) Fat-free mass was indeed higher 
in neonatal males than females. This gender difference could be attributed to the higher 
intrauterine androgen levels in boys in the last trimester, which increase lean body mass.
(36)
In our study, 96 of the 194 mothers did not have a Dutch origin, which is common 
in Dutch cities like Rotterdam. We observed no significant difference in FM% between 
neonates of Dutch origin and other ethnicities. 
The linear regression analyses showed that gestational age, birth weight, EFW at 30 
weeks and 36 weeks, and preconceptional BMI of the mother are significant contributors 
to the variance of FM% at birth. A model including all these variables is not possible, 
because several ones are closely related. For that reason, we present different models. 
The highest explained variance of these models was 56% in model D. In this model, 
the variables gestational age, birth weight SDS and preconceptional BMI are significant 
contributors to the variance in FM%.
In clinical practice, skinfold measurements are used to estimate fat mass in infants 
above 3 months of age.(37) Reference charts from birth up to 3 months of age are, 
however, not available. In the present study, we measured skinfolds in neonates and 
demonstrated that skinfold measures are reasonable indicators of overall fatness. How-
ever, skinfolds give only information about subcutaneous fat, while Peapod measures 
total FM%. Although skinfolds did correlate with FM%, it cannot reliably predict FM% in 
individual neonates and it can therefore not replace Peapod measurements. 
Our study population consisted of term neonates with a gestational age above 36 
weeks and no serious complications, thus our results cannot be generalized to all neo-
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nates. Further research is required in preterm neonates and neonates with postnatal 
complications or medication use.
In conclusion, our study shows that term neonates have a large variation in fat mass 
percentage. Neonatal FM% is associated with EFW at 30 and 36 weeks, catch-up in 
weight between 30 and 36 weeks of gestation and preconceptional BMI of the mother. 
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aBstraCt 
Introduction
Body composition in early life influences the development of obesity during childhood 
and beyond. It is, therefore, important to adequately determine longitudinal body com-
position during the first months of life. 
patients and methods
In 203 healthy term infants, we investigated longitudinal body composition, including fat 
mass percentage (FM%) and fat-free mass (FFM), by air-displacement plethysmography, 
at 1, 3 and 6 months of age, and abdominal visceral fat and abdominal subcutaneous fat, 
by ultrasound, at 3 and 6 months.
results
We found a significant increase in FM% between 1 and 3 months, but not between 3 and 
6 months (p<0.001, p=0.098, resp.). Girls had higher FM% than boys at 1 and 6 months 
(p=0.05, p<0.001 resp.) and less FFM than boys at 1, 3 and 6 months (p=0.02, p=0.02, 
p<0.001 resp.). There was a large variation in FM% at all ages, even between infants 
with similar weight SDS. Visceral fat and abdominal subcutaneous fat did not change 
between 3 and 6 months. FM% was highly correlated with abdominal subcutaneous fat, 
but not with visceral fat.
Conclusion
Changes in FM% occur mainly in the first 3 months of life, and FM%, visceral and ab-
dominal subcutaneous fat do not change between 3 and 6 months, supporting the 
concept of a critical window for adiposity development in the first three months of life. 
In addition, our study provides longitudinal reference data of FM%, FFM, visceral fat and 
abdominal subcutaneous fat during the first 6 months of life.
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IntroduCtIon
Childhood obesity is a significant public health problem in developed countries. In 
Dutch children aged 4 to 12 years, the prevalence increased from 7 to 12% over the 
last 20 years.(1) Childhood obesity is not only associated with short-term morbidity, 
but also with long-term morbidity, such as obesity, type 2 diabetes and cardiovascular 
disease(CVD) in adulthood.(2-4) Increasing adiposity in the first 6 months of life is a 
major risk factor for these adult diseases, because it tracks into adulthood.(5, 6) 
Consequently, it is crucial to accurately measure body composition and generate 
reference data for infant boys and girls. Differentiation in gender is important because 
differences in early life body composition in boys and girls will be present due to differ-
ent sex hormones levels in early life. At birth, there is evidence that girls already have 
higher fat mass and lower fat free mass compared to boys, but there are very limited 
data on gender differences later in infancy.(7-9) Accurately measured body composition 
and reference data are currently scarce.
Relationships between growth and later health have been mainly studied in retro-
spective cohort studies, or during follow-up of intervention trials.(10, 11) Most studies 
have focused on weight, length, and other anthropometric measures as a proxy for 
adiposity in infancy, instead of accurate body composition, due to the lack of available 
methods.(12, 13) The Peapod, a device based on air-displacement plethysmography, can 
assess the body composition (i.e. fat and fat-free mass) of infants. This technique allows 
for safe and accurate body composition measurements, suitable for frequent studies 
during the first 6 months of life.(14-16) Few Peapod data are available on longitudinal 
infant body composition (17), as studies either focused on body composition at birth 
(18), at one time point after birth (19), in a limited number of subjects (20) or in low-
income population.(21) No study combined longitudinal Peapod measurements with 
ultrasound measurements of subcutaneous and visceral fat.
Not only the total amount of fat, but also the location of fat accumulation is important. 
Increased visceral adipose tissue, is a major risk factor for future cardiovascular diseases. 
In obese children, greater abdominal adipose tissue is associated with an unfavorable 
metabolic profile.(22, 23) Ultrasound (US) is a non-invasive method to estimate ab-
dominal adipose tissue distribution in infancy. US-visceral fat thickness and abdominal 
subcutaneous fat thickness are reliable and reproducible estimates of respectively 
internal-abdominal (visceral) adipose tissue and abdominal subcutaneous adipose tis-
sue quantities.(24)
We hypothesized that FM% will gradually increase in the first 6 months of life and that 
girls will have more fat accrual than boys. We also hypothesized that subcutaneous and 
visceral fat thickness will also gradually increase, and that these measurements will cor-
relate with FM%. We, therefore, longitudinally measured body composition, by Peapod, 
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in a large group of infants at 1, 3 and 6 months of age, separately in boys and girls. 
We also measured visceral fat thickness and abdominal subcutaneous fat thickness by 
ultrasound at 3 and 6 months of age and studied their relationship with body composi-
tion, measured by Peapod. 
materIal and methods
subjects
The study population consisted of 203 healthy term infants. The current study is part 
of a birth cohort study (Sophia Pluto Study) aiming to provide detailed data on body 
composition and growth in early life. Children born from January 2013 were recruited 
from several hospitals in and near Rotterdam, a large city in The Netherlands. All partici-
pants fulfilled the same inclusion criteria: 1) born term (≥37 weeks of gestation), 2) Age 
<28 days, 3) uncomplicated neonatal period without signs of severe asphyxia (defined 
as an Apgar score below three after five minutes), sepsis or long-term complication of 
respiratory ventilation. Exclusion criteria were known congenital or postnatal diseases 
that could interfere with body composition development, confirmed intra-uterine in-
fection, maternal use of corticosteroids or significant maternal medical condition that 
could interfere with infant’s body composition development (e.g. diabetes). The Medical 
Ethics Committee of Erasmus Medical Center approved the study. Written informed 
consent was obtained from both parents unless mother was single. 
data collection and measurements
Outpatient clinic visits were scheduled at 1, 3 and 6 months. Birth data were taken from 
midwife and hospital records. Trained pediatric nurses performed the measurements 
according to standard procedures.
Anthropometrics
Weight was measured to the nearest gram by using an electronic infant scale (Seca, Ha-
nover, MD). Length was measured twice with the two-person technique to the nearest 
0.1 cm using an Infantometer (Seca). Head circumference was measured to the nearest 
0.1 cm using measuring tape (Seca, circumeter). Skinfolds (subscapular, biceps, triceps 
and suprailiacal) were measured to the nearest mm using a skinfold caliper (Slimguide 
C-120, Creative Health). Central skinfolds were calculated as the sum of subscapular and 
suprailiacal skinfolds and peripheral skinfolds as the sum of biceps and triceps skinfolds.
(5)
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Body	composition	
Whole-body composition was assessed using air-displacement plethysmography 
(Peapod, Infant Body Composition System, COSMED). A detailed description of the 
air-displacement plethymogragphy (ADP) system is provided elsewhere.(16) Briefly, this 
ADP system assesses fat mass (FM), fat mass percentage (FM%) and fat free mass (FFM) 
and fat-free mass percentage (FFM%) by direct measurements of body volume and body 
mass, based on the whole-body densitometric principle. Body mass was measured on 
the integrated electronic scale of the ADP system. Body volume was measured in the 
test chamber by applying pertinent gas laws that relate pressure changes to volumes 
of air in the enclosed chamber. Assessment of body volume lasted 2 min. Body density 
was then computed from the study subject’s measured mass and volume and then 
converted to %fat and fat-free mass using sex-specific equations by Fomon et al.(13) 
All measurements were obtained by experienced personnel, according to standardized 
protocol. The Peapod was calibrated every day, according to the protocol recommended 
by the supplier. 
Abdominal	fat	thickness
Visceral and abdominal subcutaneous fat thickness were measured at 3 and 6 months 
using a Prosound 2 ultrasound, with a UST-9137 convex ultrasound transducer (both 
from Hitachi Aloka Medical, Switzerland). For both measures, the transducer was posi-
tioned where the xiphoid line intercepted the waist circumference measurement plane. 
Visceral fat thickness was measured of a longitudinal plane with a probe depth of 9 cm 
and was defined as the distance between the peritoneal boundary and the corpus of 
the lumbar vertebra. Subcutaneous abdominal fat thickness was measured at the same 
location, but on a transverse plane with a probe depth of 4 cm, and was defined as the 
distance between the cutaneous boundary and the linea alba.(24)
statistical analysis
Based on literature, a power calculation was performed to calculate the sample size 
needed for determining a significant difference in percent body fat (95% confidence 
interval) between male and female infants at 6 months of age. Fields et al (17) showed that 
body fat percentage of female infants was 28.3% and 25.9% in male infants at 6 months. 
The reported difference can be determined with a power of 90% if each group consists 
of 81 infants. To take into account a possible drop-out of 30-40% over time, we included 
285 infants. There were 381 parents eligible to participate in the study. Of the 285 infants 
enrolled in study, 203 infants had complete data on body composition from birth to 6 
months of age (Supplemental figure 1). SD-scores for birth length and birth weight were 
calculated to correct for gestational age and gender, SD-scores for length and weight at 
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1, 3 and 6 months were calculated to correct for age and gender.(25) All SD-scores were 
calculated using growth analyser software (http://www.growthanalyser.org). 
All variables were normally distributed. Baseline characteristics are expressed as 
mean(sd). Differences in clinical characteristics and anthropometrics between boys and 
girls were determined with an independent sample student’s t-test. Differences in body 
composition measured by Peapod were determined using Estimated Marginal Means, 
with adjustment for length. The longitudinal changes in body composition were ana-
lyzed using repeated measures analysis. SPSS statistical package 
version 20.0 (SPSS Inc. Chicago, Illinois) was used. All statistical tests were performed 
two-sided and results were regarded statistically significant if the p-value was <0.05. 
results
Clinical characteristics of the subjects are presented in Table 1. The mean(SD) gestational 
age was 39.7(1.2) weeks and 59% of the infants were male and 87% were Caucasian. The 
mean(SD) age of the infants at follow-up was 30.1(3.4) days, 3.0(1.1) months and 6.0(0.2) 
months. 
Age, anthropometrics, BMI, sum of skinfolds, Peapod measurements and ultrasound 
measurements of boys and girls at 1, 3 and 6 months are shown in Table 1. 
table 1. Body composition of the total group and comparison between boys and girls in first 6 months of 
life.
Total group
(n= 203)
Boys 
(n=119)
Girls
(n=84)
p-value
Birth
Gestational age (weeks) 39.7(1.2) 39.7 39.8 0.30
Birthweight (grams) 3.435(1.0) 3.356 3.254 0.27
Birthweight SDS -0.34(1.1) -0.36 -0.33 0.85
Birth length (cm) 50.0(2.5) 50.0 49.6 0.98
Birth length SDS -0.19(1.3) -0.33 0.02 0.14
Age 1 month
Age (days) 30.1(3.4) 30.1 30.1 0.97
Weight (kg) 4.27(0.6) 4.39 4.15 0.02
Weight SDS 0.36(1.2) 0.36 0.35 0.94
Length (cm) 54.6(2.1) 54.9 54.1 0.006
Length SDS 0.11(0.9) 0.13 0.07 0.67
Body mass index (kg/m2) 14.3(1.3) 14.4 14.1 0.14
Body mass index SDS 0.31(1.1) 0.30 0.33 0.87
Sum of peripheral skinfolds (mm) 12.0(2.0) 11.8 12.0 0.37
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table 1. Body composition of the total group and comparison between boys and girls in first 6 months of 
life. (continued)
Total group
(n= 203)
Boys 
(n=119)
Girls
(n=84)
p-value
Age 1 month
Sum of central skinfolds (mm) 11.1(2.4) 10.9 11.3 0.30
Fat mass (kg) 0.76(0.5) 0.71 0.82 0.16#
Fat mass percentage (%) 16.8(4.8) 16.3 17.6 0.05
Fat-free mass (kg) 3.55(0.4) 3.64 3.42 0.02#
Age 3 months
Age (months) 3.01(1.1) 2.93 3.14 0.21
Weight (kg) 6.01(0.7) 6.20 5.72 <0.001
Weight SDS 0.47(1.2) 0.58 0.31 0.11
Length (cm) 61.4(2.1) 62.1 60.4 <0.001
Length SDS 0.37(0.9) 0.48 0.23 0.06
Body mass index (kg/m2) 15.9(1.4) 16.1 15.6 0.03
Body mass index SDS 0.22(1.1) 0.28 0.14 0.39
Sum of peripheral skinfolds (mm) 14.7(2.3) 14.9 14.4 0.23
Sum of central skinfolds (mm) 13.2(3.1) 13.1 13.3 0.63
Fat mass(kg) 1.39(0.8) 1.40 1.36 0.50#
Fat mass percentage (%) 22.8(5.3) 22.4 23.3 0.30
Fat-free mass (kg) 4.64(0.5) 4.80 4.41 0.02#
US-visceral fat thickness (cm) 2.51(0.6) 2.56 2.44 0.17
US-abdominal subcutaneous fat thickness (cm) 0.43(0.1) 0.44 0.42 0.54
Age 6 months
Age (months) 6.03(0.2) 6.03 6.03 0.92
Weight (kg) 7.67(0.8) 7.87 7.37 <0.001
Weight SDS 0.47(1.2) 0.25 0.13 0.95
Length (cm) 68.1(2.2) 68.8 67.0 0.006
Length SDS 0.23(0.9) 0.30 0.13 0.67
Body mass index (kg/m2) 16.5(1.4) 16.6 16.4 0.28
Body mass index SDS 0.05(1.1) 0.07 0.01 0.71
Sum of peripheral skinfolds (mm) 16.0(3.2) 15.6 16.7 0.03
Sum of central skinfolds (mm) 13.4(3.7) 13.2 13.8 0.23
Fat mass (kg) 1.85(0.5) 1.80 1.92 0.04#
Fat mass percentage (%) 24.0(5.3) 22.7 25.8 <0.001
Fat-free mass (kg) 5.80(0.6) 6.05 5.47 <0.001#
US-visceral fat thickness (cm) 2.48(0.6) 2.50 2.45 0.57
US-abdominal subcutaneous fat thickness (cm) 0.44(0.1) 0.43 0.45 0.35
Data expressed as mean(SD) Significant p-values are indicated in boldface
#=corrected for length
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peapod measurements 
Mean(SD) fat mass percentage (FM%), measured by Peapod, was at 1 month 16.8(4.8)%, 
at 3 months 22.8(5.3)% and at 6 months 24.0(5.3)%. 
In the total group, there was a significant increase in FM% between 1 and 3 months, 
but not between 3 and 6 months (p<0.001, p=0.098, resp.). When girls and boys were 
analyzed separately, we observed the same pattern in boys (p<0.001, p=0.55, resp.), but 
girls showed significant increases in FM% during both age periods (p<0.001, p<0.001, 
resp.) although less in the second period. Girls had a higher FM% than boys at 1 and 6 
months (p=0.05, p<0.001, resp.) (Table 1).
Table 2 shows the reference values for FM%, FFM%, FM and FFM. Figures 1 and 2 show 
the reference curves of FM%, FFM%, FM in kg and FFM in kg for boys and girls for ages 1 
to 6 months. Data are presented as median ± 1 and ± 2 SD- scores. 
figure 1. Reference curves for FM% and FM in kg for boys and girls
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ultrasound measurements
Mean(SD) visceral fat thickness was 2.51(0.57) cm at 3 months and 2.48(0.64) cm at 6 
months of age (p=0.24). Mean(SD) abdominal subcutaneous fat thickness was 0.43(0.12) 
cm at 3 months and 0.43(0.14) cm at 6 months. There was no difference between 
abdominal subcutaneous fat thickness at 3 and 6 months. Visceral fat thickness and 
abdominal subcutaneous fat thickness were weakly correlated at 6 months (r=0.17, 
p=0.02), but not at 3 months (r=0.01, p=0.94). Reference values are presented in Table 2. 
Supplemental figure 2 shows the scatterplots of visceral fat thickness and subcutaneous 
fat thickness at 3 and 6 months.
relationship between peapod and ultrasound measurements 
At the age of 3 and 6 months, FM% was unrelated to visceral fat thickness, but did cor-
relate positively with abdominal subcutaneous fat thickness (r=0.36, p<0.001, r=0.54, 
p<0.001, resp.).
figure 2. Reference curves for FFM% and FFM in kg for boys and girls
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relationship with other anthropometric measurements
In boys, FM% correlated with weight at the age of 3 and 6 months (r=0.45, p<0.001, 
r=0.50, p<0.001, resp.) (Table 3). In girls, FM% was also correlated with weight at 1, 3 
and 6 months of age (r=0.57, p<0.001, r=0.49, p<0.001, r=0.46, p<0.001, resp.). FM% 
correlated also with BMI at all points in boys and girls (Table 3). Despite the correlation 
between FM% and weight, the variation in FM% was high, even between infants with a 
similar weight or BMI. For instance, in infants with a weight SDS of 1 at 1 month, the FM% 
ranged from 10 to 25% and this range remained wide at 3 and 6 months with a variation 
in FM% between 12 and 30% and 17 and 33% respectively (data not shown).
table 2a. References values for FM%, FFM%, FM, 
FFM and visceral and abdominal subcutaneous 
fat thickness for boys 
Boys
Age
SDS
-2 -1 0 1 2
Peapod
FM%
1 month 6.37 11.56 16.40 19.90 27.95
3 months 11.89 17.10 22.40 26.45 35.64
6 months 11.60 17.78 22.65 28.30 33.94
FFM%
1 month 72.05 80.10 83.60 88.44 93.73
3 months 64.36 73.55 77.60 82.90 88.11
6 months 66.06 71.70 77.35 82.22 88.40
FM (kg)
1 month 0.2497 0.4885 0.7229 0.924 1.299
3 months 0.6167 0.9910 1.3533 1.771 2.535
6 months 0.7557 1.3241 1.7622 2.266 3.157
FFM (kg)
1 month 2.6854 3.2753 3.6345 4.0653 4.3050
3 months 3.7541 4.3639 4.7924 5.2230 5.6970
6 months 4.9012 5.4888 6.0881 6.5558 6.9365
Ultrasound
Visceral fat thickness (cm)
3 months 1.59 1.92 2.50 3.16 4.04
6 months 1.37 1.74 2.38 3.23 4.16
Subcutaneous fat thickness (cm)
3 months 0.21 0.32 0.41 0.54 0.76
6 months 0.25 0.32 0.41 0.55 0.67
table 2B. References values for FM%, FFM%, FM, FFM 
and visceral and abdominal subcutaneous fat thick-
ness for girls
Girls
Age SDS
-2 -1 0 1 2
Peapod
FM%
1 month 9.85 13.16 17.00 22.69 27.05
3 months 11.40 17.50 23.50 28.67 33.28
6 months 13.89 20.46 26.15 31.10 33.52
FFM%
1 month 72.95 77.31 83.00 86.84 90.15
3 months 66.72 71.33 76.50 82.50 88.60
6 months 66.48 68.90 73.85 79.54 86.11
FM (kg)
1 month 0.2746 0.4574 0.7647 1.0299 1.9258
3 months 0.5085 0.8874 1.3295 1.7581 2.5781
6 months 1.0161 1.4090 1.9141 2.4858 2.9735
FFM (kg)
1 month 2.3864 2.9109 3.4143 3.9085 4.3761
3 months 3.1018 3.9399 4.4336 5.0084 5.3220
6 months 4.4447 5.0346 5.4393 5.8724 6.5913
Ultrasound
Visceral fat thickness (cm)
3 months 1.46 1.92 2.41 2.95 3.51
6 months 1.39 1.83 2.39 3.03 3.64
Subcutaneous fat thickness (cm)
3 months 0.21 0.31 0.42 0.53 0.72
6 months 0.26 0.31 0.45 0.56 0.81
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In boys, increase in FM% between 1 and 3 months, and between 3 and 6 months were 
correlated with increase in weight SDS and BMI SDS (r=0.50, p<0.01, r=0.43, p<0.01, 
r=0.40, p<0.01, r=0.45, p<0.01 resp.). In girls, the correlations between increase in FM% 
and increase in weight SDS and BMI SDS between 1 and 3 months and between 3 and 
6 months were similar (r=0.41, p<0.01, r=0.56, p<0.01, r=0.34, p<0.01, r=0.49, p<0.01, 
resp.)
The sum of central and peripheral skinfolds at 1, 3 and 6 months correlated signifi-
cantly with FM%, both in boys and girls (Table 3). 
The sum of central or peripheral skinfolds at 3 and 6 months did not correlate with the 
visceral fat thickness, but did correlate with the abdominal subcutaneous fat thickness 
by ultrasound, both in boys and girls (Table 3).
dIsCussIon
This paper describes longitudinal reference data on fat mass percentage (FM%) and 
fat-free mass (FFM) measured by Peapod and subcutaneous and visceral fat thickness 
measured by ultrasound, in a cohort of 203 healthy term infants during the first 6 months 
of life. We revealed a significant increment in FM% during mainly the first 3 months of 
life, without a change between 3 and 6 months. When girls and boys were analyzed 
table 3. Linear correlation coefficients between anthropometric parameters, for boys and girls separately
Boys 1 month 3 months 6 months
Parameter FM% FFM FM% FFM US-V US-S FM% FFM US-V US-S
Weight 0.28* 0.85* 0.45* 0.62* 0.17 0.22^ 0.50* 0.69* 0.16 0.49*
Length 0.17^ 0.69* 0.01 0.51* 0.10 0.07 0.02 0.60* 0.14 0.07
BMI 0.29* 0.53* 0.55* 0.38* 0.12 0.22^ 0.58* 0.37* 0.09 0.54*
Sum of central skinfolds 0.37* 0.36* 0.45* -0.06 -0.09 0.33# 0.40* 0.18 0.06 0.19
Sum of peripheral skinfolds 0.21^ 0.34* 0.38* 0.16 0.00 0.24^ 0.47* 0.06 -0.01 0.28#
Girls 1 month 3 months 6 months
Parameter FM% FFM FM% FFM US-V US-S FM% FFM US-V US-S
Weight 0.57* 0.94* 0.49# 0.80* -0.20 0.46* 0.46* 0.73* 0.30# 0.29#
Length 0.34^ 0.82* 0.04 0.75* -0.18 0.26^ -0.10 0.60* 0.06 -0.16
BMI 0.61* 0.80* 0.62* 0.58* -0.14 0.45* 0.61* 0.43* 0.31# 0.46*
Sum of central skinfolds 0.59* 0.46* 0.51* 0.43* -0.06 0.28^ 0.63* -0.01 0.14 0.28^
Sum of peripheral skinfolds 0.55* 0.54* 0.23 0.43* 0.06 0.46* 0.33# 0.04 0.08 0.13
Correlation coefficients above 0.30 are indicated in boldface. p-values: *<0.001; #<0.01;^<0.05
FM%: fat mass percentage; FFM: fat free mass in kg; US-V: visceral fat thickness measured by ultrasound; 
US-S; abdominal subcutaneous fat thickness
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separately, we observed the same pattern in boys but girls showed also a significant 
increase in FM% between 3 and 6 months. Also visceral fat and abdominal subcutaneous 
fat thickness remained similar between 3 and 6 months. Girls had a significantly higher 
FM% and lower FFM at 1 and 6 months than in boys. FM% correlated with abdominal 
subcutaneous fat thickness, but not with visceral fat thickness.
Previous studies showed that the first months of life are important in the developmen-
tal programming of adiposity.(5, 10, 11) Thus data on accurate body composition in early 
life are essential. Our study is one of the first studies investigating longitudinal FM% and 
FFM by Peapod in a large group of healthy term infants.(17) Other studies investigated 
this in a smaller group or in infants in Ethiopia.(19-21, 26)
Our study shows that mainly the first 3 months of life are characterized by a rapid fat 
deposition followed by a very modest rate, supporting the concept of a critical window 
for adiposity development in the first 3 months of life.(5, 10, 11) In our study, the girls 
had a higher FM% at 1 and 6 months of age than the boys. Data on gender differences in 
body composition in the first months are limited but in studies where body composition 
was measured at 6 months by dual energy x-ray absorptiometry, girls had also a higher 
FM% than boys.(27) Our study shows that at every time point, fat-free mass was higher 
in boys than girls. This gender difference could be attributed to the higher androgen 
levels in boys in the last trimester of fetal life and during mini-puberty in the first months 
of life, which increase lean body mass.(28)
Our study also presents normative longitudinal data of abdominal subcutaneous 
and visceral fat thickness by ultrasound in a large group of infants. We found that both 
subcutaneous and visceral fat do not significantly increase in the period between 3 and 
6 months. Previous studies have consistently shown that particularly visceral obesity, 
compared to overall obesity, is a key factor in the pathogenesis of metabolic syndrome.
(29, 30) Visceral fat is considered more metabolically active compared to subcutaneous 
fat depot. Through increased release of free fatty acids to the portal circulation, it may 
be involved in the genesis of insulin resistance.(31) Furthermore, visceral adipocytes are 
known to produce vasoactive peptides and cytokines which may increase cardiovas-
cular risk via direct effects on the vasculature.(32) Therefore, accurate measurement of 
visceral fat is highly relevant when assessing infant’s risk for developing cardiovascular 
diseases later in life. 
We observed a positive correlation between FM% measured by Peapod and abdomi-
nal subcutaneous fat thickness at 3 and 6 months, but not with visceral fat thickness, 
indicating that overall FM% could not predict the amount of visceral fat and therefore 
addition of ultrasound measurements is needed.
Although there was a strong correlation between weight SDS and FM%, the variation 
in FM% was high, even in infants with a similar weight, indicating the importance of ac-
curate measurement of body composition, instead of only weight or weight for length. 
5Longitudinal body composition during first 6 months of life 91
Our findings also show that BMI is not a good marker of body composition. BMI is based 
on an estimate of the infant’s body weight and length and does not adequately capture 
the infant’s fatness. For infants, body mass index can be especially misleading because 
the relationship of lean body mass to height changes as they become older.(33)
In the present study, we measured skinfolds in infants and demonstrated that skinfold 
measures are reasonable indicators of overall fatness in a study population. However, 
skinfolds give only information about subcutaneous fat, while Peapod measures total 
FM%. Although skinfolds did correlate with FM%, it cannot reliably indicate FM% in 
individual infants, because of the wide variation, and can therefore not replace Peapod 
measurements.
Our study population was a population born in a hospital, but our data were also 
generalizable to healthy term infants born at home, because all anthropometric data 
were within -2 SDS and + 2 SDS and all variables were normally distributed, illustrating 
a normal distribution in our population. The infants of our study were mostly Caucasian 
which make our data generalizable for a large part of the developed countries. US mea-
sures were not performed at 1 month because visceral and subcutaneous fat thickness is 
then very low and therefore unreliable to measure. De Lucia Rolfe et al. reported data on 
abdominal subcutaneous and visceral fat thickness, measured by ultrasound, at 3 and 
12 months of age.(24) Our ultrasound measurements at 3 months were comparable with 
the ultrasound measurements by De Lucia Rolfe et al. There are limited data of abdomi-
nal subcutaneous and visceral fat thickness, measured by MRI, but these outcome data 
are not comparable with ultrasound data, because of different calculation of fat. In this 
study we did not include nutritional data to investigate the relationship between early 
nutrition and body composition in early life, which is a limitation of our study. Further 
studies are needed to investigate this relationship. 
In conclusion, FM% increases mainly in the first 3 months of life and stabilizes after 
3 months. Also visceral fat thickness remained stable in the period between 3 and 6 
months. These data support the concept of a critical window for adiposity development 
in the first three months of life. Girls had a longer duration of fat mass accrual than 
boys. Our study provides longitudinal reference data on body composition (FM%, FFM, 
subcutaneous fat thickness and visceral fat thickness) during the first 6 months of life.
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aBstraCt 
Introduction
Accelerated gain in fat mass and particularly in visceral fat in the first months of life 
might be major risk factors for adult diseases, because fat mass tracks into adulthood. In-
fant growth, type of feeding and maternal variables might influence the gain in weight, 
fat mass and visceral fat in early life.
patients and methods
In 300 healthy term infants, we investigated longitudinal changes in fat mass percentage 
(FM%), measured by air-displacement plethysmography (Peapod) at 1, 3 and 6 months 
of age in combination with changes in abdominal visceral and subcutaneous fat, mea-
sured by ultrasound, at 3 and 6 months, and their associations with infant growth, type 
of feeding and maternal variables
results
Gain in weight or FM% in the first 3 months of life, but not size at birth, was positively 
associated with FM% at 3 and 6 months of age. Gain in weight or FM% between 1 and 
3 months was positively associated with visceral fat at 3 months, and gain in FM% be-
tween 3 and 6 months was positively associated with visceral fat at 6 months. Exclusive 
breastfeeding (EBF) duration was positively associated with subcutaneous fat, but not 
visceral fat. Maternal characteristics did not associate with infant fat mass or visceral fat 
at 3 or 6 months.
Conclusion
Higher gain in weight and FM% in the first postnatal months lead not only to higher 
FM%, but also higher visceral fat at 6 months of age. In contrast, exclusive breastfeeding 
appears to promote subcutaneous but not visceral fat. 
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IntroduCtIon
The first three months of life are known to be a critical window for the programming 
of adiposity and cardiovascular diseases.(1-3) Unravelling the modifiable determinants 
that influence the adiposity and fat mass development in early life can provide valuable 
insights to support an optimal infant development.
We have previously shown that there were differences in risk factors for type 2 
diabetes and cardiovascular diseases at the age of 21 years between those who had a 
high versus low gain in weight-for-length during the first months of life, indicating that 
early growth might be a determinant for later life metabolic health.(4) One of the key 
elements driving early life growth is the nutrition provided to the young infant. As an 
example, it is well-known that breastfeeding is the optimal infant feeding, because it is 
associated not only with less infections and better cognitive development, but also with 
a lower incidence of childhood obesity and type 1 and type 2 diabetes.(5) However, the 
influence of breastfeeding on infant’s body composition is not straight-forward.(6-10) 
Apart from postnatal factors, higher pre-pregnancy maternal weight and more mater-
nal weight gain during pregnancy reportedly result in higher birth weight and fat mass 
percentage at birth.(11-13) However, it is not known whether these maternal factors 
continue to influence adiposity development in the first months of life. Given that the 
prevalence of overweight in adult women has increased from 29.8% to 43%(14) with 
many pregnant women being overweight or obese, this could potentially contribute to 
a vicious cycle from mother to offspring. 
Although total body fat has adverse consequences on adult disease risks, location of 
body fat is even more important. Already in childhood, abdominal visceral fat appears to 
be associated with an unfavorable metabolic profile in later life.(15) Recently, ultrasound 
has been validated to measure infant visceral fat and abdominal subcutaneous fat, en-
abling a non-invasive approach to obtain more insights in the development of these fat 
depots during infancy.(16)
Our aim was to identify the determinants of total fat mass percentage (FM%), as well 
as visceral and abdominal subcutaneous fat in the first months of life. We hypothesized 
that, independent of birth weight, early weight gain and gain in FM% between birth 
and 3 months of age are associated with a higher FM% and more visceral fat at 3 and 6 
months. We expected that a longer duration of exclusive breastfeeding would associate 
with a higher FM% at 6 months due to more subcutaneous fat. We also hypothesized 
that maternal weight gain during pregnancy and pre-pregnancy BMI would influence 
infant’s FM% and visceral fat at 3 and 6 months.
We, therefore, measured in a cohort of healthy term infants longitudinal total body 
composition by air-displacement plethysmography at 1, 3 and 6 months of age as well 
100 Chapter 6
as visceral and abdominal subcutaneous fat by ultrasound at 3 and 6 months of age and 
associated these outcomes with infant data, type of feeding and maternal variables.
materIal and methods
subjects
The study population consisted of 300 healthy term infants, who are part of a birth 
cohort study (Sophia Pluto Study) examining the postnatal determinants of body 
composition during infancy. Children were recruited from several hospitals in and near 
Rotterdam, a large city in The Netherlands. All participants fulfilled the same inclusion 
criteria: 1) born at term (≥37 weeks of gestation), 2) Age at recruitment <28 days, 3) 
uncomplicated neonatal period without severe asphyxia (defined as an Apgar score 
below three after five minutes), sepsis or long-term complication of respiratory ventila-
tion. Exclusion criteria were known congenital or postnatal diseases that could interfere 
with body composition development, confirmed intra-uterine infection, maternal use of 
corticosteroids or a maternal medical condition that could interfere with infant’s body 
composition development (e.g. diabetes). The Medical Ethics Committee of Erasmus 
Medical Center approved the study. Written informed consent was obtained from both 
parents unless the mother was single. 
data collection and measurements
Parental	and	pregnancy	characteristics
Maternal data, i.e. pre-pregnancy weight and weight just before delivery, height, parity, 
smoking, ethnicity and complications during pregnancy, were obtained from medical 
records and questionnaires.
Maternal underweight was defined as a pre-pregnancy BMI <18.5kg/m2, overweight 
as a BMI ≥25 kg/m2 , and obesity as a BMI ≥ 30 kg/m2.(17) Information regarding socio-
economic status, educational levels of the parents was obtained using questionnaires. 
The Dutch Standard Classification of Education was used to categorize mothers to 
one of four levels of education: high (university degree), mid-high (higher vocational 
training, Bachelor’s degree), mid-low (>3 years general secondary school, intermediate 
vocational training), low (no education, primary school, lower vocational training or 3 
years or less general secondary school).(18) Data on gestational age were extracted from 
medical records.
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Infant	characteristics
Research clinic visits were scheduled at ages 1, 3 and 6 months. Birth data were taken 
from midwife- and hospital records. Information on breast- and formula feeding was 
asked at the clinic visits. 
Anthropometrics
Weight was measured to the nearest gram by an electronic infant scale (Seca, Hanover, 
MD). Length was measured with the two-persons technique to the nearest 0.1 cm by 
a length meter (Seca). Head circumference was measured to the nearest 0.1 cm using 
measuring tape (Seca, circumeter). Weight SDS, length SDS and weight for length SDS 
were calculated with Growth Analyser Research Calculation Tools 4.0 (available at www.
growthanalyser.org), according to Dutch age- and gender-matched reference values.(19)
Body composition
Whole-body composition was estimated using air-displacement plethysmography 
(ADP) using the Peapod, Infant Body Composition System (COSMED).(20-23) Briefly, this 
ADP system assesses fat mass (FM), fat mass percentage (FM%) and fat free mass (FFM) 
and fat-free mass percentage (FFM%) by direct measurements of body volume and 
body mass, based on the whole-body densitometric principle. All measurements were 
obtained by experienced personnel, according to standardized protocol. The Peapod 
was calibrated every day, according to the protocol recommended by the supplier. 
Abdominal fat 
Visceral and abdominal subcutaneous fat were estimated at 3 and 6 months using a 
Prosound 2 ultrasound, with a UST-9137 convex ultrasound transducer (both from Hita-
chi Aloka Medical, Switzerland). For both measurements, the transducer was positioned 
where the xiphoid line intercepted the waist circumference measurement plane. Vis-
ceral fat was estimated by measuring visceral depth, which is the distance between the 
peritoneal boundary and the corpus of the lumbar vertebra, assessed in the longitudinal 
plane with the ultrasound probe depth set at 9 cm. Subcutaneous abdominal fat was 
estimated by the distance between the cutaneous boundary and the linea alba at the 
same location, but on a transverse plane with a probe depth of 4 cm.(16)
Statistical	analysis
SPSS statistical package version 20.0 (SPSS Inc. Chicago, Illinois) was used. Variables were 
normally distributed. Baseline characteristics were expressed as median and interquartile 
range (IQR). Linear correlations, with adjustments for gender and age, were performed 
in the total study population to determine associations between birth size SDS, increase 
in FM% between 1-3 months, duration of exclusive breastfeeding, maternal variables, 
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such as pre-pregnancy BMI and maternal weight during pregnancy with the dependent 
variables: FM%, visceral and abdominal subcutaneous fat at ages 3 and 6 months. We also 
performed multiple regression (MR) analyses to investigate the independent determinants 
of the above dependent variables. Firstly, we entered age, gender, birth weight SDS, dura-
tion of exclusive breastfeeding and W/LSDS at 1 month to the model (model A). Secondly, 
we entered W/LSDS at 3 months, instead of W/LSDS at 1 month, to the model (model B). 
Thirdly, we entered delta W/LSDS0-1mo, instead of W/LSDS at 3 month, to the model (model C). 
Fourthly, we entered delta W/LSDS1-3mo, instead of delta W/LSDS0-1mo, to the model (model D). 
Finally, we entered delta FM%1-3mo, instead of delta W/LSDS1-3mo, to the model (model E). In 
all multiple linear regression models, adjustments were made for gender and age. Models 
testing maternal variables were adjusted for birth weight to test for their independent 
effects on postnatal adiposity. All statistical tests were performed two-sided and results 
were regarded statistically significant if the p-value was ≤0.05. 
results
Clinical characteristics
Maternal and infant demographic characteristics are presented in Table 1. The median 
(IQR) age of the mothers was 33.0 (29.5-35.7) years and gestational age was 39.7 (38.9-
40.7) weeks. Fifty-eight percent of the infants were male and 87% were Caucasian. 
Table 1 also summarises the body composition and abdominal fat measurements. 
Median (IQR) fat mass percentage (FM%) at 1 month was 16.4% (14.1-19.4), at 3 months 
23.0% (19.7-25.9) and at 6 months 23.4% (19.9-27.5). Median (IQR) visceral fat was 
2.48 cm (2.10-2.89) at 3 months and 2.39 cm (2.06-2.94) at 6 months. The median (IQR) 
duration of breastfeeding was 99 days (41-178). Median (IQR) maternal pre-pregnancy 
BMI was 23.4 kg/m2 (21.2-26.5) and maternal weight gain during pregnancy was 14.0 
kg (10-18). Weight gain during pregnancy differed between maternal pre-pregnancy 
BMI-groups (p<0.001).
table 1. Maternal and infant characteristics
Median Interquartile range
Infant characteristics
Gender (boys) (%) 58
Mode of delivery (cesarean delivery) (%) 32.3
Gestational age (weeks) 39.7 38.9-40.7
Birth weight SDS -0.29 -0.99-0.33
Birth length SDS -0.36 -1.00-0.69
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table 1. Maternal and infant characteristics (continued)
Median Interquartile range
At 1 month
Weight SDS 0.44 -0.49-1.08
Length SDS 0.03 -0.58-0.68
Fat mass% 16.4 14.1-19.4
At 3 months
Weight SDS 0.52 -0.22-1.23
Length SDS 0.48 -0.18-0.94
Fat mass% 23.0 19.7-25.9
US-visceral fat (cm) 2.48 2.10-2.89
US-abdominal subcutaneous fat (cm) 0.41 0.35-0.50
At 6 months
Weight SDS 0.11 -0.35-0.78
Length SDS 0.25 -0.40-0.82
Fat mass% 23.4 19.9-27.5
US-visceral fat (cm) 2.39 2.06-2.94
US-abdominal subcutaneous fat (cm) 0.41 0.35-0.50
Duration of breastfeeding (days) 99 41-178
Maternal characteristics
Age (y) 33.0 29.5-35.7
Height (cm) 169 165-174
Pre-pregnancy weight (kg) 68 61-75
Pre-pregnancy body mass index (kg/m2) 23.4 21.2-26.5
Highest weight in pregnancy (kg) 83 74-92
Highest body mass index in pregnancy (kg/m2) 28.7 25.6-32.8
Weight gain during pregnancy (kg) 14.0 10.0-18.0
In mothers with low pre-pregnancy BMI(<18.5) 14.0 13.0-18.5
In mothers with normal pre-pregnancy BMI (18.5-24.9) 14.0 11.0-17.0
In mothers with high pre-pregnancy BMI (25.0-30.0) 15.0 11.5-22.0
In mothers with obese pre-pregnancy BMI (>30.0) 10.0 4.8-17.0
Smoking during pregnancy (%) 4.7
Caucasian ethnicity (%) 87
Educational level (%)
High 26
Mid-high 25
Mid-low 21
Low 4
Other or unknown 23
Data are expressed as median(interquartile range) or percentage. US-visceral fat = visceral fat thickness, mea-
sured by ultrasound. US-abdominal subcutaneous fat = abdominal subcutaneous fat, measured by ultrasound.
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associations with fm% at 6 months
Table 2 shows the associations of infant and maternal variables with FM% at 3 and 6 
months. 
table 2. Associations of FM% at 1,3 and 6 months with infant and maternal variables 
FM% at 3 months FM% at 6 months
β p-value β p-value
Infant characteristics
Gestational age (weeks) -0.67 0.01 -0.40 0.18
Birth weight SDS 0.11 0.71 -0.14 0.68
Birth length SDS -0.10 0.78 -0.01 0.99
At 1 month
Weight SDS 0.47 0.09 0.13 0.67
W/LSDS 1.58 <0.001 0.96 0.02
FM% 0.46 <0.001 0.32 <0.001
Delta W/LSDS0-1mo 1.05 0.08 0.59 0.34
At 3 months
Weight SDS 2.15 <0.001 1.21 0.001
W/LSDS 2.94 <0.001 2.10 <0.001
FM% 0.72 <0.001
Delta W/LSDS1-3mo 2.86 <0.001 2.53 <0.001
Delta FM%1-3mo 0.53 <0.001 0.40 <0.001
At 6 months
Weight SDS 2.51 <0.001
W/LSDS 2.87 <0.001
Delta W/LSDS3-6mo 1.92 0.002
Delta FM%3-6mo 0.52 <0.001
Duration of exclusive breastfeeding (days) 0.01 0.02 0.02 <0.01
Maternal variables
Age (y) 0.09 0.23 0.15 0.06
Height of mother (cm) -0.05 0.44 -0.03 0.61
Maternal pre-pregnancy BMI (kg/m2)^ -0.14 0.13 -0.10 0.30
Maternal weight gain during pregnancy (kg)^ 0.01 0.82 0.01 0.79
Parity mother ^ 0.88 0.04 0.55 0.23
Smoking mother during pregnancy (yes/no) 0.77 0.62 1.38 0.40
Ethnicity 0.01 0.89 0.02 0.86
Educational level 0.00 0.38 0.00 0.81
Values presented are results of multiple linear regression. β=unstandardized regression coefficient. All 
models are adjusted for gender and age. ^=Adjusted for birth weight. W/LSDS = weight for length SDS. 
Delta W/LSDS= gain in weight for length SDS. Delta FM%=gain in FM%. Significant p-values are indicated 
in boldface
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Weight for length SDS (W/LSDS), a measure of adiposity, at 1 and 3 months was positively 
associated with FM% at 6 months (p=0.02, p<0.001, respectively). Gains in weight for 
length SDS (delta W/LSDS1-3mo) and FM% (delta FM%1-3mo) between 1 and 3 months were 
both positively associated with FM% at 6 months (all p<0.001). Duration of exclusive 
breastfeeding was positively associated with FM% at 6 months (p<0.01). We could not 
identify an association between any of maternal variables (including pre-pregnancy BMI 
and maternal weight gain during pregnancy) and FM% at 6 months. 
associations with visceral and subcutaneous fat at 3 and 6 months
Table 3 shows the linear associations, corrected for gender and age, of infant and mater-
nal variables with visceral and subcutaneous fat at 3 and 6 months. 
Delta W/LSDS1-3mo was positively associated with visceral fat at 3 months (p=0.01), but 
not at 6 months(p=0.78), while a delta W/LSDS3-6mo showed a positive trend with visceral 
fat at 6 months (p=0.06). 
W/LSDS at 1 month was positively associated with subcutaneous fat at 3 months and 6 
months (p=0.04, p=0.05, resp.). W/LSDS at 3 months was also positively associated with 
subcutaneous fat at 3 and 6 months (both p<0.001) while delta W/LSDS1-3mo and delta W/
LSDS3-6mo were positively associated with subcutaneous fat only at 6 months (p<0.001). 
Delta FM%1-3mo was positively associated with visceral fat at 3 months (p=0.02), but not 
at 6 months(p=0.98), while delta FM%3-6mo was positively associated with visceral fat at 
6 months (p=0.02). 
Delta FM%1-3mo was also positively associated with subcutaneous fat at 3 and 6 months 
(p=0.01, p<0.001, resp.). 
Duration of exclusive breastfeeding was positively associated with subcutaneous fat 
at 3 and 6 months (p=0.01, p=0.03, resp.), but not visceral fat (Table 2 and 3).
Maternal pre-pregnancy BMI was not associated with infant visceral or subcutaneous 
fat at 3 and 6 months. Maternal weight gain during pregnancy was positively associated 
only with subcutaneous fat at 6 months (p=0.03). Other maternal variables were not 
associated with visceral or subcutaneous fat.
multiple regression models with dependent variables fm%, visceral and 
subcutaneous fat 
To identify determinants of FM% at 6 months that were independent of age, gender and 
birth weight, we used multiple regression (MR) models (Table 4). The first model showed 
that female gender, duration of exclusive breastfeeding and W/LSDS at 1 month were 
positively associated with FM% at 6 months, after correction for age and birth weight 
(model R2=0.166). W/LSDS at 3 months, as well as delta W/L SDS between 1 and 3 months 
were positively associated with FM% at 6 months, after correction for age, gender, birth 
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table 3. Associations of ultrasound measurements at 3 and 6 months with infant and maternal variables
At 3 months At 6 months
Visceral fat Subcutaneous fat Visceral fat Subcutaneous fat
β p-value β p-value β p-value β p-value
Infant variables
Gestational age (weeks) -0.05 0.13 0.01 0.07 0.00 0.74 0.00 0.68
Birth weight SDS -0.02 0.67 0.00 0.35 0.04 0.83 0.00 0.84
Birth length SDS -0.03 0.45 0.01 0.15 0.10 0.01 0.00 0.88
At 1 month
Weight SDS -0.07 0.05 0.03 0.001 0.06 0.08 0.00 0.42
W/LSDS 0.02 0.76 0.02 0.04 0.03 0.52 0.02 0.05
FM% -0.01 0.11 0.01 0.01 0.00 0.62 0.00 0.30
Delta W/LSDS0-1mo -0.13 0.07 0.05 0.002 0.07 0.31 0.00 0.88
At 3 months
Weight SDS 0.01 0.86 0.04 <0.001 0.07 0.07 0.03 <0.001
W/LSDS 0.07 0.20 0.04 <0.001 0.04 0.44 0.04 <0.001
FM% 0.00 0.63 0.01 <0.01 0.00 0.76 0.01 <0.001
Delta W/LSDS1-3mo 0.16 0.01 0.02 0.16 0.00 0.95 0.04 <0.001
Delta FM%1-3mo 0.02 0.02 0.01 0.01 0.00 0.99 0.01 <0.001
At 6 months
Weight SDS 0.13 0.004 0.05 <0.001
W/LSDS 0.10 0.02 0.05 <0.001
FM% 0.09 0.09 0.01 <0.001
Delta W/LSDS3-6mo 0.14 0.06 0.04 0.004
Delta FM%3-6mo 0.03 0.02 0.01 <0.001
Duration of exclusive 
breastfeeding (days)
0.00 0.49 0.00 0.01 0.00 0.74 0.00 0.03
Maternal variables
Age (y) 0.00 0.91 0.00 0.57 0.02 0.13 0.00 0.06
Height of mother (cm) -0.01 0.08 0.00 0.64 -0.01 0.19 0.00 0.05
Maternal pre-pregnancy BMI (kg/
m2)
0.01 0.43 0.00 0.13 0.00 0.18 0.00 0.57
Maternal weight gain during 
pregnancy (kg)
0.01 0.14 0.00 0.46 0.00 0.18 0.00 0.20
Parity mother -0.02 0.79 0.02 0.15 0.07 0.17 0.02 0.02
Smoking mother during 
pregnancy (yes/no)
0.30 0.11 -0.07 0.10 0.00 1.00 -0.01 0.78
Ethnicity 0.00 0.78 0.00 0.65 0.02 0.09 0.00 0.17
Educational level 0.00 0.47 0.00 0.42 0.00 0.62 0.00 0.42
Values presented are results of multiple linear regression. β=unstandardized regression coefficient. All 
models are adjusted for gender and age. W/LSDS = weight for length SDS. Delta W/LSDS= gain in weight 
for length SDS. Delta FM%=gain in FM%Significant p-values are indicated in boldface.
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weight and duration of exclusive breastfeeding (β=2.148, p<0.001, β=2.249, p<0.001, 
β=0.459, p<0.001, resp.).
As weight SDS and W/LSDS at 6 months, and delta W/LSDS3-6mo and delta FM%3-6mo were 
the only determinants for visceral fat at 6 months, we did not investigate MR models 
for 6 month of age. MR analyses with visceral fat at 3 months of age as dependent vari-
able showed associations with delta W/LSDS1-3mo, after adjustment for gender and age 
(β=0.161, p=0.010) and also further adjustment for duration of breastfeeding (β=0.128, 
p=0.044). 
To investigate which determinants determine subcutaneous fat at 6 months, we used 
the same models (data not shown). After correction for age, gender, birth weight SDS 
and duration of breastfeeding, W/LSDS at 3 months, but not at 1 month, was positively 
associated with subcutaneous fat at 6 months (β=0.042, p<0.001). Also delta W/LSDS 
between 1 and 3 months was positively associated with subcutaneous fat at 6 months 
(β=0.047, p=0.001). 
Delta FM% between 1 and 3 months was significantly associated with visceral fat at 
3 months, after adjustment for gender and age (β=0.007, p=0.022), also after further 
adjustment for duration of breastfeeding (p=0.029)(data not shown). A higher delta 
FM% between 1 and 3 months was also associated with subcutaneous fat at 6 months 
(β=0.007, p=0.002)(data not shown). 
dIsCussIon
In this prospective cohort study, we found a strong association of gain in weight SDS 
and FM% in the first 3 months of life with FM% at 6 months. Gain in weight for length 
SDS and in FM% between 1 and 3 months was associated with visceral fat at 3 months 
and a higher gain in FM% between 3 and 6 months was associated with more visceral fat 
at 6 months. Exclusive breastfeeding duration was positively associated with FM% and 
subcutaneous fat at 6 months, but not visceral fat. 
To our knowledge, this is the first study investigating determinants of infant FM% as 
well as visceral and subcutaneous fat during the first 6 months of life. Gain in weight 
for length SDS in the first 3 months of life was associated with higher FM% at 6 months. 
This is in line with previously reported associations of weight for length SDS in the 
same period with risk factors for type 2 diabetes and cardiovascular diseases.(24) These 
data support our previous findings, showing that young adults at the age of 21 years 
had higher risk factors for type 2 diabetes and cardiovascular diseases when they had 
a higher gain in weight for length SDS in the first 3 months, while after 3 months no 
associations between adiposity and risk factors at 21 years could be found. Also other 
research-groups have confirmed these findings.(1,25)
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We show that especially the gain in FM% between 1 and 3 months leads to a higher 
FM% at 6 months and more visceral fat at 3 months. For example, there is 0.459% higher 
FM% at 6 months per 1% increase between 1 and 3 months. We have previously shown 
that infants with a higher FM% at 6 months, measured by DXA scan, tended to keep 
this higher FM% during childhood (26), while other studies showed that visceral fat in 
early life tends to track into childhood and adulthood.(27-29) Our results show that this 
might start in the first 3 months of life. A strength of the current study is its prospective 
design to investigate whether different growth patterns result indeed in differences in 
total body FM%.
We found no association between total body FM% and visceral fat, which is in line 
with the literature showing that in children total body FM% is more associated with 
subcutaneous fat rather than with visceral fat.(30) Our data show that associations with 
total FM% cannot be simply extrapolated to visceral fat. 
Infants with exclusive breastfeeding at 6 months had a higher FM% at 6 months than 
those with exclusive formula feeding. This contrasted our expectations, as exclusive 
breastfeeding during infancy has been associated with a lower risk of childhood obesity.
(31) However, we found that longer duration of exclusive breastfeeding was associated 
with a higher FM%, due to more subcutaneous fat and not to more visceral fat, indicat-
ing that the higher FM% in exclusively breastfed infants consists predominantly of a 
higher amount of subcutaneous fat. Increased subcutaneous fat in childhood has been 
associated with a more beneficial phenotype for obesity and adult diseases.(32) 
While parents play a major role in deciding the mode of nutrition for their infant, other 
parental and heritable factors may be even more important in determining the body 
composition and obesity risk in their infants. In contrast to our expectations, maternal 
variables, like BMI before pregnancy, did not associate with infant FM% at 3 and 6 
months. In a previous study, we showed that maternal BMI before pregnancy associates 
with FM% at birth (2) and also other studies have shown associations between maternal 
variables and FM% of newborns (13,33), but apparently this early effect disappears after 
the first month of life. Our findings are in line with another study, showing that maternal 
BMI and weight gain during pregnancy had no influence on FM%, measured by DXA, in 
infants at 6 months of age.(34) We now show that there is already a lack of association 
between maternal variables and FM% of the infants at the age of 3 months. 
In conclusion, our study shows that a higher gain in weight for length in the first 
months of life leads to more visceral fat at 3 months and to more FM% at 3 and 6 months. 
Similar associations were found with a higher increase in FM% in the first months of 
life. We consider that these changes in adiposity may underlie the reported long-term 
associations between weigh for length SDS in early life and risks for obesity and adult 
diseases in later life. We also show that the consistently reported association between 
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exclusive breastfeeding and higher total body FM% in mid-infancy appears to be due to 
higher subcutaneous fat, but not visceral fat. 
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aBstraCt
Introduction
Body composition in early life influences the development of obesity during childhood 
and beyond. Appetite regulating hormones, such as ghrelin and leptin, play a role in the 
regulation of food intake and energy balance and might thus influence body composi-
tion in later life. Studies on associations between appetite regulating hormones and 
body composition in early life are limited. We, therefore, investigated serum appetite 
regulating hormones and associated these with type of feeding and body composition, 
including fat mass percentage (FM%), visceral and subcutaneous fat.
patients and methods
In 197 healthy term infants, we measured serum fasting levels of ghrelin, leptin, insu-
lin, glucose-dependent insulinotropic peptide (GIP), pancreatic polypeptide (PP) and 
peptide YY (PYY) at 3 months and in 41 infants also at 6 months. We investigated their 
associations with type of feeding and longitudinal fat mass percentage (FM%) measured 
by air-displacement plethysmography at 1, 3 and 6 months and with abdominal visceral 
and subcutaneous fat, measured by ultrasound, at 3 and 6 months.
results
Infants with exclusive formula feeding for 3 months had significantly higher serum 
levels of ghrelin, leptin, insulin, GIP and PP (p=0.026, p=0.018, p=0.002, p<0.001, resp.) 
and lower serum levels of PYY (p=0.002) at 3 months than breastfed infants. Leptin and 
ghrelin were positively correlated with FM% at 3 months and insulin with change in 
FM% between 1 and 3 months (r=0.40, p<0.001, r=0.23, p<0.05, r=0.22, p<0.01, resp.). 
Leptin at 3 months correlated with subcutaneous fat at 3 months (r=0.23, p<0.001), but 
not with visceral fat. Other appetite regulating hormones did not correlate with body 
composition.
Conclusion
Formula fed infants had a very different profile of serum appetite regulating hormones 
than breastfed infants, suggesting that lower levels of ghrelin, leptin and insulin in 
breastfed infants could contribute to the protective role of breastfeeding against obe-
sity development. Leptin, ghrelin and insulin were associated with fat mass percentage 
or changes in fat mass percentage.
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IntroduCtIon
Childhood obesity is a worldwide problem with an increasing prevalence of 7 to 11% in 
Dutch children aged 4 to 12 years.(1) It is not only associated with short-term morbidity, 
but also with long-term morbidity, such as adult obesity, type 2 diabetes and cardio-
vascular diseases.(2-4) Accelerated weight gain during the first three months of life is 
associated with accumulation of fat mass during childhood and a worse cardiovascular 
and metabolic profile in young adulthood.(5-7) Appetite regulating hormones play a 
role in the regulation of food intake and body composition by signaling satiety and 
energy reserves through hypothalamic receptors.(8) However, little is known about the 
relation between body composition and appetite regulating hormones in early life.(9) 
Changes in body composition might be influenced by programming of the orexigenic 
and anorectic appetite regulating hormones.(10) Orexigenic appetite stimulating hor-
mones, such as ghrelin, are important in the initiation, cessation and frequency of eating. 
Anorectic appetite regulating hormones, such as leptin and peptide YY (PYY), decrease 
food intake and increase metabolic rate. The glucose-dependent insulinotropic peptide 
(GIP) stimulates pancreatic beta-cells in response to the ingestion of meals or glucose.
(11,12) All these signals act at several sites in the central nervous system (CNS) but the 
pathways converge to the hypothalamus, which contains a large number of peptides 
and other neurotransmitters that influence food intake. 
The protective role of breastfeeding for obesity could be partly explained by the 
composition of the human milk, but probably also by different appetite regulating 
hormones in infants due to breastfeeding. Knowledge about the changes in appetite 
regulating hormones during infancy is very limited.(13) 
We hypothesized that formula fed infants would have a different profile of serum ap-
petite regulating hormones than breastfed infants and that fasting serum ghrelin, leptin 
and insulin levels would be positively associated with gain in weight and in fat mass 
during the first 3 months after birth while GIP, PP and PYY levels would be negatively 
associated. We, therefore, investigated fasting serum levels of ghrelin, leptin and insulin, 
GIP, PP and PYY at 3 months and associated these with type of feeding and body compo-
sition, including FM% and visceral and subcutaneous fat at 3 and 6 months.
materIal and methods
subjects
The current study is part of a birth cohort study (Sophia Pluto Study) which started in 
January 2013, aiming to provide detailed data on body composition and growth in early 
life.
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Serum levels of appetite regulating hormones (ghrelin, leptin, insulin, GIP, PYY, PP) 
were determined in a random subgroup of 197 infants at 3 months of age and in 41 of 
them also at 6 months of age.
Infants were recruited from several hospitals in and near Rotterdam, a large city in 
The Netherlands. All participants fulfilled the same inclusion criteria: 1) born term (≥37 
weeks of gestation), 2) age <28 days, 3) uncomplicated neonatal period without signs 
of severe asphyxia (defined as an Apgar score below three after five minutes), sepsis or 
long-term complication of respiratory ventilation. Exclusion criteria were known con-
genital or postnatal diseases that could interfere with body composition development, 
confirmed intra-uterine infection, maternal use of corticosteroids or significant maternal 
medical condition that could interfere with infant’s body composition development 
(e.g. diabetes).
The Medical Ethics Committee of Erasmus Medical Center approved the study. Written 
informed consent was obtained from both parents unless mother was single. 
data collection and measurements
Information about the type of feeding was recorded during research clinic visits.
Infant	characteristics
Research clinic visits were scheduled at 1, 3 and 6 months. Birth data were taken from 
midwife and hospital records. Trained pediatric nurses performed the measurements 
according to standard procedures.
Anthropometrics
Weight was measured to the nearest gram by an electronic infant scale (Seca, Hanover, 
MD). Length was measured to the nearest 0.1 cm by a length meter (Seca). Head circum-
ference was measured to the nearest 0.1 cm using measuring tape (Seca, circumeter). 
Weight SDS, length SDS and weight for length SDS were calculated with Growth Analy-
ser Research Calculation Tools 4.0 (available at www.growthanalyser.org), according to 
Dutch age- and gender-matched reference values.(14) 
Body composition
Whole-body composition was assessed using air-displacement plethysmography 
(Peapod, Infant Body Composition System, COSMED). A detailed description of the air-
displacement plethymogragphy (ADP) system is provided elsewhere.(15-18) Briefly, this 
ADP system assesses fat mass (FM), fat mass percentage (FM%) and fat free mass (FFM) 
and fat-free mass percentage (FFM%) by direct measurements of body volume and 
body mass, based on the whole-body densitometric principle. All measurements were 
7Appetite regulating hormones in early life 119
obtained by experienced personnel, according to standardized protocol. The Peapod 
was calibrated every day, according to the protocol recommended by the supplier. 
Abdominal fat 
Visceral and abdominal subcutaneous fat were measured at 3 and 6 months using a Pro-
sound 2 ultrasound, with a UST-9137 convex ultrasound transducer (both from Hitachi 
Aloka Medical, Switzerland). For both measures, the transducer was positioned where 
the xiphoid line intercepted the waist circumference measurement plane. Visceral fat 
was estimated by measuring visceral depth, which is the distance between the peri-
toneal boundary and the corpus of the lumbar vertebra, assessed in the longitudinal 
plane with the ultrasound probe depth set at 9 cm. Subcutaneous abdominal fat was 
estimated by the distance between the cutaneous boundary and the linea alba at the 
same location, but on a transverse plane with a probe depth of 4 cm.(19)
Collection	of	blood	and	assays
At 3 months, blood samples were collected from a heel prick after the infants had fasted 
for at least 3 hours. To stabilize the appetite regulating hormones, blood samples were 
collected in EDTA tubes and dipeptidyl peptidase-4 inhibitor (DPP4-inhibitor, Merck 
Chemicals) and 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (serine prote-
ase inhibitor, Calbiochem) were added at the time of collection. Blood was centrifuged 
at 4 ºC to prepare plasma, which was quickly frozen. Samples were stored at -80 ºC.
Ghrelin (active), leptin, insulin, GIP, PP and PYY concentrations in serum were deter-
mined by the MILLIPLEX MAP-Human Metabolic Hormone Magnetic Bead Panel, catalog 
number HMHMAG-34K (Millipore Corporation, Billerica, MA) using the commercial 
protocol.
statistical analysis
Descriptive results are expressed as median (interquartile range). Differences between 
groups were examined using Mann-Whitney U tests. We assessed linear correlations 
between levels of ghrelin, leptin, insulin, GIP, PP and PYY and other parameters using 
Pearson’s correlation coefficient. Correlation coefficient below 0.20 was considered to be 
a negligible correlation. SPSS statistical package version 20.0 (SPSS Inc. Chicago, Illinois) 
was used. All statistical tests were performed two-sided and results were regarded 
statistically significant if the p-value was <0.05. 
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table 1. Clinical characteristics
Total group Girls Boys p-value
♀ vs. ♂
Subgroup
p-value #
(n=197) (n=93) (n=104) (n=41)
Birth
Gestational age (weeks) 39.9 38.9-40.6 39.9 39.7 0.58 39.4 0.03
Birth weight SDS -0.38 -1.12-0.33 -0.42 -0.35 0.60 -0.85 0.08
Birth length SDS 0.13 -1.05-0.80 0.13 -0.38 0.47 -0.97 0.10
Age 1 month
Age (months) 0.95 0.92-1.05 0.95 0.99 0.38 0.95 0.34
Weight SDS 0.33 -0.51-1.09 0.42 0.33 0.79 -0.04 0.09
Length SDS 0.04 -0.61-0.68 0.04 0.02 0.61 -0.11 0.03
Sum of peripheral skinfolds (mm) 11.0 10.0-13.0 11.0 11.0 0.73 11.0 0.33
Sum of central skinfolds (mm) 11.0 9.0-12.0 11.0 11.0 0.67 11.0 0.46
Fat mass (kg) 0.68 0.54-0.86 0.65 0.73 0.62 0.74 0.65
Fat mass percentage (%) 16.4 13.7-19.4 16.5 16.3 0.39 17.7 0.49
Age 3 months
Age (months) 2.99 2.92-3.06 2.99 2.99 0.90 2.99 0.40
Weight SDS 0.49 -0.24-1.22 0.36 0.57 0.05 0.27 0.58
Length SDS 0.43 -0.17-0.90 0.27 0.56 0.04 0.18 0.14
Sum of peripheral skinfolds (mm) 15.0 13.0-16.0 14.0 15.0 0.10 15.0 0.28
Sum of central skinfolds (mm) 13.0 11.0-15.0 12.0 13.0 0.53 13.0 0.05
Fat mass (kg) 1.33 1.12-1.59 1.29 1.37 0.23 1.32 0.79
Fat mass percentage (%) 22.6 19.7-25.8 23.1 22.4 0.34 23.2 0.92
Visceral fat (cm) 2.53 2.03-2.89 2.39 2.54 0.23 2.54 0.31
Abdominal subcutaneous fat (cm) 0.42 0.35-0.50 0.42 0.43 0.14 0.41 0.42
Age 6 months
Age (months) 6.01 5.95-6.11 6.01 6.01 0.57 5.98 0.57
Weight SDS 0.14 -0.31-0.71 0.06 0.18 0.33 0.09 0.37
Length SDS 0.29 -0.34-0.78 0.25 0.31 0.64 0.20 0.14
Sum of peripheral skinfolds (mm) 16.0 14.0-17.0 17.0 15.0 0.18 15.0 0.75
Sum of central skinfolds (mm) 12.0 11.0-15.0 13.0 12.0 0.36 13.0 0.85
Fat mass (kg) 1.76 1.44-2.09 1.79 1.75 0.42 1.70 0.31
Fat mass percentage (%) 23.5 20.2-27.3 24.8 22.8 <0.01 22.6 0.16
Visceral fat (cm) 2.34 2.00-2.84 2.34 2.45 0.80 2.19 0.91
Abdominal subcutaneous fat (cm) 0.41 0.35-0.51 0.45 0.41 0.63 0.40 0.39
Data expressed as median (interquartile range) 
Significant p-values are indicated in boldface # Differences between total group and subgroup
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results
Clinical characteristics of the infants are presented in Table 1. The median (IQR) gesta-
tional age was 39.9 (38.9-40.6) weeks and 53% of the infants were boys. Forty-one boys 
had their appetite regulating hormones longitudinally determined at 3 and 6 months. 
Fifty-six per cent of the infants received exclusive breastfeeding at 1 month, 32% at 3 
months and 16% at 6 months. 
Table 2 shows serum levels of ghrelin, leptin, insulin, GIP, PP and PYY at 3 and 6 months. 
Median fasting time had been 3:00 (2:30-3:40) hours at 3 months and 2:52 (2:13-4:15) 
hours at 6 months. Ghrelin, GIP and PP levels increased significantly from 3 to 6 months 
(p<0.001, p=0.016, p<0.001, resp.), while the leptin levels decreased between 3 and 6 
months (p=0.009). 
There were no differences in appetite regulating hormone levels between boys and 
girls (Table 2).
table 2. Serum levels of appetite regulating hormones in infants at 3 and 6 months of age
3 months 6 months p-value
girls vs. boys
at 3 monthsGirls Boys Boys
Total group (n=197) 
Hours fasting (h) 2:50 2:22-3:30 3:12  2:30-3:55 0.11
Ghrelin (pg/ml) 44.0 23.4-82.1 48.9  23.4-68.3 0.57
Leptin (pg/ml) 1439.6 875.3-2364.7 1405.2  742.6-2001.4 0.24
Insulin (pg/ml) 369.0 232.3-619.5 430.5  265.7-738.1 0.30
GIP (pg/ml) 244.8 133.0-393.1 237.3  138.5-350.8 0.87
PP (pg/ml) 59.8 31.7-94.2 68.3  46.5-104.1 0.08
PYY (pg/ml) 210.6 159.4-293.8 196.9  156.3-250.8 0.24
p-value 
3 vs. 6 months
Subgroup (n=41)
Hours fasting (h) 3:25  2:38-4:00 2.52  2.13-4.15 0.252
Ghrelin (pg/ml) 46.2  20.2-67.6 83.1  48.7-102.6 <0.001
Leptin (pg/ml) 1560.4  945.4-1991.4 827.2  424.6-1247.2 <0.001
Insulin (pg/ml) 464.9  291.6-718.5 483.8 324.4-635.6 0.821
GIP (pg/ml) 263.1  137.1-345.4 310.9  201.5-421.1 0.008
PP (pg/ml) 70.9  41.4-127.8 115.7  68.4-241.6 <0.001
PYY (pg/ml) 171.6  150.1-231.7 158.7 130.7-205.6 0.065
Data expressed as median (interquartile range)
Significant p-values are indicated in boldface
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associations between appetite regulating hormones and type of feeding 
Table 3 shows the serum levels of appetite regulating hormones during exclusively 
formula feeding vs. exclusively breastfeeding for 3 months. There were no significant 
differences in weight SDS, FM%, visceral and subcutaneous fat at 1, 3 and 6 months 
between the formula fed and breastfed infants but all appetite regulating hormones 
were different between the formula fed and breast fed groups. Serum levels of ghrelin, 
leptin, insulin, GIP and PP were significantly higher in the formula fed group compared 
to the breastfed group (p=0.026, p=0.018, p=0.002, p<0.001, resp.), whereas PYY was 
significantly lower (p=0.002). 
At 3 months, a shorter duration of exclusive breastfeeding correlated only with a 
higher PP level (r=-0.24, p=0.005). At 6 months, we found no significant correlations of 
duration of breastfeeding with appetite regulating hormones.
associations between appetite regulating hormones and fat mass percentage 
Serum leptin at 3 months correlated with fat mass percentage (FM%) at that age (r=0.37, 
p<0.001) (Table 4). Similar associations were found between serum leptin at 3 months 
and FM% at 6 months (r=0.41, p<0.001). Serum insulin at 3 months correlated with the 
increase in FM% between 1 and 3 months (r=0.22, p<0.01). The other appetite regulat-
ing hormones did neither correlate with FM% nor with changes in FM%. We found in 
the formula fed infants a positive correlation between ghrelin at 3 months and FM% 
(r=0.23, p<0.05) at that age. In the breastfed infants, we did not find this correlation, 
but a stronger correlation between leptin and FM% (r=0.61, p<0.001) (data not shown).
associations between appetite regulating hormones and visceral and 
subcutaneous fat
Serum leptin, ghrelin and insulin at 3 months did not correlate with visceral and subcu-
taneous fat at 3 and 6 months. Breastfed infants showed a correlation between leptin 
and subcutaneous fat at 3 months (r=0.38, p<0.01) (data not shown).
table 3. Serum levels of appetite regulating hormones in 197 infants at 3 months, divided by type of feed-
ing 
Exclusive FF at 3 months Exclusive BF at 3 months p-value
Ghrelin (pg/ml) 49.1 33.2 0.026
Leptin (pg/ml) 1719.1 1190.1 0.018
Insulin (pg/ml) 560.9 287.8 <0.001
GIP (pg/ml) 304.1 198.5 0.002
PP (pg/ml) 87.7 46.3 <0.001
PYY (pg/ml) 180.2 231.0 0.002
 Data were expressed as medians. Significant p-values are indicated in boldface
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associations between appetite regulating hormones and anthropometrics
As a proxy for body composition, anthropometrics are often used. We, therefore, also 
analyzed correlations between appetite regulating hormones and anthropometrics. 
Serum leptin at 3 months correlated positively with weight for length SDS at 3 months 
(r=0.48, p<0.001) and 6 months (data not shown) (Table 4). A higher PYY at 3 months 
correlated with lower weight for length SDS at 3 months (r=-0.23, p<0.01). Serum leptin 
and insulin at 3 months correlated with the increase in weight for length SDS between 1 
and 3 months of life (r=0.45, p<0.001, r=0.20, p<0.01, resp.).
dIsCussIon
In this study, we investigated the fasting serum levels of appetite regulating hormones, 
such as ghrelin, leptin, insulin, GIP, PP and PYY in infants at 3 and 6 months and their 
associations with type of feeding, FM%, visceral fat and subcutaneous fat. Interestingly, 
all appetite regulating hormones were different between infants with formula feeding 
compared to the breastfed infants. Serum levels of ghrelin, leptin, insulin, GIP and PP 
were significantly higher in the formula fed group, whereas PYY was significantly lower. 
Leptin at 3 months correlated positively with FM% at 3 and 6 months, but only with 
subcutaneous fat and not with visceral fat. Also ghrelin at 3 months correlated with FM% 
at 3 months, but only in formula fed infants. Serum insulin correlated positively with 
gain in FM% between 1 and 3 months. Other appetite regulating hormones were not 
associated with fat mass percentage and visceral fat in the first 3-6 months. 
We show that formula fed infants have different levels of appetite regulating hor-
mones than infants with exclusive breastfeeding. For healthy term infants exclusive 
breastfeeding is considered the reference to which formula feeding must be compared. 
Serum levels of ghrelin were significantly higher in formula fed than in breastfed infants. 
These data are in line with a cross-sectional study where the same results were found in 
table 4. Correlations of appetite regulating hormones with body composition and anthropometry at 3 
months in 197 infants
FM% Delta FM% 
1-3mo
Visceral 
fat
Subcutaneous 
fat
Weight for 
length SDS
Delta weight for 
length SDS 
1-3mo
Ghrelin (pg/ml) 0.11 0.01 <0.01 <0.01 0.06 0.04
Leptin (pg/ml) 0.37** 0.04 0.01 0.16^ 0.48** 0.45**
Insulin (pg/ml) <0.01 0.22* 0.19* -0.01 0.08 0.20*
GIP (pg/ml) 0.03 -0.16^ 0.11 -0.08 0.04 0.13
PP (pg/ml) 0.04 -0.02 0.04 -0.02 0.03 0.09
PYY (pg/ml) -0.08 0.03 0.03 -0.12 -0.23* -0.12
Significant p-values are indicated in boldface if r>0.20 and p<0.05. ^:p<0.05 *: p<0.01 **: p<0.001
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the first year of life in a group of Italian infants.(20) It has been demonstrated in animal 
studies that neonatal ghrelin is important for normal maturation of hypothalamic neural 
circuits. The neural developmental activity of ghrelin is essentially restricted to the neo-
natal period.(21) Proper expression of ghrelin during neonatal life is, therefore, crucial for 
lifelong metabolic regulation and too high ghrelin levels during the first months of life 
result in lifelong metabolic disturbances.(22) In the formula fed infants, we did not find 
very high levels of ghrelin, but their levels were significantly higher than in the breastfed 
infants. In this critical period, this could have adverse effects on the maturation of the 
hypothalamic neural circuits resulting in less favorable metabolic regulation in later 
life.(23) We found also higher leptin levels in formula fed infants. Like ghrelin, leptin is 
known to promote the development of the arcuate nucleus in the hypothalamus and its 
developmental action is also restricted to a critical window in the first months of life(24), 
but higher ghrelin levels could impair leptin signaling in the arcuate nucleus in early life.
(21) Our data are in line with another study, reporting higher leptin levels in formula fed 
infants compared to breastfed newborns.(25) 
Infants with formula feeding had lower levels of PYY. One of the actions of PYY is to 
reduce food intake by reducing the gastro-intestinal tract motility and the gastric emp-
tying, via the vagal-brainstem-hypothalamic pathway.(26) As the breastfed infants had 
higher PYY levels, that could be a link in the protective role of breastfeeding for obesity. 
In addition, we found that higher levels of PYY were associated with a lower weight for 
length SDS at 3 months. These results are in line with the data of Helsinki Birth Cohort 
Study, where they found higher PYY levels in adulthood when the infants had a lower 
growth rate during infancy.(27) Our study shows that these differences can already be 
found in early life. Infants with formula feeding had also higher levels of insulin, GIP and 
PP. A possible explanation of the higher insulin levels in formula fed infants could be the 
amount of proteins, which is in general higher in formula feeding than in breastfeeding.
(28) Another higher appetite regulating hormone in formula fed infants was GIP, which 
plays an important role in the regulation of plasma glucose and insulin secretion.(29) It 
is possible that higher GIP levels could account for an enhanced insulin release.(30) Also 
PP was higher in formula fed infants. The function of PP is to self-regulate pancreatic 
secretion activities.(31) However, the mechanism how the type of feeding influences 
the GIP and PP levels is not fully understood. For further interpretation of the potential 
relevance of these findings more research is required. 
To our knowledge, this is the first large study investigating the relationship between 
simultaneously measured serum levels of appetite regulating hormones and detailed 
measurements of infant body composition, by air-displacement plethysmography (Pea-
pod). We found a significant positive correlation between serum ghrelin and FM% at 3 
months in the formula fed infants, but not in the breastfed group. Leptin was also cor-
related with FM% in both formula fed and breastfed groups. The associations of leptin 
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with FM% could be explained by the known physiology of adipose tissue. During early 
life, the adipocytes proliferate and differentiate.(32) Leptin levels increase in parallel to 
the number of adipocytes during the last part of the third trimester during gestation 
and the first months of life.(33) We demonstrated that leptin levels in male infants were 
higher at 3 months than at 6 months. This fits with our previous findings that there is an 
increase in fat mass in the first 3 months of life and a stabilization thereafter in male in-
fants.(34) Serum insulin correlated positively with gain in FM% between 1 and 3 months. 
Earlier studies showed a positive association of insulin and insulin resistance with fat 
mass in childhood and adulthood.(35,36) The other appetite regulating hormones such 
as PP and GIP did not associate with FM% or gain in FM% in the total group, which partly 
contrasted our expectations. There is a need for further studies to identify the underly-
ing mechanisms and potential implications for possible programming effects of serum 
appetite hormones on later body composition. 
We could not identify differences in appetite regulating hormones between boys and 
girls, which is in line with studies in older children and in a study with a subset of ap-
petite regulating hormones in infants.(29,37,38)
We did not investigate hormone levels in breastmilk. Some studies investigated levels 
of ghrelin, leptin or insulin in breastmilk.(39-41) In these studies, associations between 
appetite regulating hormones in breast milk and anthropometric data of infants were 
found. An unhealthy maternal diet can lead to an unfavorable appetite regulating 
hormone profile in breast milk, but it is not clear by which mechanism this unfavorable 
profile in breastmilk could influence infant growth as hormones will be degraded when 
passing the stomach. In our study, we only investigated fasting levels of appetite regu-
lating hormones. We realize that several appetite regulating hormones are low in fasting 
state (29), but our study shows that even in fasting state all hormones were different 
between the formula fed and breastfed infants. It would be interesting to investigate ap-
petite regulating hormone levels before and after a meal, but in our study it was found 
unethical to collect blood for research purpose twice in healthy infants.
In conclusion, we found significantly higher serum levels of ghrelin, leptin, insulin, GIP 
and PP and lower serum levels of PYY in infants who received exclusive formula feeding 
for at least 3 months compared to breastfeeding. Besides associations of leptin, ghrelin 
and insulin with body composition in infants of 3 and 6 months of age, we could not 
identify other associations of serum appetite regulating hormones with body composi-
tion. Further studies on appetite regulating hormones and the interactions between 
these and body composition later in infancy would be helpful to further elucidate 
whether appetite regulating hormones contribute to the programming of metabolic 
health in later life. 
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aBstraCt
Introduction
The first three months of life are known to be a critical window for the programming 
of adiposity and cardiovascular diseases. Studies suggest a relationship between the 
compositional pattern of the gut microbiota and obesity in adults, but such data are 
very limited in infants. We, therefore, investigated several fecal parameters in early life, 
such as secretory immunoglobulin A (sIgA) and short chain fatty acids (SCFA) contents, 
and the composition of the microbiota at the first and third month of life, also in relation 
to type of feeding, infant’s body composition and accelerated weight gain.
patients and methods
Fecal samples of 51 infants were obtained at 1 and 3 months after birth. The microbiota 
composition was characterized by targeted 16S rRNA gene amplicon pyrosequencing. 
Associations of type of feeding, infant’s body composition and accelerated weight gain 
in combination with the sIgA, SCFAs and microbiota were investigated. 
results
Formula fed (FF) infants had lower levels of sIgA at 1 and 3 months than their breastfed 
(BF) counterparts (both p<0.001), but levels increased over time in contrast to BF infants. 
In FF infants, we found that a higher change in sIgA between 1 and 3 months correlated 
with a higher increase in FM% between 1 and 3, and 3 and 6 months (p=0.02, p=0.003) and 
that higher sIgA and acetic acid at 3 months correlated with more visceral fat at that age 
(p=0.04, p=0.02), while a higher level of propionic acid at 1 month correlated with a lower 
increase in FM% between 3 and 6 months (p=0.02). Besides higher levels of Firmicutes at 
3 months, FF infants had no different microbiota compared to BF infants. Infants with ac-
celerated weight gain had higher amounts of sIgA at 3 months and lower levels of butyric 
acid at 1 month (p=0.009, p=0.02, resp.). Microbiota were not different between infants 
with and without accelerated weight gain at month 1, 3, or over time, although infants 
with accelerated weight gain had a significantly higher increase in Enterobacter compared 
to FF and BF infants without accelerated weight gain (p=0.048, p=0.035, resp.).
Conclusion
Formula fed infants had lower levels of sIgA and higher SCFAs at 1 and 3 months. Only 
in FF infants, we found correlations of sIgA and SCFAs with total fat mass, visceral and 
subcutaneous fat. Besides higher levels of Firmicutes at 3 months, FF infants had no 
different microbiota compared to BF infants. Infants with accelerated weight gain in the 
critical window had a higher increase in Enterobacter which might contribute to a differ-
ent metabolic programming and increased risks for adult diseases.
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IntroduCtIon
The prevalence of overweight and obesity in children is increasing.(1) Overweight and 
obesity in childhood increases the risk for obesity, type 2 diabetes and cardiovascular 
diseases in later life. The first three months of life are known to be a critical window for 
the programming of adiposity and cardiovascular diseases. Accelerated weight gain and 
particularly fat accumulation in early life has been associated with a higher risk for these 
adult diseases.(2-5) Obesity and its associated disorders are characterized by a state of 
chronic, low-grade inflammation.(6)
Various studies suggest a relationship between the compositional pattern of the gut 
microbiota and obesity in adults.(7) Especially the levels of short-chain fatty acids (SC-
FAs) are linked to obesity.(8) These SCFAs, such as acetate, butyrate and propionate are 
the main fermentation products of the gut bacteria ensuing from fiber breakdown.(9) 
Although the SCFAs are neither purely obesogenic nor anti-obesogenic and their mech-
anism of action is still unknown, butyrate and propionate show more anti-obesogenic 
potential whereas acetate shows more obesogenic potential.(10-12) 
Secretory immunoglobulin A (sIgA) protects against infections of the intestinal epi-
thelium and is the first line of defense in protecting epithelium from enteric toxins and 
pathogenic microorganisms.(13) Elevated levels of sIgA have been associated with an 
upregulated immune response, but high levels could also be measured in infants with 
breastfeeding in the first months of life because of sIgA in breast milk.(14) The micro-
biome of obese patients contains more Firmicutes and less Bacteroidetes, suggesting 
that specific compositions of the gut microbiota might be linked to weight status of the 
host.(15-17) Different hypotheses are currently being investigated, with one postulating 
that an altered gut microbiota composition is related to obesity via low-grade inflam-
mation.(18) Other studies showed that microbiota in humans changed after losing 
weight, suggesting that body weight can also influence microbiota.(19) However, no 
data are available about microbiota in infancy and the relation with body composition 
and weight gain in early life. The latter is unfortunate since published data suggest that 
some bacteria which colonize the gut during the first months of life become part of 
the adult microbiome.(20) An adult colon harbors a vast number of microorganisms, 
which is extremely diverse, yet infants are born without microbes, or at least very few, 
and experience a huge influx of maternal and environmental bacteria after birth which 
rapidly colonize the infant gut.(21,22) The microbial composition in the first year of life 
is typically characterized by high instability and low species diversity.(23) Type of feed-
ing is one of the major determinants of subsequent development of the microbiota.
(24-27) Breastfed infants have a higher amount of sIgA and a relative high abundance of 
bifidobacteria and lactic acid bacteria, such as Lactobacillus and Enterococcus spp, which 
are linked to a reduced risk for infections and chronic illness.(28) 
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Based on the literature, we hypothesized that infants with formula feeding have, com-
pared to those with exclusive breastfeeding, a different composition of sIgA, SCFAs and 
microbiota in their stools at 1 and 3 months. In addition, we hypothesized that infants 
with formula feeding have, compared to infants with exclusive breastfeeding, different 
development of sIgA and SCFAs and microbiota in the first 3 months of life, which are 
associated with development of more total fat mass and visceral fat.
Thirdly, we hypothesized that accelerated weight gain in the first 3 months of life is 
of influence on the levels of sIgA, SCFAs and microbiota at 1 and 3 months and their 
changes.
We, therefore, investigated several fecal parameters, such as sIgAs, SCFAs and the 
microbiota composition at the first and third month of life and associated the results 
with type of feeding, infant body composition and accelerated vs. non-accelerated 
weight gain in the first months of life. We first present the sIgA and SCFA levels and 
subsequently the microbiota data.
materIal and methods
subjects
The current study is part of a birth cohort study (Sophia Pluto Study) examining the 
postnatal determinants of body composition during infancy. Detailed analyses of the 
stool microbiota at the age of 1 and 3 months were conducted in a subgroup of 51 
infants, 30 with exclusive breastfeeding and 21 with exclusive formula feeding for 3 
months, with oversampling of infants with accelerated weight gain in the first 3 months 
in order to increase the statistical power to find differences in body composition de-
velopment. Accelerated gain in weight was defined as an increase in weight between 
birth and 3 months of ≥ 0.67 SDS. The study group consisted of 15 infants with exclusive 
breastfeeding and 6 with exclusive formula feeding with accelerated weight gain and 
15 infants with exclusive breastfeeding and 15 with exclusive formula feeding without 
accelerated weight gain.
Children were recruited from several hospitals in and near Rotterdam, a large city in 
The Netherlands. All participants fulfilled the same inclusion criteria: 1) born term (≥37 
weeks of gestation), 2) Age <28 days, 3) uncomplicated neonatal period without signs 
of severe asphyxia (defined as an Apgar score below three after five minutes), sepsis or 
long-term complication of respiratory ventilation. Exclusion criteria were known con-
genital or postnatal diseases that could interfere with body composition development, 
confirmed intra-uterine infection, maternal use of corticosteroids or significant maternal 
medical condition that could interfere with infant’s body composition development (e.g. 
diabetes). For the present study, infants were excluded when they received antibiotics 
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in the first 3 months of life. The Medical Ethics Committee of Erasmus Medical Center 
approved the study. Written informed consent was obtained from both parents unless 
mother was single.
data collection and measurements
Birth	characteristics
Birth data were taken from midwife and hospital registries. 
Feeding	information
Information on formula and breastfeeding was recorded at the research clinic visits at 1 
and 3 months. Most formula fed infants were fed with prebiotic formula (n=19). 
Anthropometrics	of	the	child
Weight was measured to the nearest gram by an electronic infant scale (Seca, Hanover, 
MD). Length was measured with the two-person technique to the nearest 0.1 cm by 
a length meter (Seca). Head circumference was measured to the nearest 0.1 cm using 
measuring tape (Seca, circumeter). Weight SDS, height SDS and BMI SDS were calculated 
with Growth Analyser Research Calculation Tools 4.0 (available at www.growthanalyser.
org), according to Dutch age- and gender-matched reference values.(29)
Body	composition
Whole-body composition was assessed using air-displacement plethysmography 
(Peapod, Infant Body Composition System, COSMED). This ADP system assesses fat mass 
and fat free mass by direct measurements of body volume and body mass, based on 
the whole-body densitometric principle.(30-32) All measurements were obtained by 
experienced personnel, using standardized protocol. The Peapod was calibrated every 
day, according to the instructions of COSMED.
Fecal	samples
Fecal samples were collected at home at 1 and 3 months of age and stored at -18 °C or 
lower from the day of collection. Samples remained no longer than 4 months in -18 °C 
and were transported in cool-bags with freezing-elements to our hospital, where the 
samples were stored at -80 °C. 
The following parameters were determined: pH, secretory immunoglobulin A (sIgA), 
short chain fatty acid (SCFA) levels (i.e. acetate, butyrate, propionate, iso-butyrate, valer-
ate, and iso-valerate), D- and L-lactate, and as previously described.(33,34) In short, a 
Shimadzu GC2010 gas chromatograph (Shimadzu Corporation, Kyoto, Japan) with a 
flame ionization detector was used to determine the different SCFA levels, while using 
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2-ethylbutyric acid as an internal standard. Lactic acids were determined enzymatically 
using a D/L-lactic acid detection kit with D- and L-lactate dehydrogenase (EnzyPlus, 
BioControl Systems, Inc., Bellevue, WA, USA). The following SCFA could be detected in 
a lower number of samples: Butyric acid at 1 month was detected in 20 samples and 
at 3 months in 24 samples; Iso-butyric acid at 1 month was detected in 7 samples, at 3 
months in only 14 samples; Iso-valeric acid at 1 month in 31 samples and at 3 months 
in 23 samples. 
Fecal DNA extraction and pyrosequencing
DNA was extracted from the fecal samples by combining bead-beating with QIAmp DNA 
Stool Mini Kit (Qiagen) according to the manufacturers protocol except for the addition 
of two bead-beating steps: to 0.2 - 0.3 g of fecal sample 300 mg of 0.1 mm glass beads 
together with 1.4 mL of ASL (lysis) buffer and on this suspension the first bead-beating 
step was applied, after addition of the InhibitEx tablet the second bead-beating step 
was applied. Each bead-beating step consisted of bead-beating three times for 30 sec 
(FastPrep-24 instrument program 5.5) and was followed by cooling the sample for 5 min 
on ice. Extracted DNA purity was checked using the NanoDropTM spectrophotometer 
(Thermo Fisher Scientific Inc.), whereas DNA quality and concentration was measured 
using the Quant-iTTM 193 dsDNA BR Assay kit (InvitrogenTM). DNA aliquots were stored 
at -20°C until use. On the purified fecal DNA extracts primers 357F (5’-CCTACGGGAG-
GCAGCAG-3’) and 926Rb (5’-CCGTCAATTYMTTTRAGT-3’) were used to amplify the V3-V5 
regions of the bacterial 16S rRNA gene and the generated amplicons were subsequently 
pyrosequenced with a 454 FLX Sequencer (454 Life Sciences, Branford, CT, USA) as de-
scribed previously.(35)
Bioinformatic analysis
Sequencing data was analyzed using the Quantitative Insights Into Microbial Ecology 
(QIIME) v.1.9.0 pipeline.(36) Sequences with mismatched primers were discarded. Qual-
ity control filters were set to retain sequences with: a length between 200 and 1000 
bases; a mean sequence quality score >25; no ambiguous bases; no homopolymers 
stretches of >6 bases. The filtered sequences were grouped into Operational Taxonomic 
Units (OTUs) by de novo OTU picking using the USEARCH algorithm (37) at 97% sequence 
identity. Subsequently, the Ribosomal Database Project Classifier (RDP) (38) was applied 
to assign taxonomy to the representative sequence (i.e. the most abundant sequence) of 
each OTU by alignment to the SILVA ribosomal RNA database (release version 1.0.8).(39) 
ChimeraSlayer was applied, as part of QIIME, to filter for chimeric sequences. Rarefac-
tion was applied to the OTUs by QIIME to ensure identical number of reads per sample 
in order to perform α-diversity calculations using the following metrics: Chao-1 and 
Observed species.
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statistical analysis
SD-scores for birth length and birth weight were calculated to correct for gestational 
age and gender.(40) All SD-scores were calculated using growth analyser software 
(http://www.growthanalyser.org). 
Continuous variables are presented using medians with inter-quartile ranges (IQR). 
Differences in fecal parameters between 2 groups were assessed with Mann-Whitney 
test, as the data were not normally distributed. Differences in the fecal parameters be-
tween the 4 subgroups were assessed with Kruskal-Wallis, as the data were not normally 
distributed. All statistical tests were performed two-sided and results were regarded 
statistically significant if the p-value was <0.05.
Differences between the infant groups at the different phylogenetic levels were calcu-
lated on the relative abundances of each taxonomic category and compared between 
two infants groups by dependent 2-group Wilcoxon signed rank tests. No statistical 
comparisons were performed within the formula fed infants with accelerated weight 
gain due to low number. For all statistical tests performed on multiple parameters, the 
false discovery rate was estimated by calculating q-values. Results with both p-values 
and q-values <0.05 were regarded as significant. For taxa that occurred in >50% of the 
samples in only one of the investigated groups a Fisher’s exact test was performed. 
Spearman correlations were applied for the correlations of fecal parameters at 1 and 
3 months with growth data. SPSS statistical package version 20.0 (SPSS Inc. Chicago, 
Illinois) was used. 
results
The clinical characteristics of the exclusively formula fed and breastfed infants are pre-
sented in Table 1. 
Exclusively formula fed (FF) infants had a lower weight SDS and BMI SDS at 1 month 
and less weight gain between birth and 1 month than exclusively breastfed (BF) infants 
(p=0.05, p=0.02, p=0.001, resp.). The formula fed infants had a higher gain in weight SDS 
between 1 and 3 months (p=0.04, p=0.03, resp.) and less decline in weight SDS between 
3 and 6 months than breastfed infants. 
levels of sIga and short chain fatty acids
Results of short chain fatty acids (SCFA) are presented in Table 2. 
Formula feeding vs. breastfeeding 
Secretory IgA was lower in the stools of FF infants at 1 and 3 months, compared to the 
BF infants (both p<0.001)(Table 2.). FF infants had higher levels of acetic and propionic 
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table 1. Clinical characteristics 
Total group 
(n=51)
Formula fed infants 
(n=21)
Breastfed infants 
(n=30)
p-value
Median Median IQR Median IQR
Gestational age 40.1 38.4 37.9-40.4 40.1 39.1-41.0 0.002
Gender (female) [n(%)] 18(35) 6(29) 12(40) 0.98
Mode of delivery (vaginal) [n(%)] 33(65) 14(70) 22(73) 0.41
Birth weight SDS -0.04 -0.03 -0.60-0.40 -0.14 -0.93-0.32 0.48
Birth length SDS 0.13 0.13 -1.10-0.76 0.13 -1.03-0.60 0.80
At 1 month
Weight SDS 0.61 0.04 -0.40-0.86 0.94 -0.21-1.40 0.05
Length SDS -0.02 -0.07 -0.31-0.74 0.37 -0.37-0.71 0.52
BMI SDS 0.51 0.10 -0.70-0.78 0.65 0.04-1.23 0.02
Fat mass percentage 17.8 17.1 13.9-20.3 18.3 15.8-21.4 0.37
Weight gain SDS 0-1mo 0.71 0.11 -0.23-0.78 0.91 0.59-1.48 0.001
At 3 months
Weight SDS 0.64 0.54 0.21-0.92 0.73 0.13-1.35 0.42
Length SDS 0.65 0.65 0.31-0.80 0.57 0.16-1.01 0.86
BMI SDS 0.33 0.07 -0.22-0.79 0.45 -0.53-1.13 0.62
Fat mass percentage 23.3 21.3 19.1-26.0 24.2 22.3-26.9 0.04
US-visceral fat (cm) 2.44 2.44 2.09-2.90 2.44 2.09-2.65 0.63
US-subcutaneous fat 0.42 0.40 0.36-0.52 0.43 0.40-0.52 0.25
Weight gain SDS 1-3mo 0.21 0.54 0.02-0.85 0.14 -0.34-0.46 0.03
Delta FM% 1-3 months 5.1 4.3 2.6-6.2 5.9 3.5-9.0 0.10
At 6 months
Weight SDS 0.13 0.05 -0.20-0.85 0.23 -0.41-0.92 0.74
Length SDS 0.33 0.70 0.30-0.97 0.23 -0.12-0.42 0.03
BMI SDS -0.08 -0.30 -0.91-0.81 0.19 -0.85-0.93 0.46
Fat mass percentage 23.5 22.7 18.5-28.3 25.4 22.7-28.3 0.17
US-visceral fat (cm) 2.14 2.15 2.04-2.86 2.14 1.95-2.81 0.69
US-subcutaneous fat 0.40 0.40 0.36-0.48 0.40 0.31-0.51 0.87
Weight gain SDS 3-6 mo -0.44 -0.31 -0.65-0.06 -0.57 -0.93-0.15 0.04
Delta FM% 3-6 months 0.5 -0.1 -3.0-3.1 0.9 -1.4-1.8 0.91
Data are expressed as median(interquartile range) or percentage. Bolded p-values are p-values below 0.05. 
US-visceral fat = visceral fat thickness, measured by ultrasound. US-subcutaneous fat = abdominal subcu-
taneous fat, measured by ultrasound. 
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acid at 1 and 3 months (p=0.01, p=0.006, p<0.001, p<0.001, resp.), while butyric acid at 
1 and 3 months was not different between the 2 feeding groups. 
We also investigated the changes in sIgA and SCFAs between 1 and 3 months in FF 
vs. BF infants, but there were no significant differences between these groups (Table 2).
Associations	of	sIgA	and	SCFA	with	FM%,	visceral	and	subcutaneous	fat
Formula fed infants
Levels of sIgA at 1 and 3 months and the change in sIgA between 1 and 3 months did 
not correlate with FM% at 1, 3 or 6 months (Table 3). We found, however, that a higher 
change in sIgA correlated with the increase in FM% between 1 and 3 months of age and 
3 and 6 months (r=0.53, p=0.02, r=0.72, p=0.003, resp.). SIgA at 1 and 6 months did not 
correlate with visceral and subcutaneous fat, but at 3 months, sIgA correlated positively 
with visceral fat at 3 months (r=0.46, p=0.04). 
Levels of acetic acid at 1 and 3 months did not correlate with FM% at 1, 3 or 6 months, 
but the change in acetic acid between 1 and 3 months correlated positively with the 
increase in FM% between 3 and 6 months (r=0.66, p=0.01) and tended to be correlated 
with FM% at 6 months (r=0.50, p=0.07). Acetic acid at 1 month did not correlate with vis-
ceral and subcutaneous fat at 3 months, but acetic acid at 3 months correlated positively 
with visceral fat at 3 months (r=0.49, p=0.02).
Levels of butyric acid at 1 month did not correlate with FM% at 1, 3 or 6 months , but 
higher butyric acid at 3 months correlated with higher FM% at 3 and 6 months (r=0.62, 
p=0.02, r=0.81, p=0.005, resp.). butyric acid at 3 months and the change in butyric 
acid between 1 and 3 months correlated positively with subcutaneous fat at 3 months 
(r=0.77, p=0.001, r=0.70, p=0.03, resp.) 
Levels of propionic acid at 1 and 3 months and the change between 1 and 3 months 
did not correlate with FM% at 1, 3 or 6 months. Higher propionic acid at 1 month cor-
related with a higher decrease in FM% between 3 and 6 months (r=-0.60, p=0.02) and 
higher propionic acid at 3 months tended to be correlated with a higher decrease in 
FM% between 1 and 3 months and 3 and 6 months (r=-0.42, p=0.07, r=-0.44, p=0.10, 
resp.). 
Breastfed infants
We also investigated the correlations in the breastfed infants. In contrast to the formula 
fed infants, we could not find any significant correlation of sIgA and SCFAs with FM% and 
changes in FM% in the breastfed infants. There were also no significant correlations with 
visceral and subcutaneous fat at 3 and 6 months (data not shown).
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table 2. Amounts of short chain fatty acids per subgroup
Total group Formula fed infants Breastfed infants p-value*
FF vs. BF
p-value**
AWG vs.
nAWG
Median (IQR)
Accelerated 
weight gain
Non-
accelerated 
weight 
gain
Accelerated 
weight gain
Non-
accelerated 
weight 
gain
1 month
pH 5.5 5.0-6.0 5.54 6.1 5.4 5.1 0.002 0.29
sIgA 1575.1 551.6-2395.0 563.3 385.1 2108.9 2387.3 <0.001 0.19
Acetic acid 55.3 34.5-81.4 61.8 64.7 28.4 55.3 0.01 0.13
Butyric acid 2.9 1.8-4.9 2.0 2.7 0.7 5.2 0.82 0.02
Propionic acid 2.7 1.2-8.6 15.6 10.6 2.0 1.0 <0.001 0.51
Iso-butyric acid 1.1 0.8-1.7 0.8 0.9 NA 1.8 0.19 NA
Iso-valeric acid 1.0 0.8-1.2 1.1 0.8 1.0 0.9 0.72 0.16
Total SCFA 63.8 39.9-85.0 73.8 83.6 41.3 62.4 0.001 0.08
Total lactate 17.4 5.2-33.6 35.6 16.1 8.6 20.8 0.40 0.99
D-Lactate 1.5 1.3-12.5 13.8 5.2 2.5 1.4 0.05 0.71
L-Lactate 15.5 4.6-27.7 21.8 12.8 7.7 23.2 0.63 0.67
3 months
pH 5.3 5.0-6.1 5.2 6.2 5.3 5.1 0.02 0.22
sIgA 1043.8 416.7-2126.5 658.4 367.8 2227.2# 1102.5 <0.001 0.009
Acetic acid 56.1 39.2-70.6 71.3 67.2 56.2 41.9 0.006 0.89
Butyric acid 2.8 1.5-2.0 3.5 2.9 0.8 3.4 0.26 0.26
Propionic acid 3.4 1.1-11.1 6.7 12.3 1.5 1.0 <0.001 0.41
Iso-butyric acid 0.9 0.7-2.0 1.8 1.2 0.5 0.7 0.01 0.36
Iso-valeric acid 1.0 0.5-1.4 1.8 1.3 0.5 0.5 0.02 0.28
Total SCFA 62.6 45.4-82.8 74.6 89.0 60.0 53.1 <0.001 0.79
Total lactate 27.4 9.1-38.7 42.4 24.8 29.1 24.5 0.46 0.40
D-Lactate 5.1 2.3-8.2 19.8 5.6 5.0 2.1 0.10 0.04
L-Lactate 24.6 7.4-32.4 22.5 21.6 28.1 30.0 0.57 0.73
Change between 1 – 3 months
sIgA -92.2 -1053.5-436.9 65.8 -36.6 164.0 -1472.4 0.24 0.07
Acetic acid -1.7 -16.8-17.5 16.6 1.8 -2.5 -9.8 0.77 0.11
Butyric acid -1.0 -2.0-1.0 1.8 0.4 -2.4 -1.5 0.08 1.00
Propionic acid 0.0 -1.7-3.6 -12.3 2.3 0.0 0.0 0.49 0.40
Iso-butyric acid 0.4 -0.19-.. -0.2 0.9 NA NA NA NA
Iso-valeric acid -0.4 -0.8-0.6 -0.2 0.6 -0.5 -0.6 0.14 0.28
Total SCFA 1.5 -15.4-17.8 5.0 3.0 -2.4 -9.1 0.66 0.24
Total lactate 6.6 -0.1-16.3 10.2 5.3 6.6 6.8 0.96 0.57
D-Lactate 0.9 -3.6-4.5 4.15 0.7 3.54 0.8 1.00 0.59
L-Lactate 5.7 -3.3-12.6 6.07 -1.2 11.0 5.9 0.19 0.49
Data are expressed as median interquartile range). All values are in mmol/kg. Bolded p-values are 
p-values below 0.05. 
*: p-values comparing infants with formula feeding FF) vs. breastfeeding BF)
**: p-values comparing infants with accelerated weight gain AWG) vs. non-accelerated weight gain 
(nAWG)
#: p<0.05 compared to BF infants without accelerated weight gain 
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Differences in infants with and without accelerated weight gain
As accelerated weight gain in the first 3 months of life is associated with a higher risk for 
obesity and adult diseases, we also analyzed differences in sIgA and SCFAs in infants with 
and without accelerated weight gain. We found a significantly higher amount of sIgA at 
3 months in infants with accelerated weight gain compared to those without acceler-
ated weight gain (p=0.009). Infants with accelerated weight gain had a higher increase 
in sIgA levels between 1 and 3 months while those without accelerated weight gain 
had a decrease in sIgA (p=0.05)(Table 2). After dividing the FF and BF infants into two 
groups, either with accelerated weight gain or without, we found that in both groups 
infants with accelerated weight gain had higher levels of sIgA at 3 months, but this did 
not reach significancy in the formula group, due to low number of formula fed infants 
with accelerated weight gain (breastfed group: p=0.02#). We also found that breastfed 
infants with accelerated weight gain had a smaller decrease in sIgA between 1 and 3 
months (p=0.05).
table 3. Correlations of sIgA and SCFAs with FM%, visceral and subcutaneous fat and changes in fat in 
formula fed infants.
At 1 
month
At 3 months At 6 months Delta 
FM% 1 
and 3 
months
Delta 
FM% 
3 and 6 
months
FM% FM% Visceral 
fat 
Subcuta-
neous fat 
FM% Visceral 
fat
Subcuta-
neous fat
1 month
sIgA 0.13 0.07 0.40 0.27 -0.20 0.01 0.04 -0.27 -0.31
Acetic acid -0.23 -0.18 0.14 0.03 -0.51 0.25 -0.07 0.02 -0.19
Butyric acid -0.31 0.12 -0.31 <0.01 0.36 0.02 -0.09 0.53 0.55
Propionic acid 0.25 0.13 0.25 -0.16 -0.14 -0.17 -0.11 -0.22 -0.60*
3 months
sIgA -0.38 -0.28 0.46* 0.09 -0.24 0.32 0.27 0.10 0.21
Acetic acid -0.06 0.07 0.49* 0.29 0.24 0.36 0.29 0.24 0.43
Butyric acid 0.30 0.62* -0.09 0.77** 0.81** 0.01 0.36 0.40 0.29
Propionic acid 0.36 0.18 -0.15 -0.24 0.06 -0.33 0.12 -0.42 -0.44
Change between 1 - 3 months
sIgA -0.60** -0.37 0.21 0.07 0.07 0.42 0.43 0.53* 0.72**
Acetic Acid -0.05 0.09 0.35 0.23 0.50 0.21 0.38 0.37 0.66*
Butyric acid 0.47 0.32 -0.12 0.70* -0.04 0.05 0.24 -0.38 -0.57
Propionic Acid 0.22 0.17 0.35 -0.07 0.31 -0.38 0.18 -0.25 0.09
Significant correlation coefficients are indicated in boldface. *: p-value <0.05, **:p-value<0.01
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Composition of high level microbiota, diversity and richness
Formula feeding vs. breastfeeding
At the phylum level, the relative abundances showed quite some variation but only the 
Firmicutes were significantly higher in FF infants at 3 months (p=0.01). We found no dif-
ferences in changes in microbiota between 1 and 3 months between FF and BF infants 
(Table 4).
table 4. Relative abundances (%) of the bacterial phyla detected in the fecal samples 
Formula fed infants Breastfed infants p-value*
FF vs. BF
p-value**
AWG vs. 
nAWG
Accelerated 
weight gain
Non-
accelerated 
weight gain
Accelerated 
weight gain
Non-
accelerated 
weight gain
1 month (n=5) (n=14) (n=15) (n=14)
Actinobacteria 64.06 70.17 50.32 34.77 0.22 0.74
Bacteroidetes 0.146 0.06835 0.0907 0.1594 0.35 0.48
Firmicutes 20.34 17.63 13.9 14.73 0.45 0.848
Fusobacteria 0 0 0 0 1.00 1.00
Proteobacteria 1.997 2.107 4.971 1.963 0.62 0.43
Verrucomicrobia 0 0 0 0 0.40 1.00
3 months (n=6) (n=15) (n=14) (n=13)
Actinobacteria 16.98 31.35 26.52 45.22 0.69 0.37
Bacteroidetes 5.062 0.3273 0.02125 1.457 0.65 0.65
Firmicutes 29.53 15.22 8.159 8.102 0.01 0.21
Fusobacteria 0 0 0 0 0.19 0.75
Proteobacteria 14.91 9.877 19.39 16.12 0.24 0.12
Verrucomicrobia 0 0 0 0 0.08 0.71
Change between 
1 -- 3 months
(n=5) (n=14) (n=14) (n=13)
Actinobacteria -34.23 -1.576 -6.363 -6.169 0.59 0.53
Bacteroidetes 1.057 0 -0.003965 0.016 0.96 0.55
Firmicutes 9.067 1.391 -14.01 -4.235 0.23 0.51
Fusobacteria 0 0 0 0 0.17 0.75
Proteobacteria 9.612 7.838 14.41 11.36 0.35 0.24
Verrucomicrobia 0 0 0 0 0.21 1.00
 Data expressed as medians %. Bolded p-values are p-values below 0.05. *: p-values comparing infants with 
formula feeding vs. breastfeeding **: p-values comparing infants with accelerated weight gain (AWG) vs. 
non-accelerated weight gain (nAWG).
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Differences in infants with and without accelerated weight gain
Neither significant differences for the Firmicutes and Bacteroidetes phyla, nor for the 
other detected phyla, were found between the infants with and without accelerated 
weight gain neither at 1 month, nor at 3 months, nor over time (Table 4). 
Actinobacteria was the most dominant phylum at both timepoints, followed by Fir-
micutes in all infants except for the breastfed infants with accelerated weight gain where 
Proteobacteria was the most dominant phylum followed by Actinobacteria (Table 4).
Although the samples of the FF infants at 1 month and 3 month showed a higher di-
versity than those of BF infants, independent of accelerated weight gain, this difference 
was only significant at 3 months (p=0.001). The number of the observed species at 1 and 
3 months of age were significantly higher in the FF group without accelerated weight 
gain compared to the BF groups with or without accelerated weight gain (p=0.033, 
p=0.002, resp.).
Composition at lower level microbiota, diversity and richness
Next, the specific bacterial groups at lower phylogenetic levels were assessed. 
Formula feeding vs. breastfeeding
No significant differences in the levels of Bifidobacterium were found between the FF 
and BF infants. Staphylococcus and Haemophilus were less abundant genera in FF in-
fants, compared to BF infants at 1 month (p=0.007, q=0.04, p=0.001, q=0.007, resp.). No 
significantly more abundant genera were found at 3 months or over time in FF infants.
Characterizing bacteria in formula fed and breastfed infants with and without accelerated 
weight gain
The bacterial class of Coriobacteriia was significantly higher in the FF infants without 
accelerated weight gain compared to their breastfed counterparts. From this bacterial 
class only the genus Atopobium was significantly more abundant in FF infants without 
accelerated weight gain compared to their BF counterparts at 1 month (p=0.008, 
q=0.041). It should be noted that Atopobium was detected in six FF infants without ac-
celerated weight gain, but not detectable in any breastfed infant without accelerated 
weight gain (Figure 1).
The Enterococcus genus was detected in most FF infants without accelerated weight 
gain and was significantly more abundant compared to BF infants without accelerated 
weight gain where it was detected in only three infants at 1 month (p<0.001, q=0.001) 
(Figure 1). Enterococcus appeared frequently and abundantly in the FF infants with ac-
celerated weight gain as well. Moreover, in both FF groups, Enterococcus appeared to 
decrease over time but this was not significant.
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The genus Enterobacter, as well as its corresponding higher level taxonomy groups up 
to phylum level Proteobacteria, increased in time in all infant groups. This increase of 
Enterobacter occurred significantly more in BF infants with accelerated weight gain com-
pared to BF infants without accelerated weight gain (p= 0.048) and FF infants without 
accelerated weight gain (p= 0.035), but this resulted only in a nearly significant higher 
abundance level at 3 months of age compared to BF infants without accelerated weight 	
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figure 1. Bacteria more specific for formula-fed infants
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gain (p= 0.038; q= 0.201; Figure 2). From the same family as Enterobacter, the Escherichia-
Shigella genus group was significantly more abundant in BF infants with accelerated 
weight gain at 3 months of age compared to BF infants without accelerated weight gain 
(p<0.001; q= 0.020; Figure 2). In contrast, the Rothia genus group occurred significantly 
more in the BF infants without accelerated weight gain than in the BF infants with ac-
celerated weight gain at 3 months. (p=0.03).	 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figure 2. Bacteria more specific for accelerated weight gain in breastfed infants
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dIsCussIon
Our study shows that exclusive formula fed (FF) infants have lower levels of IgA and 
higher levels of acetic and propionic acid at 1 and 3 months, compared to the exclusively 
breastfed (BF) infants. Formula fed infants had a higher change in sIgA between 1 and 3 
months, which correlated with a higher increase in FM%. Formula fed infants, a higher 
sIgA and acetic acid at 3 months correlated with more visceral fat at that age, while a 
higher level of propionic acid correlated with a lower increase in FM%. In BF infants, 
there were no correlations of sIgA and SCFAs with body composition. There appeared to 
be no significant effect of type of feeding on the phylum level, although the FF infants 
had a significantly higher abundance of Firmicutes at 3 months of age compared to BF 
infants. Infants with accelerated weight gain had a higher increase in Enterobacter.
We identified differences in sIgA and short-chain fatty acids (SCFAs) between FF 
and BF infants. Breastfed infants had higher levels of sIgA. It is known that BF infants 
have higher levels of sIgA in their stools because breast milk contains sIgA.(41) In the 
first weeks of life, they receive the sIgA from the breastmilk and over time infants are 
going to produce sIgA by their own. The sIgA levels in BF infants decline during the 
first weeks and months of lactation.(42) The phenomenon of enhanced fecal sIgA in BF 
infants is, however, not solely caused by the presence of IgA in breast milk, it includes 
sIgA levels due to a stimulatory effect of breast milk on the gastrointestinal humoral 
immunologic development. In infants fed with formula without prebiotics, the gut will 
be less stimulated to produce its own sIgA, and in these infants higher amounts of sIgA 
are mostly related to low-grade inflammation or infection.(43) We demonstrated that BF 
infants with accelerated weight gain had even higher levels of sIgA than those without 
accelerated weight gain. This may imply that there could be an additional low grade 
inflammation in these infants. In infants with FF with accelerated weight gain, we also 
identified higher sIgA than in formula fed infants without accelerated weight gain, but 
this did not reach significance due to low number of FF infants with accelerated weight 
gain. Our data support the hypothesis that accelerated weight gain in the first months 
of life is related with higher sIgA levels in the stools.
We also studied the differences in microbiome in infants with and without accelerated 
weight gain because accelerated weight gain in early life is associated with unfavor-
able outcomes in later life, such as obesity, type 2 diabetes and cardiovascular diseases. 
Changes in microbiome in early life may be one of the links between these associations. 
To our knowledge, this is the first study investigating SCFA in combination with detailed 
data on body composition in human infants. A recently published review discussed 
the effects of SCFAs on energy homeostasis and metabolism, as well as how SCFAs can 
modulate adipose tissue and liver tissue function in adult life.(44) It was concluded that 
8Gut microbiome in early life 147
SCFAs can modulate adipose tissue in adulthood. With our results, we demonstrate that 
associations between SCFAs and FM% can already be found in early life.
We only found small differences in microbiome between infants with and without 
accelerated weight gain. A possible explanation could be that the differences in microbi-
ome are present but small and therefore not yet detectable in this group of infants. The 
microbiome of the infants at 1 and 3 months is still developing and possibly differences 
between the infants with and without accelerated weight gain become more prominent 
later in infancy or childhood. It remains unclear if the microbiome influences the gain in 
weight and fat mass in early life or that the gain in weight and fat mass influences the 
microbiome. It seems that there are interactions between these elements.
Interestingly, we found more Firmicutes at 3 months in the formula fed infants. This is 
in line with other studies, investigating microbiota in newborns and 4-weeks old infants.
(28,45) Because higher levels of Firmicutes might be associated with obesity, this could 
be one of the links between formula feeding and obesity in later life.(17) Remarkably, we 
found no major differences in the levels of Bifidobacterium, a genus of Actinobacteria, 
between the FF and BF infants, in contrast to previous reports.(46) Over the last de-
cades, many approaches have been used to improve infant formulas by inducing a more 
‘breastfed like’ composition with higher Bifidobacterium levels.(34,47-49) Our study 
suggests that these approaches are effective with respect to the Bifidobacterium levels. 
On the other hand, the overall microbiota profile diversity remained different between 
FF and BF infants, which is in line with current literature, i.e. FF infants having a higher 
bacterial diversity compared to BF infants.(24) By adding prebiotics to formula feeding, 
infants have a lower stool pH and higher concentrations of Bifidobacteria.(50) Nowadays, 
most formula feedings contain prebiotics and in our study, only 2 FF infants did not 
receive prebiotic-containing formula feeding.
There were, however, bacteria that were more specific for FF infants or BF infants and 
bacteria more specific for accelerated weight gain. Enterococcus species are among the 
first colonizers in newborn infants and have even been detected on the first day of life.
(60,61) Our results indicate that Enterococcus, a genus of Firmicutes, decreases in the first 
months of life, which is in line with current literature. The lower amount of Enterococcus 
in BF infants is likely due to the significantly lower pH of stools of BF infants. Lower 
amounts of Enterococcus have also been found in a study in 16 BF infants at 1 month 
of age.(62) Staphylococcus and Haemophilus were more abundant in BF infants. These 
findings are in line with the literature, and these bacteria are known as early colonizers 
and part of the normal breastfed microbiota. The Atopobium genus, a genus of Actino-
bacteria, harbors anaerobic species that mainly produce lactate (55) and the Atopobium 
cluster, which consists of Atopobium, Coriobacterium, Eggerthella and Collinsella species 
(56), has been detected in infants that were six weeks of age.(57) Our study shows that 
the Atopobium genus can already be detected in infants at 4 weeks of age. Interest-
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ingly, it has been suggested that Atopobium species are active protein degraders in 
the gastrointestinal tract since significant associations between protein fermentation 
end products and the bacteria of the Atopobium cluster have been reported.(58,59) In 
our study, Bacteroides represented one of the most predominant bacterial genera in 
BF infants. The presence of high levels of Bacteroides may be beneficial, because mem-
bers of Bacteroides have shown to exert immunomodulatory effects on the host.(63) 
We found a more pronounced increase in Enterobacter and Escherichia-Shigella, both 
genera of Proteobacteria, in infants with accelerated weight gain. Some bacterial strains 
belonging to these genera have been described as potentially harmful, already at mod-
erately abundant levels. Enterobacter and Escherichia-Shigella are significant producers 
of lipopolysaccharide (LPS) endotoxins, which is the primary structural component of 
the outer membrane of Gram-negative bacteria. Several studies have shown that if 
endotoxins translocate from the gut into serum, they can cause low-grade inflammation 
that can contribute to the development of obesity, type 2 diabetes and cardiovascular 
diseases.(8,51,52) Rothia, a genus of Actinobacteria, was more present in infants without 
accelerated weight gain. Rothia is in adults an oral/upper gastrointestinal tract inhabit-
ant. As Rothia was more present in stools of infants without accelerated weight gain, 
these infants might have had less intestinal absorption due the faster transit time. 
In conclusion, formula fed infants had lower levels of sIgA, higher levels of SCFAs at 
1 and 3 months and also higher levels of Firmicutes at 3 months of age compared to 
breastfed infants. Only in formula fed infants, we found correlations of sIgA and SCFAs 
with body composition. Infants with accelerated weight gain had higher sIgA levels at 
3 months. No significant differences in the microbiota were found between the infants 
with and without accelerated weight gain at month 1, 3, or over time, although infants 
with accelerated weight gain in the critical window had a higher increase in Enterobac-
ter which might contribute to a different metabolic programming and increased risks 
for adult diseases.
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general dIsCussIon
This thesis describes results of studies performed to investigate if infant growth is as-
sociated with risks for non-alcoholic fatty liver disease in term and preterm born adults. 
Also the effects of fetal, maternal and infant growth determinants on body composi-
tion during the first 6 months of life were investigated, as well as the associations with 
the serum appetite regulating hormones levels and gut microbiome in healthy infants 
participating in the Sophia Pluto Study.
In this chapter, results of the studies described in this thesis are discussed in view of 
current literature. In addition, the clinical implications of these data, as well as directions 
for future research are given.
9.1 Influence of infant growth on later health
Our research group, but also other researchers demonstrated that the first months of 
life are of influence on later health.(1-8) Accelerated gain in weight for length in early 
life has been associated with the prevalence of metabolic syndrome at age 21 years, 
independently from birth weight.(9,10) Given that non-alcoholic fatty liver disease 
(NAFLD) is considered the hepatic metabolic syndrome (11,12), it might well be that 
the previously found association between small size at birth and NAFLD can also be 
ascribed to accelerated early weight gain.(13,14) 
In Chapter 2 we showed that gain in weight SDS in the first 3 months of life was as-
sociated with a higher fatty liver index (FLI) at 21 years, a validated measure to predict 
hepatic steatosis in the general population(15,16), whereas low birth weight SDS was 
not, independent of gestational age, indicating that these earlier described association 
between small for gestational age (SGA) and NAFLD is likely due to the gain in weight 
SDS in the first 3 months.(17) We also found that subjects with rapid catch-up in weight 
for length have a significantly higher FLI in early adulthood than subjects with slow 
catch-up in weight, also after adjustment for birth weight SDS. Furthermore, when a FLI 
score (low, intermediate, or high risk for NAFLD) was assigned to each participant and 
ordinal regression analysis was performed, it was shown that higher gain in weight for 
length in the first 3 months of life associates with more risk of having a higher FLI score 
in early adulthood (OR: 11.7, p=0.016), whereas low birth weight does not. The FLI refers 
to a clustering of risk factors representing a condition of underlying hepatic steatosis. 
Our study population consisted of healthy young adults, which made it impossible to 
perform liver biopsy to study hard endpoints such as NAFLD, steatohepatitis and fibro-
sis. We, therefore, used the FLI as a proxy. Although the study group consisted of healthy 
young adults, we found intermediate and high FLI-scores in a quite large number of 
participants. A high FLI-score has a positive predictive value of 72.2% for fatty liver.(18) 
It was striking that in young adults with catch-up significantly more intermediate and 
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high FLI-scores were found than in young adults without catch-up in weight for length 
in the first months of life.
In Chapter 3 we showed that rapid infant weight gain after term age in young adults 
born preterm was also associated with an increased risk of NAFLD in early adulthood. 
Subjects born preterm with rapid weight gain after term age had a significantly higher 
FLI in early adulthood than subjects without rapid catch-up in weight, independent of 
size at birth and gestational age. Previous studies demonstrated associations between 
a low birth weight and risk factors for NAFLD in adulthood, but associations between 
first year growth data and NAFLD were neither investigated in term born adults nor in 
preterm born adults.(17,19) Ayonrinde et al. showed in a large cohort of young adults 
that pre-school age growth was associated with the risk for NAFLD at age 17 years: the 
adiposity rate from 3 years and onwards was greater in adolescents diagnosed with 
NAFLD than in those without NAFLD.(20) These results demonstrate that pathways lead-
ing to NAFLD are established during early childhood. Our findings suggest that it might 
even occur during the first months of life. 
Conclusions,	clinical	implications	and	directions	for	future	research
To our knowledge, we are the first investigating the relationship of early life weight tra-
jectories with risk factors for non-alcoholic fatty liver disease. Over the last decades, the 
number of patients with NAFLD is increasing (21), also in young adults and it is, therefore, 
important to identify persons who are at risk to develop NAFLD. We have shown that 
infants with rapid weight gain in the first months after term age are at increased risk. 
Based on the findings presented in Chapter 2 and 3, we conclude that accelerated gain 
in weight compared to length after term age, should be avoided to reduce the risk for 
NAFLD. Further studies examining the role of infant diet, as well as the contribution of 
emerging factors such as microbiome diversity and epigenetic variations are important 
to guide interventions to prevent future NAFLD. 
9.2 early life determinants of obesity, type 2 diabetes and cardiovascular 
disease
Previously and in the studies described in chapter 2 and 3, we investigated associations 
of birth size, preterm birth and early postnatal weight gain with risk factors for later 
disease.(2,9,22-24) However, the question remained whether combinations of determi-
nants will lead to adult diseases in later life and how changes in early life can influence 
the risk for adult diseases. 
Previous studies demonstrated that increased fat mass in early life can track to obesity 
in childhood and in adulthood.(25,26) We, therefore, investigated body composition at 
birth and during early life and its determinants. 
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In Chapter 4 we investigated body composition in 194 healthy newborns born term. 
These newborns had a large variation in fat mass percentage, ranging from 1.4 to 
19.9%, also after correction for gender and gestational age, indicating that it is difficult 
to predict fat mass based on weight or ponderal index at birth. This large variation in 
FM% in newborns with a similar birth weight had not yet been reported. Estimated 
fetal weight (EFW) at 30 and 36 weeks and catch-up in fetal weight between 30 and 36 
weeks of gestation was positively associated with more FM% of the newborn. A recently 
published systematic review showed various prenatal markers of newborn fat mass.
(27) Two of the reviewed studies showed also a positive associations between EFW and 
newborn FM%, but catch-up in estimated fetal weight was not investigated.(28,29) In 
our study, pre-pregnancy BMI of the mother was positively associated with FM% of the 
newborn, which is in line with other studies, showing positive associations between pre-
pregnancy BMI and newborn FM%.(30-32) It has been reported that the pre-pregnancy 
BMI influences the cardiovascular health of the offspring, which confirms the clinical 
importance of this marker.(33,34) Also maternal gestational weight gain has been re-
ported to be positively related to newborn FM%, but in contrast to our expectations we 
could not identify this relationship.(35-37) A possible explanation of this contradiction 
is the difference in the timing of weight gain during pregnancy. One study showed that 
newborns of women who gained excessive weight in the first part of their pregnancy 
had higher FM% compared to newborns of women who gained excessive weight in the 
last part of their pregnancy.(38) In the Netherlands, it is common to gain more weight 
in the last trimester of pregnancy, so this might explain why we found no associations 
between maternal weight gain during gestation and newborn FM%.(39)
Although estimated fetal weight and pre-pregnancy BMI are significant contributors 
to the variance of FM% at birth, the highest explained variance of these models was 
56%, indicating that other unidentified factors could play a role, such as (epi)genetics 
and feedings habits of mother.(40-42)
In Chapter 5 we describe longitudinal reference data on fat mass percentage (FM%) and 
fat-free mass (FFM), measured by Peapod, and subcutaneous and visceral fat thickness, 
measured by ultrasound, in a cohort of 203 healthy term infants during the first 6 months 
of life. We revealed a significant increment in FM% during mainly the first 3 months of 
life, without a change between 3 and 6 months. When girls and boys were analyzed 
separately, we observed the same pattern in boys but girls showed significant increases 
in FM% during both age periods. Also visceral fat and abdominal subcutaneous fat thick-
ness remained similar between 3 and 6 months. Girls had a significantly higher FM% and 
lower FFM at 1 and 6 months than boys. FM% correlated with abdominal subcutaneous 
fat thickness, but not with visceral fat thickness. This is one of the first large studies 
investigating longitudinal fat mass percentage in healthy term infants. We showed that 
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the highest increase in FM% is in the first months of life, supporting the concept that 
the first 3 months of life are of major influence for establishing fat deposition. Also other 
researchers have showed evidence that the first months are important.(1,2,25) For that 
reason accurate body composition data in early life are essential to individualize dietary 
intake and to guide parents and caregivers, particularly of infants born SGA or being at 
risk for obesity development later in life.(43-45) 
In Chapter 6 we investigated the influence of gain in weight, type of feeding and 
maternal characteristics on infant total body fat mass percentage (FM%), measured by 
Peapod, at 1, 3 and 6 months of age in combination with visceral fat and abdominal 
subcutaneous fat, measured by ultrasound, at 3 and 6 months of age. Our study shows a 
strong association of gain in weight for length SDS and FM% in the first 3 months of life 
with FM% at 6 months. Higher gain in weight SDS and in FM% between 1 and 3 months 
was associated with more visceral fat at 3 months and a higher gain in FM% between 3 
and 6 months was associated with more visceral fat at 6 months. Exclusive breastfeeding 
was associated with more FM% at 6 months due to more subcutaneous fat, but not due 
to more visceral fat. This is reassuring because increased subcutaneous fat in childhood 
has been associated with a more beneficial phenotype for obesity and adult diseases.
(46) A higher visceral fat is detrimental, because it will effluent to the portal vein which 
drains into the liver where hepatocytes are directly exposed to its metabolites and 
secretory products, whereas subcutaneous fat drains systemically.(47)
We showed that breastfed infants had a higher total body FM% at 6 months of age. Sev-
eral studies showed different growth patterns in breast- and formula fed infants (48,49), 
but reports about different patterns in FM% are limited.(50-53) In general, breastfed 
infants tend to grow rapidly in the first 2 to 3 months, but they grow, subsequently, more 
slowly than their formula fed counterparts, which results in significantly heavier infants 
at the age of 12 months when formula fed.(49,54) Although formula fed infants had 
significantly lower fat mass than breastfed infants at the age of 3 and 6 months, which 
is in line with our results, by 12 months this was no longer apparent. There was a trend 
toward reversal with higher fat mass in 12-months-old formula fed infants.(53) Exclusive 
breastfeeding during infancy has been associated with a lower incidence of childhood 
obesity.(55-60) After the period of breastfeeding, it is, however, important for parents to 
be careful with food during weaning. Early introduction of solid foods, before 4 months, 
may increase the likelihood of obesity.(61-63) Unhealthy infant feeding practice, such 
as introducing of sugar-sweetened beverages, is the one the most important factors in 
relation to early childhood obesity.(64-66) 
We could not demonstrate that maternal variables were of influence on infant body 
composition at 3 and 6 months. Literature data show conflicting results about this topic. 
Most of these studies were performed in newborns, including our own study (chapter 
4). Some studies observed a higher FM% in newborns of obese mothers compared to 
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mothers with a normal BMI, but other studies did not find it either.(31,36,38,67-69) 
Apparently the effect of maternal variables on the body composition of the offspring 
disappears after the first months of life. This has also been found in a study from Ay 
et al, in a large group of 6-month-old infants.(70) Possibly this disappearance is only 
temporary, because studies showed associations between maternal pre-pregnancy BMI 
and body composition of children above the 2 years of age.(71-73) This might suggest 
that the fetal period and first months of life are critical windows for programming with 
effects on the longer term.
Conclusions,	clinical	implications	and	directions	for	future	research
We found a wide variation in fat mass in newborns with a similar weight, indicating the 
necessity of measuring fat mass instead of only weight and length, particularly when 
infants are at risk to develop overweight or obesity later on.(24,58,74-76) Infants with 
catch-up in estimated fetal weight during pregnancy had a higher fat mass percentage 
at birth. Future studies, investigating the mechanisms underlying the variations in fat 
mass are needed and should be focused on both environmental and (epi)genetic varia-
tions in infants and their influence on body composition. 
We provided reference data of fat mass percentage in healthy tem infants at birth and 
at 1, 3 and 6 months of age and reference data of subcutaneous and visceral fat at 3 and 
6 months. These reference data are mandatory for an appropriate evaluation of the fat 
mass or visceral or subcutaneous fat in individual infants and for group analyses. 
Breastfeeding was related to an increase in FM% at 6 months of age but this increase 
in FM% was largely due to an increase in subcutaneous fat instead of visceral fat. Future 
longitudinal studies are needed to examine the effects of various types of feeding on 
FM%, visceral and subcutaneous fat later in infancy and childhood.
We found that infants with accelerated weight gain during the first months of life had 
more FM% and visceral fat at 6 months. Follow-up studies are needed to examine if 
these infants have also a higher FM% and more visceral and subcutaneous fat later in 
childhood and eventually in adulthood. 
In Chapter 7 we studied the serum levels of appetite regulating hormones, ghrelin, 
leptin, insulin, GLP-1, GIP, PP, PYY at 3 and 6 months and their associations with type 
of feeding and body composition (including FM% and visceral and subcutaneous fat). 
We found significantly higher serum levels of ghrelin, leptin, insulin, GIP and PP and 
lower serum levels of PYY in infants with exclusive formula feeding compared those with 
exclusive breastfeeding. This suggests that type of feeding can influence the appetite 
regulating hormones in very early life and could thereby have programming effects for 
later life. It has been shown that high levels of ghrelin induces adiposity in rodents (77) 
and that lower levels of PYY inhibit the effect of reducing food intake.(78) These actions 
could be explanations why formula fed infants are at higher risk for developing obesity 
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than breastfed infants.(79) Breastfeeding during the first year promotes satiety respon-
siveness in children aged 18-24 months.(80,81) We showed that only ghrelin and leptin 
were positively correlated with FM% at 3 months. It has been demonstrated in animal 
studies that neonatal ghrelin is important for normal maturation of hypothalamic neural 
circuits. The neural developmental activity of ghrelin is essentially restricted to the neo-
natal period.(82) Proper expression of ghrelin during neonatal life is, therefore, crucial 
for lifelong metabolic regulation and too high ghrelin levels during the first months of 
life result in lifelong metabolic disturbances.(83). The associations of leptin and body 
composition could be explained by the known physiology of adipose tissue. During 
early life, the adipocyte proliferate and differentiate (84) and leptin levels increase in 
parallel to the number of adipocytes in the first months of life.(85) The other appetite 
regulating hormones did not seem to be involved in the regulation of body composition 
in 3- and 6-months-old infants. 
Conclusions,	clinical	implications	and	directions	for	future	research
In conclusion, there are large differences in appetite regulating hormones between 
formula fed and breastfed infants at 3 months of age and these differences might 
contribute to differences in growth patterns between those infants. The formula fed 
infants had higher serum levels of ghrelin, leptin and insulin, which is remarkable for 
that early age. It is, therefore, important to stimulate mothers to give breastfeeding for 
at least 3 months in order to give the babies the benefits of a “better” profile of appetite 
regulating hormones. Future research is needed to elucidate the role of these appetite 
regulating hormones in early life with respect to adult health and disease. 
In Chapter 8 we investigated the gut microbiome of healthy term infants in the first 3 
months of life in relation with type of feeding and fat mass. In exclusively formula fed 
infants, we found lower levels of sIgA at 1 and 3 months, compared to the exclusively 
breastfed infants. It is known that breastfed infants have higher levels of sIgA in their 
stools because breastmilk contains sIgA.(86) In the first weeks of life, the levels of sIgA 
decreased in these infants. In formula fed infants, the gut contains less sIgA because it is 
dependent from the production of the gut. Higher amounts of sIgA will be produced in 
case of inflammation or infection. We showed that infants with accelerated weight gain 
had higher levels of sIgA, supporting our hypothesis about the relationship between 
accelerated weight gain and higher sIgA, a marker of inflammation, which associates 
with obesity. The microbial population established in the initial stages of life has a 
profound impact on epigenetic programming and future homeostasis and well-being 
of the individual.(87,88) It is known that nutrition, of mother and infant, may promote 
an inadequate gut microbiota composition and functionality, accounting for worse 
programming of later immunity and of regulation of genes involved in the develop-
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ment of obesity and cardiovascular diseases.(89,90) Breast milk is the gold standard for 
infants, because it provides the most optimal nutritional, immunological and emotional 
nurturing for growth and development of infants.(91) However, in instances where 
breast-feeding is not possible, unsuitable or inadequate, formula feeding is used as 
breast milk substitute. Many attempts have been made to improve infant formula, not 
only with respect to the protein, carbohydrate and lipid content but also in immunologic 
aspects.(92-96) This has resulted in a gut microbiota composition with a higher level of 
bifidobacteria, as it is found in stools of breastfed infants.(97-101) Our data show that 
these approaches are quite effective, as we found no major differences in microbiota, 
and particularly similar levels of bifidobacteria in formula fed infants as in breastfed 
infants. We identified small differences in microbiota composition between infants with 
and without accelerated weight gain, infants with accelerated weight gain having more 
abundance of Proteobacteria. 
Conclusions,	clinical	implications	and	directions	for	future	research
As there were only small differences in sIgA, SCFA and microbiota between breast- and 
formula fed infants, we can conclude that approaches to create a more breastfed-like 
formula, with respect to the microbiota composition, are quite adequate. No significant 
differences in the microbiota were found between the infants with and without acceler-
ated weight gain at month 1, 3, or over time, although infants with accelerated weight 
gain in the critical window had a higher increase in Enterobacter. Long-term follow-up 
studies are needed to evaluate if these differences persist during childhood and adult-
hood. Follow-up research is warranted to assess if changes in microbiota occur after 
weaning and later on in childhood.
general conclusions
Our studies show that the first 3 months of life are a critical period in which increased 
weight for length increases the risk for non-alcoholic fatty liver disease in adults born at 
term or preterm. Balanced weight gain during the first months of life is, therefore, im-
portant to reduce this risk. We also present body composition at birth and longitudinally 
during the first 6 months after birth, in healthy term born infants. Based on these data, 
we can conclude that fat mass percentage is highly variable between infants.
When data on infant body composition are required, it is, therefore, important to 
measure fat mass instead of only weight and length. Fat mass increases mainly during 
the first 3 months of life and stabilizes thereafter, supporting the concept of a critical 
window for programming of adiposity in the first three months of life. We demonstrated 
that a higher gain in estimated fetal weight in the third trimester is associated with a 
higher fat mass percentage at birth and that pre-pregnancy BMI of mother is of influence 
on fat mass percentage at birth, but that the influence of mother disappeared in the first 
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months of infancy. Breastfeeding is positively associated with fat mass percentage at 
3 months but mainly through subcutaneous fat, not visceral fat, which is reassuring. 
Formula fed infants have a different profile of serum appetite regulating hormones than 
breastfed infants, suggesting that these hormones could contribute to the protective 
role of breastfeeding against obesity development. Besides associations with ghrelin, 
leptin and insulin, we could not identify associations with other appetite regulating hor-
mones with anthropometrics and body composition in infants of 3 and 6 months of age, 
indicating that possible early programming effects of appetite regulating hormones do 
not have their influence on body composition in early life. In addition, we found differ-
ences in sIgA in the stools of formula fed and breastfed infants, with lower levels of sIgA 
at 1 and 3 months in the formula fed infants but we found no major differences in levels 
of bifidobacteria between those groups, indicating that approaches to create a more 
breastfed-like formula, with respect to the microbiota composition, are quite adequate. 
No significant differences in the microbiota were found between the infants with and 
without accelerated weight gain at month 1, 3, or over time, although infants with ac-
celerated weight gain in the critical window had a higher increase in Enterobacter. This 
could imply that these bacteria could influence accelerated weight gain during early life 
and thereby increasing the risk for later adult diseases. 
directions for sophia pluto study
In the coming years, we should also focus on the (epi)genetic influences on body 
composition and health profile, not only during infancy but also across childhood into 
adulthood.
It would be interesting to investigate the risks for metabolic syndrome and non-
alcoholic fatty liver disease in our Sophia Pluto Study birth cohort and investigate if 
infants who showed accelerated gain in weight and particularly in fat mass in early life 
will have a higher fatty liver index than those who did not. Also the long-term effects of 
various types of formula feeding would be interesting to investigate.
We already investigated the influence of accelerated weight gain in the first 3 months 
of life and type of feeding on fat mass percentage at birth and on body composition (fat 
mass percentage, but also visceral and subcutaneous fat) in the first 6 months of life, but 
it would be interesting to examine if accelerated weight gain and type of feeding are 
associated with body composition later in infancy and in childhood. Also if there are ef-
fects of maternal determinants on later infant’s body composition would be interesting 
to investigate. In this thesis we described the effect of fetal growth on body composi-
tion of newborns, but it would be valuable to also associate the fetal growth with later 
infant’s body composition. In the Sophia Pluto Study, we included only healthy term 
infants. However, as preterm born infants have higher risks for accelerated post-term 
weight gain, it would also be interesting to explore the associations described in this 
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thesis in infants born preterm. We showed associations of serum appetite regulating 
hormones levels with type of feeding and body composition of infants, but associations 
with appetite regulating hormones in maternal human milk and their interactions with 
serum levels and gut microbiota would also be important. We explored associations of 
accelerated weight gain and type of feeding with gut microbiota. It would be valuable 
to confirm these associations with microbiota data during late infancy and childhood, 
to confirm the programming hypothesis. The results of this thesis show the relevance to 
continue the Sophia Pluto Study as it provides very detailed measurements and allows 
to find important determinants of adult health and disease. 
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summary
Chapter 1
This chapter provides a general introduction to the different hypotheses with regard to 
influences of fetal size, birth weight and childhood growth on adult diseases. Potential 
early life determinants of these adult diseases are discussed. In addition, we describe our 
study populations, provide the aims of the studies performed, and present the outline 
of this thesis.
Chapter 2
Rapid catch-up in weight in early life has been associated with metabolic syndrome in 
adulthood. Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic meta-
bolic syndrome, but its association with rapid catch-up remained unknown. The fatty 
liver index (FLI) is an estimation of risk for NAFLD in the general population. We studied 
in 323 young adults born at term associations of birth weight, first-year gain in weight 
for length and rapid catch-up in weight with the fatty liver index (FLI) at 21 years. We 
showed that gain in weight for length in the first three months of life was associated 
with FLI as a continuous variable, whereas low birth weight was not. There were no sig-
nificant associations with γ-GT, ALT or AST. Of the subjects with rapid catch-up in weight 
for length, 27.8% had an intermediate or high FLI at the age of 21 years, compared with 
5.3% of subjects with slow catch-up. 
In conclusion, accelerated gain in weight for length in the first three months of life is 
associated with a higher risk for NAFLD in early adulthood, whereas small size at birth 
is not.
Chapter 3
We reported an association between accelerated catch-up in weight during infancy in 
subjects born at term and increased risk for NAFLD in early adulthood (see chapter 2), 
but this association had not been studied in subjects born preterm.
We describe, in 162 young adults born preterm, associations of birth weight, gain in 
weight for length and accelerated catch-up in weight in the first year after term age with 
the FLI and with individual biochemical markers of FLI as well as with other markers indi-
cating liver damage. We showed that accelerated gain in weight in the first three months 
after term age was associated with FLI as a continuous variable, whereas gestational age 
and low birth weight were not. Of the subjects with accelerated catch-up in weight for 
length after term age, 7.3 % had a high FLI at the age of 21 years, whereas none of the 
subjects without accelerated catch-up in weight had a high FLI.
In conclusion, accelerated weight gain after term age is associated with an increased 
risk of developing NAFLD in young adults born preterm.
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Chapter 4
Body composition in early life influences the development of obesity during child-
hood and beyond. Fetal growth and maternal factors might influence neonatal fat 
mass percentage (FM%), independent of birth weight. We studied in 194 healthy term 
neonates, within 24 hours after birth, body composition, measured by air-displacement 
plethysmography (Peapod), and its associations with estimated fetal weight (EFW), neo-
natal anthropometric data and maternal preconceptional BMI and weight gain during 
pregnancy. There was a large variation in neonatal FM%, even in case of a similar birth 
weight, corrected for gender and gestational age. Neonatal FM% was associated with 
EFW at 30 and 36 weeks of gestation and with catch-up in weight between 30 and 36 
weeks of gestation, but not with EFW at 20 weeks. Neonatal FM% was also associated 
with preconceptional BMI of the mother. There was no correlation with maternal weight 
gain during pregnancy. This study shows that term neonates have a large variation in fat 
mass percentage. 
In conclusion, neonatal FM% is associated with EFW at 30 and 36 weeks, catch-up in 
weight between 30 and 36 weeks of gestation and preconceptional BMI of the mother. 
Chapter 5
We investigated in 203 healthy term infants longitudinal body composition, including fat 
mass percentage (FM%) and fat-free mass (FFM), by air-displacement plethysmography, 
at 1, 3 and 6 months of age, and abdominal visceral fat and abdominal subcutaneous fat, 
by ultrasound, at 3 and 6 months. We found a significant increase in FM% between 1 and 
3 months, but not between 3 and 6 months. Girls had higher FM% than boys at 1 and 6 
months and less FFM than boys at 1, 3 and 6 months. There was a large variation in FM% 
at all ages, even between infants with similar weight SDS. Visceral fat and abdominal 
subcutaneous fat did not change between 3 and 6 months. FM% was highly correlated 
with abdominal subcutaneous fat, but not with visceral fat.
In conclusion, changes in FM% mainly occur in the first 3 months of life, and FM%, 
visceral and abdominal subcutaneous fat do not change between 3 and 6 months, sup-
porting the concept of a critical window for adiposity development in the first three 
months of life. In addition, this study provides longitudinal reference data of FM%, FFM, 
visceral fat and abdominal subcutaneous fat during the first 6 months of life.
Chapter 6
Accelerated gain in fat mass and particularly in visceral fat in the first months of life might 
be major risk factors for adult diseases, because fat mass tracks into adulthood. Infant 
growth, type of feeding and maternal variables might influence the gain in weight, fat 
mass and visceral fat in early life. We investigated in 300 healthy term infants, longitudinal 
changes in fat mass percentage (FM%), measured by air-displacement plethysmography 
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(Peapod) at 1, 3 and 6 months of age in combination with changes in abdominal visceral 
and subcutaneous fat, measured by ultrasound, at 3 and 6 months, and their associations 
with infant growth, type of feeding and maternal variables. A higher gain in weight and 
FM% in the first 3 months of life was associated with a higher FM% at 3 and 6 months of 
age, whereas size at birth was not associated with FM% at 3 and 6 months. A higher gain 
in weight and FM% between 1 and 3 months was associated with more visceral fat at 3 
months and a higher gain in FM% between 3 and 6 months with more visceral fat at 6 
months. Exclusive breastfeeding (EBF) duration was associated with more subcutaneous 
fat, but not with more visceral fat. Maternal characteristics did not associate with infant’s 
fat mass and visceral fat at 3 and 6 months.
In conclusion, a higher gain in weight SDS and FM% in the first postnatal months leads 
not only to a higher FM%, but also to more visceral fat at 6 months of age and exclusively 
breastfed infants develop more subcutaneous fat. 
Chapter 7
Appetite regulating hormones, such as ghrelin and leptin, play a role in the regulation 
of food intake and energy balance and might influence body composition in later life. 
Studies on associations between appetite regulating hormones and body composition 
in early life are limited. We, therefore, investigated serum fasting levels of ghrelin, leptin, 
insulin, glucose-dependent insulinotropic peptide (GIP), pancreatic polypeptide (PP) 
and peptide YY (PYY) in 197 healthy term infants at 3 and 6 months and associated these 
with type of feeding and body composition, including FM%, visceral and subcutaneous 
fat. Infants with exclusive formula feeding for 3 months had significantly higher serum 
levels of ghrelin, leptin, insulin, GIP and PP and lower serum levels of PYY at 3 months 
than breastfed infants. Leptin and ghrelin were positively correlated with FM% at 3 
months and insulin with change in FM% between 1 and 3 months. Leptin at 3 months 
correlated with subcutaneous fat at 3 months but not with visceral fat. Other appetite 
regulating hormones did not correlate with body composition.
In conclusion, formula fed infants had a very different profile of serum appetite regu-
lating hormones than breastfed infants, suggesting that lower levels of ghrelin, leptin 
and insulin in breastfed infants could contribute to the protective role of breastfeeding 
against obesity development. 
Chapter 8
Studies suggest a relationship between the compositional pattern of the gut microbiota 
and obesity in adults, but such data are very limited in infants. We, therefore, investigated 
in 51 healthy infants several fecal parameters, such as secretory immunoglobulin A (sIgA) 
and short chain fatty acids (SCFA) contents, and the composition of the microbiota at 1 
and 3 months of life, also in relation to type of feeding, infant’s body composition and 
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accelerated weight gain. Formula fed (FF) infants had lower levels of sIgA at 1 and 3 
months than their breastfed (BF) counterparts, but levels increased over time in contrast 
to BF infants. In FF infants, we found that a higher change in sIgA between 1 and 3 
months correlated with a higher increase in FM% between 1 and 3, and 3 and 6 months 
and that higher sIgA and acetic acid at 3 months correlated with more visceral fat at that 
age, while a higher level of propionic acid at 1 month correlated with a lower increase 
in FM% between 3 and 6 months. Besides higher levels of Firmicutes at 3 months, FF 
infants had no different microbiota compared to BF infants. Infants with accelerated 
weight gain had higher amounts of sIgA at 3 months and lower levels of butyric acid at 
1 month. Microbiota were not different between infants with and without accelerated 
weight gain at month 1, 3, or over time, although infants with accelerated weight gain 
had a significantly higher increase in Enterobacter compared to infants without acceler-
ated weight gain, which might contribute to a different metabolic programming and 
increase the risk for adult diseases.
Chapter 9
In this chapter, we discuss our findings in a broader context. We emphasize clinical 
implications and give suggestions for further research.
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samenvattIng
hoofdstuk 1
Dit hoofdstuk geeft een algemene inleiding over de verschillende hypotheses ten 
aanzien van invloeden van foetale groei, geboortegewicht en groei in de kindertijd op 
ziekten op de volwassen leeftijd. Mogelijke vroege determinanten van deze ziekten wor-
den ook besproken. Bovendien beschrijven we onze studiepopulaties, de doelstellingen 
van de uitgevoerde studies en de opzet van het proefschrift.
hoofdstuk 2
Niet-alcoholische vervetting van de lever (non-alcoholic fatty liver disease (NAFLD)) 
wordt gezien als het hepatisch metabool syndroom. Sommige studies hebben laten zien 
dat er een associatie is tussen te klein zijn bij geboorte en NAFLD. Versnelde toename 
van gewicht is meestal het gevolg van te klein zijn bij geboorte en is geassocieerd met 
het metabool syndroom, maar associaties met NAFLD zijn onbekend. We beschrijven de 
studie waarin we de associaties hebben onderzocht tussen geboortegewicht, eerste jaar 
toename in gewicht t.o.v. lengte en versnelde gewichtstoename met de Fatty Liver Index 
(FLI), een maat om NAFLD te voorspellen. We verrichtten onze studie in 323 jongvol-
wassenen en lieten zien dat gewichtstoename in de eerste 3 maanden van het leven 
is geassocieerd met de FLI als continue variabele en laag geboortegewicht niet. Er was 
geen associatie met gamma-gt, ALAT of ASAT. Van de jongvolwassenen met versnelde 
gewichtstoename t.o.v. lengte had 27.8% een gemiddelde of hoge FLI op de leeftijd van 
21 jaar, vergeleken met 5.3% van de jongvolwassenen met langzame gewichtstoename. 
We concluderen daarom dat versnelde gewichtstoename t.o.v. lengte in de eerste 3 
maanden is geassocieerd met een hoger risico op NAFLD op jongvolwassen leeftijd, 
terwijl te klein zijn bij geboorte niet geassocieerd is.
hoofdstuk 3
We hadden laten zien dat versnelde toename in gewicht t.o.v. lengte in op tijd geboren 
jongvolwassenen geassocieerd is met een verhoogd risico op NAFLD (zie hoofdstuk 
2), maar deze associatie was nog niet onderzocht bij jongvolwassenen die prematuur 
geboren waren. We beschrijven de studie waarin we de associaties hebben onderzocht 
tussen geboortegewicht, eerste jaar groei in gewicht t.o.v. lengte en versnelde gewich-
tstoename met de FLI in 162 prematuur geboren jongvolwassenen. We laten zien dat 
versnelde gewichtstoename in de eerste 3 maanden na de uitgerekende datum geas-
socieerd is met een hogere FLI. Zwangerschapsduur en laag geboortegewicht waren 
dit niet. Van de jongvolwassenen met versnelde gewichtstoename t.o.v. lengte na de 
uitgerekende datum had 7.3% een hoge FLI-score, terwijl geen enkele jongvolwassene 
zonder versnelde gewichtstoename dit had. We concluderen daarom dat ook in prema-
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tuur geboren jongvolwassenen versnelde gewichtstoename t.o.v. lengte in de eerste 3 
maanden na de uitgerekende datum geassocieerd is met een hoger risico op NAFLD op 
jongvolwassen leeftijd.
hoofdstuk 4
Lichaamssamenstelling in het vroege leven beïnvloedt de ontwikkeling van obesitas 
gedurende de jeugd en daarna. We beschrijven neonatale lichaamssamenstelling bin-
nen 24 uur na de geboorte en determinanten daarvan zoals foetale groei en maternale 
factoren. In 194 gezonde pasgeborenen onderzochten we de lichaamssamenstelling 
met behulp van air-displacement plethysmografie (Peapod) en analyseerden associa-
ties met geschat foetaal gewicht, neonatale antropometrische data en maternaal BMI 
voor de zwangerschap en gewichtstoename van moeder in de zwangerschap. Er was 
een grote variatie in neonataal vetpercentage, zelfs als er sprake was van een zelfde 
gewicht, ook na correctie voor geslacht en zwangerschapsduur. Neonatale FM% was 
geassocieerd met het geschatte foetale gewicht op 30 en 36 weken zwangerschapsduur 
en met snelle inhaalgroei in gewicht tussen 30 en 36 weken zwangerschapsduur, maar 
niet met het geschatte foetale gewicht op 20 weken. Neonataal vetpercentage was ook 
geassocieerd met de BMI van de moeder vóór de zwangerschap. Er was geen correlatie 
met gewichtstoename van moeder in de zwangerschap. Onze conclusies zijn dat er een 
grote variatie in neonataal vetpercentage kan zijn, zelfs als er sprake is van een zelfde 
gewicht en dat neonataal vetpercentage is geassocieerd het foetale gewicht op 30 en 36 
weken zwangerschapsduur, catch-up in foetaal gewicht tussen 30 en 36 weken en met 
de BMI van moeder voor de zwangerschap.
hoofdstuk 5
We onderzochten in 203 gezonde à terme zuigelingen longitudinaal de lichaams-
samenstelling, inclusief het vetpercentage en de vetvrije massa, door middel van de 
Peapod, op 1, 3 en 6 maanden en abdominaal visceraal en subcutaan vet, door middel 
van ultrasound, op 3 en 6 maanden. We vonden een significante stijging in vetpercent-
age tussen 1 en 3 maanden, maar niet tussen 3 en 6 maanden. Meisjes hadden een 
hoger vetpercentage dan jongens op 1 en 6 maanden en minder vetvrije massa op 1, 
3 en 6 maanden. Er was een grote variatie in vetpercentages op alle leeftijden, zelfs 
tussen zuigelingen met een zelfde gewicht SDS. Visceraal en subcutaan vet veranderde 
niet tussen 3 en 6 maanden. We zagen dat het vetpercentage sterk gecorreleerd was 
met subcutaan vet, maar niet met visceraal vet. We concludeerden dat veranderingen 
in vetpercentage met name optreden in de eerste 3 maanden van het leven en dat het 
vetpercentage, visceraal en subcutaan vet niet meer significant veranderen tussen 3 
en 6 maanden. Onze data ondersteunen het concept van een kritische periode voor 
adipositas ontwikkeling in de eerste drie maanden van het leven. Bovendien voorziet 
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deze studie in longitudinale referentie data van vetpercentage, vetvrije massa, visceraal 
en subcutaan vet gedurende de eerste 6 maanden van het leven.
hoofdstuk 6
Versnelde toename in vetmassa en met name visceraal vet in de eerste maanden van 
het leven kunnen risicofactoren zijn voor de ontwikkeling van ziekten op de volwassen 
leeftijd omdat vetmassa de neiging heeft tot “tracking” tot in de volwassenheid. Groei 
in de eerste maanden van het leven, alsmede het type voeding en maternale variabelen 
zouden de toename in gewicht, vetmassa en visceraal vet kunnen beïnvloeden. We 
onderzochten de ontwikkeling in vetpercentage, gemeten met de Peapod, op 1, 3 en 6 
maanden en visceraal en subcutaan vet, gemeten met de ultrasound, op 3 en 6 maanden 
en de associaties met de toename in gewicht in de eerste maanden, het type voeding en 
maternale variabelen. We vonden dat een hoger gewicht en vetpercentage tussen 1 en 
3 maanden geassocieerd was met een hoger vetpercentage op 3 en 6 maanden, terwijl 
geboortegewicht dat niet was. Een grotere toename in gewicht en vetmassa in de eerste 
3 maanden was ook geassocieerd met meer visceraal vet op 3 maanden en een grotere 
toename in vetmassa tussen 3 en 6 maanden met meer visceraal vet op 6 maanden. De 
duur van het exclusief borstvoeding geven was geassocieerd met meer subcutaan vet, 
maar niet met meer visceraal vet. Maternale variabelen waren niet geassocieerd met 
het vetpercentage en het visceraal vet op 3 en 6 maanden. Onze conclusie is dat een 
grotere toename van gewicht SDS en vetpercentage in de eerste maanden van het leven 
niet alleen leidt tot een hoger vetpercentage, maar ook tot meer visceraal vet en dat 
zuigelingen die exclusief borstvoeding krijgen meer subcutaan vet ontwikkelen.
hoofdstuk 7
Eetlustregulerende hormonen, zoals ghreline en leptine, spelen een rol in de regulatie 
van voedselinname en energiebalans en kunnen mogelijk de lichaamssamenstelling 
later in het leven beïnvloeden. Studies naar associaties tussen eetlustregulerende 
hormonen en lichaamssamenstelling in de eerste maanden van het leven zijn beperkt. 
Daarom onderzochten we in 197 gezonde zuigelingen op de leeftijd van 3 en 6 maan-
den de serum spiegels van ghreline, leptine, insuline, glucose-afhankelijke insulinotrope 
peptide (GIP), pancreatisch polypeptide (PP) en peptide YY (PYY) en associeerden deze 
met het type voeding en de lichaamssamenstelling, waaronder vetpercentage, visceraal 
en subcutaan vet. Zuigelingen met flesvoeding gedurende 3 maanden vanaf geboorte 
hadden op de leeftijd van 3 maanden significant hogere spiegels van ghreline, lep-
tine, insuline, GIP en PP, en lagere spiegels van PYY dan de borstgevoede zuigelingen. 
Leptine en ghreline waren positief gecorreleerd met vetpercentage op 3 maanden en 
insuline met de verandering in vetpercentage tussen 1 en 3 maanden. Leptine was op 
3 maanden ook gecorreleerd met subcutaan vet, maar niet met visceraal vet. De andere 
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eetlustregulerende hormonen waren niet gecorreleerd met lichaamssamenstelling. 
Onze conclusie is dat de flesgevoede zuigelingen een heel ander profiel van eetlust-
regulerende hormonen hebben dan borstgevoede zuigelingen, hetgeen suggereert dat 
de lagere spiegels van ghreline, leptine en insuline in borstgevoede zuigelingen een rol 
kunnen spelen in de gevonden bescherming tegen de ontwikkeling van overgewicht. 
hoofdstuk 8
Studies suggereren een relatie tussen de samenstelling van de darmflora en obesitas 
bij volwassenen, maar data in zuigelingen zijn beperkt. Daarom onderzochten we in 
51 gezonde zuigelingen diverse fecale parameters, zoals secretoir IgA (sIgA) en korte 
keten vetzuren en de bacteriële samenstelling van de darmflora op 1 en 3 maanden 
en ook in relatie met type voeding, lichaamssamenstelling en versnelde gewichtstoe-
name. Flesgevoede zuigelingen hadden lagere sIgA spiegels op 1 en 3 maanden dan 
borstgevoede zuigelingen, maar deze spiegels stegen in de tijd in tegenstelling tot bij 
de borstgevoede zuigelingen. In flesgevoede zuigelingen vonden we dat een grotere 
toename in sIgA tussen 1 en 3 maanden gecorreleerd was met een grotere toename in 
vetpercentage tussen 1 en 3 maanden en tussen 3 en 6 maanden en dat hogere sIgA 
en azijnzuur spiegels op 3 maanden gecorreleerd waren met meer visceraal vet op die 
leeftijd, terwijl een hogere waarde van propionzuur op 3 maanden gecorreleerd was 
met een kleinere toename in vetpercentage tussen 3 en 6 maanden. Behoudens grotere 
aanwezigheid van Firmicuten waren er geen verschillen in darmflora tussen fles- en 
borstgevoede zuigelingen. Zuigelingen met versnelde gewichtstoename in de eerste 
3 maanden hadden hogere spiegels van sIgA op 3 maanden en lagere spiegels van 
butyraat op 1 maand. De darmflora op 1 en 3 maanden was niet verschillend tussen zui-
gelingen met en zonder versnelde gewichtstoename, al zagen we wel dat zuigelingen 
met versnelde gewichtstoename meer toename in Enterobacter hadden ten opzichte 
van de zuigelingen zonder versnelde gewichtstoename, en dat kan betekenen dat deze 
bacterie kan bijdragen aan de verschillen in metabole programmering en de toename 
in risico’s op ziekten op de volwassen leeftijd.
hoofdstuk 9
In dit hoofdstuk worden de resultaten van de verschillende studies besproken in een 
bredere context. Wij sluiten dit hoofdstuk af met algemene overwegingen en suggesties 
voor toekomstig onderzoek.
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lIst of aBBrevIatIons
ADP  air-displacement plethysmography 
AGA  appropriate for gestational age
ALP  alkaline phosphatase
ALT  alanine aminotransferase
AST  aspartate aminotransferase
AWG  accelerated weight gain
BF  breastfeeding
BMI  body mass index
CNS  central nervous system
CU  catch-up
CVD  cardiovascular disease
DM2  type 2 diabetes
DXA  dual-energy x-ray absorptiometry
EBF  exclusive breastfeeding
EFW  estimated fetal weight
FF  formula feeding
FFM  fat-free mass
FFM%  fat-free mass percentage
FLI  Fatty Liver Index
FM  fat mass
FM%  fat mass percentage
GIP  glucose-dependent insulinotropic peptide
γ-GT  gamma-glutamyltransferase
HDLc  high density lipoprotein cholesterol
IQR  interquartile range
LDLc  low density lipoprotein cholesterol
MR  multiple regression
MRI  magnetic resonance imaging
NAFLD  non-alcoholic fatty liver disease
NASH  non-alcoholic steatohepatitis
n-AWG  non-accelerated weight gain
PI  ponderal index
PP  pancreatic polypeptide
PYY  peptide YY
SCFAs  short-chain fatty acids
SDS  standard deviation score
SES  socio-economic status
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SGA  small for gestational age
sIgA  secretory immunoglobulin A
TG  triglycerides
US  ultrasound
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summary of phd training
Year Workload 
(ECTS)
General courses
Good Clinical Practice, Erasmus MC 2012 1.0
Biostatistical Methods, Basic Principles, NIHES, Erasmus MC 2012 5.7
Integrity in scientific research, Erasmus MC 2012 2.0
Biomedical English Writing and Communication, Molmed, Erasmus MC 2014 4.0
Specific courses
Basic and Translational Endocrinology 2012 2.2
Pubmed and Endnote, Medical Library, Erasmus MC 2013 0.3
Radiation protection 5A, Zorgacademie, Erasmus MC 2012 1.0
Photoshop & Illustrator CS5, Molmed, Erasmus MC 2014 0.3
Indesign CS5, Molmed, Erasmus MC 2014 0.3
Microsoft Access 2010: Basic & Advanced 2014 0.7
Seminars and workshops
Annual PhD day 2012-2013 0.6
Annual Research Day, Sophia Children’s Hospital 2013-2014 0.6
Annual Interclinical evening 2012-2015 0.3
Weekly research meetings, department of Pediatric Endocrinology 2011-2015 4.0
Research and social media 2014 0.3
International and national conferences
Developmental Origins of Health and Disease Satellite Meeting 2012: 
New Developments in Developmental Epidemiology, Rotterdam (poster 
presentation)
2012 0.3
8th World Congress on Developmental Origins of Health and Disease, 
Singapore, Singapore (2x Poster presentation)
2013 1.0
53rd Annual European Society for Pediatric Endocrinology Meeting, Dublin, 
Ireland (oral presentation)
2014 1.0
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48th Annual meeting of the European Society for Pediatric Gastroenterology, 
Hepatology and Nutrition, Amsterdam (poster presentation)
2015 1.0
54rd Annual European Society for Pediatric Endocrinology Meeting, Barcelona, 
Spain (poster presentation)
2015 1.0
1st Peapod User meeting, Rome (expert-opinion) 2015 0.3
Lecturing
Lecture Refer evening Metabolism, Endocrinology and Feeding 2015 0.5
Annual IMC Weekendschool day “Growth and Development”, Rotterdam 2013-2014 1.0
Other
Planning weekly research meetings of the department of Pediatric 
Endocrinology
2011-2015 2.0
11
Dankwoord 193
dankwoord
De afgelopen vier jaar heb ik met veel enthousiasme aan dit proefschrift gewerkt. Ik heb 
in deze jaren veel mogen leren en ontzettend veel slimme, lieve en leuke mensen leren 
kennen. Zonder jullie inzet en steun was dit nooit gelukt. Ik wil graag een aantal mensen 
in het bijzonder bedanken.
Als eerste wil ik alle kinderen en hun ouders bedanken voor hun inspanningen en 
enthousiasme voor de Sophia Pluto Studie. Zonder jullie deelname had ik dit proef-
schrift niet kunnen schrijven. Ik heb velen in de afgelopen jaren zien groeien en vond 
het bijzonder om te zien hoe de kinderen zich ontwikkelden en hoe ouders de rol als 
ouder aannamen.
Mijn promotor, prof. dr. A.C.S Hokken-Koelega. Beste Anita, ik wil u bedanken voor 
de door u geboden kans om onderzoek te doen binnen de kinderendocrinologie. De 
afgelopen jaren heb ik veel geleerd en ben ik persoonlijk gegroeid. Uw kritische blik, 
heldere visie, gedrevenheid en passie bewonder ik enorm aan u. Ik ben heel erg blij dat 
ik uw promovenda heb mogen zijn! Enorm bedankt!
Prof. dr. A.J. van der Lelij. Graag wil ik u bedanken voor uw bereidheid om plaats te ne-
men als secretaris in de kleine commissie en het beoordelen van mijn proefschrift.
Prof. dr. H. Labefer. Hartelijk dank voor het beoordelen van mijn proefschrift en het 
plaatsnemen in de kleine commissie.
Dr. K.K. Ong. Thank you very much for taking place in the reading Committee.
Dr. L.C. de Graaff, beste Laura, ik wil je bedanken voor het plaatsnemen in de commissie.
Dr. D. Acton, beste Dennis, je bent al vanaf het begin betrokken geweest bij de Sophia 
Pluto Studie dus ik vind het erg mooi dat je plaats wilde nemen in mijn promotiecom-
missie.
Prof.dr. J.B. van Goudoever. Hartelijk dank voor uw bereidheid deel te nemen aan de 
promotiecommissie.
Prof.dr. F. de Zegher. Veel dank voor het plaatsnemen in mijn promotiecommissie.
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Prof.dr. I.K.M. Reiss. Ook u wil ik hartelijk danken voor de bereidheid plaats te nemen in 
mijn promotiecommissie.
Sandra de Kort, dankjewel voor het vervullen van de rol als onafhankelijk arts voor de 
Sophia Pluto Studie. 
Nutricia Research, en in het bijzonder Marieke en Dennis. Bedankt voor het meedenken 
bij de verschillende facetten die aan bod kwamen tijdens mijn promotie-onderzoek en 
bedankt voor de prettige samenwerking bij de verschillende manuscripten. Daarnaast 
natuurlijk hartelijk dank voor de financiële ondersteuning van de Sophia Pluto Studie. 
De betrokken medewerkers van ziekenhuizen, geboortehotels en Centra voor Jeugd en 
Gezin (CJG), waar we ouders hebben mogen informeren over de Sophia Pluto Studie: 
Sophia Kinderziekenhuis, Sint Franciscus Gasthuis, Vlietland ziekenhuis, Maasstad ziek-
enhuis, Ikazia ziekenhuis, IJsselland ziekenhuis, Geboortehotel Sophia, Geboortehotel 
Maasstad, CJG Eudokiaplein, CJG Prins Alexander, bedankt!
Dr. E de Lucia Rolfe. Dear Ema, thank you for learning us how to use the ultrasound 
to measure visceral and subcutaneous fat thickness in infants and thank you for our 
pleasant collaboration.
Medewerkers van het lab van Nutricia, in het bijzonder Sebastian Tims, dankjewel voor 
al je hulp aangaande het microbiome-manuscript en de prettige samenwerking, door 
jou ben ik een hoop wijzer geworden op dit vlak.
Medewerkers van het vasculaire lab van het Erasmus MC, in het bijzonder Leonie van 
der Zee, bedankt voor alle hulp en flexibiliteit bij het meten van de Milliplex-bepalingen.
Alle co-auteurs van de manuscripten in dit proefschrift wil ik van harte bedanken voor 
de samenwerking.
De Vereniging Trustfonds wil ik bedanken voor de financiële bijdragen voor de jaarlijkse 
kinderendocrinologie-congressen.
Medewerkers van het Trial Lab, met name Monique de Waart, voor de praktische zaken 
omtrent de Sophia Pluto Studie. 
Dr. E. L. T. van den Akker, beste Erica, bedankt voor de prettige samenwerking en het 
meedenken en discussiëren tijdens de endobesprekingen.
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Medewerkers Stichting Kind en Groei, met name Ineke, dank je wel voor je hulp de 
afgelopen jaren!
Al mijn collega’s uit de kelder van het Sophia; Merel, Ingrid, Joke, Annette, Marianne M., 
Rineke, Jacqueline, bedankt voor jullie gezelligheid en interesse, het was een fijne tijd 
bij jullie.
De researchverpleegkundigen. Tja, wat had ik zonder jullie gekund? Janneke, Marianne, 
Christel en Esther, ontzettend bedankt voor jullie betrokkenheid, inzet en gezelligheid. 
Janneke, dankjewel voor al je hulp, het wegwijs maken in onderzoeksland, je goede 
adviezen en eerlijkheid. Marianne, dank voor je goede ideeën en al je hulp. Chris(tel), 
toen het allemaal wat drukker werd, kwam jij als reddende engel. Door jou konden we 
ook de vrijdagen helemaal gaan volplannen en dat gebeurde ook, gelukkig liet ook jij je 
niet gek maken. Esther, dankzij jou kregen we het voor elkaar om onze inclusie-aantallen 
te halen, dank daarvoor. Ondanks dat we elkaar niet veel zagen, was het altijd gezellig!
Naast de researchverpleegkundigen van de Sophia Pluto Studie, wil ik ook de endo-
researchverpleegkundigen van de andere studies bedanken. Berber, wat fijn om jou als 
collega te hebben, altijd geïnteresseerd, enthousiast en in voor een lunch! José, Jorien 
en Mariëlle, bedankt voor jullie gezelligheid bij de lunches en biosavondjes.
Endo-collega’s uit verleden, heden en de toekomst: Annemieke, Elbrich, Gerthe, Petra, 
Yvonne, Florentien, Judith, Lidewij, Sinddie, Nienke, Stephany, Renske, Manouk, Lin en 
Kirsten. Ik kon altijd bij jullie terecht om over mijn onderzoek te discussiëren, maar vooral 
ook om even gezellig te kletsen. We hebben heel wat gezellige momenten met z’n allen 
meegemaakt, bedankt daarvoor! Gerthe, dank je wel voor al je inzet en hulp tijdens het 
inwerken van mij en tot ver daarna. Je bent de afgelopen 4 jaar mijn voorbeeld geweest. 
Kirsten, heel veel succes en plezier bij het voortzetten van de Sophia Pluto Studie! Lieve 
Renske en Manouk, lieve paranimfen, bedankt voor jullie behulpzaamheid, gezelligheid 
en belangstelling!
Alle Z-flat collega’s, in de Z-flat begonnen en na een paar jaar Sophia weer teruggeko-
men, Suzanne, Charlotte, Sandra, Marjolein, Sjoerd, Nienke, Nynke, Yuen, Karlijn, Esther, 
Maarten, Dwight, Gertrude, Badies, Eva, Marijke en natuurlijk Noortje, dank jullie wel 
voor al de gezellige momenten!
Alle andere collega-onderzoekers van het Sophia. Dank je wel voor de gezellige lunches, 
SOV-borrels, nieuwjaarsdiners, biosavonden en natuurlijk de fantastische Sophie-op-
de-Ski-weekenden en het survivalweekend. 
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Vrienden uit de Pasta-Peper-Saus-groep, Joppe en Francine, Martin en Paula, Lars en 
Noortje, Nolan en Marion en Bart en Pleunie, bedankt voor alle feestjes, etentjes en de 
gezelligheid, op naar nog veel meer gezellige momenten!
Mijn lieve turnvriendinnen, Olke, Carina en Carline, wat is het altijd gezellig om met jullie 
af te spreken, misschien de laatste tijd iets minder frequent, maar dat gaat zeker weer 
goed komen!
Lieve dansvrienden en vriendinnen, en in het bijzonder Christa en Marcel, jullie hebben 
altijd gezorgd voor een hoop gezelligheid op de zondagavond (en op een hoop andere 
avonden ook). Ondanks de drukte was ik altijd volledig ontspannen na een avondje 
dansen!
Vriendinnen van de middelbare school; José, Tanja, Marlous, Sandra, Femke, Puck, be-
dankt voor alle gezellige etentjes, weekendjes weg, het lachen en nog veel meer. 
Marieke, lieve studie-vriendin, ook van jou word ik altijd heel blij! De afgelopen jaren 
heb je me geholpen door met verhelderende ideeën te komen, andere inzichten, maar 
met name ook door me te steunen en een hart onder de riem te steken op momenten 
dat het onderzoek niet vanzelf liep. Je nuchtere gezelligheid waardeer ik enorm aan je!
Anna, Nina, Michelle en Carolien, met jullie heb ik sinds de basisschool cq. middelbare 
school super veel mooie momenten meegemaakt, jullie betekenen heel veel voor mij en 
ik voel me gezegend met zulke leuke en lieve vriendinnen!!
Mijn schoonfamilie, Elly, Geniu, Aniela en Jules. Wat heb ik een geluk met jullie, bedankt 
dat jullie er altijd voor mij zijn, en knap hoe jullie altijd vol interesse hebben geluisterd 
naar mijn onderzoeksverhalen!
Tjeerd en Daniëlle, mijn lieve broer en schoonzus. Tjeerd, wat hebben we vroeger veel 
ruzie gehad, maar wat is het toch leuk geworden om jou als broer te hebben. Jouw 
energie en enthousiasme voor je werk herken ik ook in mezelf en jouw meedenken op 
allerlei vlakken tijdens mijn promotie heb ik enorm gewaardeerd. Samen met Daan heb 
je het goed voor mekaar in Utrecht en ik wens jullie alle geluk!
Tom, mijn andere lieve broer(tje), ook met jou ben ik heel blij. Een super gezellige, leuke 
broer, waarmee ik altijd een hoop lol kan beleven! Ook al snap je niks van de medische 
wereld, jij bent weer heel goed op andere vlakken! Ik weet zeker dat je een hele mooie 
toekomst tegemoet gaat!
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En dan natuurlijk nog Melanie, lieve Melanie, ook al ben je dan maar half mijn zusje, het 
gevoel is er niet minder om.
Lieve pap en Monique, jullie hebben altijd vol interesse naar mijn onderzoeksperikelen 
en “baby”-verhalen geluisterd, bedankt daarvoor.
Lieve mam en Rob, de afgelopen jaren zijn niet makkelijk geweest voor jullie. Zoek-
tochten naar banen, ziek worden van Rob, weer opklimmen, weer hard zakken en toch 
weer opklimmen, maar toch positief blijven en er het beste van maken. Ondanks jullie 
eigen problemen, stonden jullie altijd voor mij klaar. Dank jullie wel voor jullie rotsvaste 
vertrouwen in mij.
Last but not least, Stefan. Allereerst excuses voor die eindeloze verhalen over baby’s, 
analyses en artikelen. Dank voor je luisterende oor, wat fijn dat je na 12,5 jaar nog steeds 
naar mij wilt luisteren. Dank je wel voor je onvoorwaardelijke liefde, je geduld, je begrip 
en je hulp! Samen kunnen we de hele wereld aan!
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CurrICulum vItae
Laura M. Breij was born in Gouda, the Netherlands on July 12, 1986. She received her 
Gymnasium degree at the St.-Antoniuscollege in Gouda in 2004. In the same year she 
started her medical training at the Medical Faculty of the Erasmus University of Rotter-
dam. She finished the theoretical part of medical school in 2008. Her graduate research 
focused on transition in care in children with Inflammatory Bowel Diseases (supervisor 
Prof. dr. J.C. Escher). In 2008, she started her medical internships and as part of her clini-
cal training, she did an elective internship at the department of pediatrics at the Mater 
Dei Hospital in Malta. She concluded her internships at the department of pediatrics at 
the Reinier de Graaf Gasthuis in Delft.
Laura worked at the department of pediatrics in the Maasstad Ziekenhuis for almost 
a year, after which she started her PhD in 2011. She was supervised by Prof. dr. A.C.S. 
Hokken-Koelega, pediatric endocrinologist at the Erasmus Medical Center-Sophia Chil-
dren’s hospital in Rotterdam. The research performed during this PhD is presented in 
this thesis. 
Laura is currently working as a resident at the department of pediatrics in Noordwest 
Ziekenhuis Groep (MCA Alkmaar) and lives in Heerhugowaard with the love of her life 
Stefan Kowalski.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
